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Abstract 
Assessment of treatment outcome in clinical trials of temporomandibular disorders (TMD) 
lacks validated patient-based measures of the condition and its improvement. Such measures 
are questionnaire-based. The questions need to be chosen and framed appropriately. In line 
with the guidelines of the National Institute for Health and Clinical Excellence in the U. K., 
this project aimed to start the development of a patient-derived quality of life instrument to 
measure TMD treatment outcome. Three studies were conducted for this purpose. 
Study One aimed to establish the optimal time to assess treatment outcome for TMD (the 
Review Period), and the best Reference Period to determine the time-frame of questions. Data 
consisted of daily diaries of pain intensity from 72 patients who had participated in a clinical 
trial of conservative TMD treatment. The study involved two stages. The first aimed to 
identify patients responding to treatment, so-called "Improvers" and to exclude the "Non- 
Improvers" whose data might dilute the results. This was accomplished in two ways: firstly by 
visually assessing individual plots of pain versus time; secondly by mathematically calculating 
the reduction of pain scores during treatment. Criteria for improvement were set and tested for 
both methods. Definite improvers were selected if they met criteria of both assessments. In 
the second stage, only improvers' data were examined to analyse the general trend of 
improvement and establish the review and reference periods. Study One determined 15 weeks 
as the best review period and four weeks as the best reference period when assessing a 
commonly used TMD treatment. 
Study Two was intended to triangulate with Study One and had the same aim. Study Two 
explored, using a qualitative approach, patients' perception of improvement of TMD 
symptoms and rates of their recovery. Ten TMD patients showing improvement to 
conservative treatment were interviewed. Data were collected using a pre-designed topic 
guide and analysed using the Framework approach. The interviewees consistently reported 
X 
that pain was the symptom with the most impact on their quality of life, and the one to which 
improvement was linked the most. Other TMD symptoms were also important, but were less 
linked to patients' suffering and to perceived improvement. Different symptoms followed 
various rates of recovery. It was not possible to determine a definite time when all symptoms 
are considered improved. This study confirmed that the approach used in Study One, i. e. 
assessing TMD recovery based on measurement of pain intensity, was reasonable. It also 
confirmed that sufficient time (in a frame of some months) is needed before outcome for 
TMD conservative treatment can be assessed meaningfully. In addition, this study identified 
important new themes related to patient's journey throughout illness and their perception of 
received care. 
Study Three was the core study in this project. It aimed to establish a quality of life 
measure of TMD treatment outcome using the Oral Health Impact Profile (OHIP) as a starting 
point, using the reference period identified in studies one and two. A short form of OHIP was 
derived by identifying OHIP items with the largest impact on TMD patients' quality of life. A 
case-control design was used and 110 patients (PG) undergoing a variety of conservative 
treatments and matching controls (CG) were included. Candidate questions (items) for the 
intended short form (OHIP/TMD-I) were selected based on three criteria: 1- showing statistical 
differences between PG and CG; 2- showing largest score difference (PG: CG) as measured by 
four analyses: Mean, Median, Prevalence and Item-Impact; 3- representing all domains of OHIP's 
theoretical framework. This was followed by testing aspects of validity and reliability of the 
short form and comparing them to those of the full OHIP. Twenty items were identified. Their 
psychometric properties were comparable or better than those of the mother instrument. 
Future work is needed to analyse the responsiveness to change with treatment of the short 
form, to investigate whether items outwith OHIP are needed to furnish the intended TM) outcome 
instrument, and to test the psychometric properties of the final instrument in a new sample. 
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Chapter 1. 
Introduction to project 
Chapter 1. Introduction to project 
Over the past decades, emphasis has been increasingly given in health research to use a 
comprehensive biopsychosocial model of "illness" in lieu of the old biomedical model of 
"disease" that has failed to account for the various psychological and psychosocial variables, 
essential elements in the aetiology and recovery of illness (Dworkin and Massoth, 1994). 
Health care regulatory bodies recommend that patients' quality of life (QOL) should be 
considered as a principal element of outcome assessment (National Institute for Health and 
Clinical Excellence, 2006). They stress the fact that what matters is how patients feel and not 
how professionals think they feel. This becomes especially essential when dealing with 
chronic disorders, where patients' experience and suffering extend over long periods. 
Temporomandibular Disorders (TMD) are recognised as chronic disorders affecting the 
temporomandibular joints, muscles of mastication or both. These, like other chronic pain 
conditions affect patients' quality of life, and should be assessed using a multi-axial 
biopsychosocial approach. There is a lack, however, of outcome measures that incorporate 
this model in research on TMD clinical trials. 
This project aimed to start the development of a patient-based quality of life measure of 
TMD treatment outcome. It involved three stages. The first and second stages shared the same 
aim, which was to establish the optimal time to conduct the outcome assessment (Review 
Period), and the best time frame for patients to retrospectively assess impact of treatment on 
quality of life (Reference Period). Using quantitative methods in Study One and a qualitative 
approach in Study Two, data from patients undergoing conservative TMD treatments were 
analysed to examine rates of recovery and to consequently determine the above review and 
reference periods. 
The third stage of the project sought to develop a quality of life measure of TMD 
treatment outcome, based on a well established measurement of oral health-related quality of 
life (OHrQOL), the Oral Health Impact Profile (OHIP) (Slade and Spencer, 1994). OHIP has 
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been successfully used to measure the impact of TMD and orofacial pain on quality of life 
(Murray et al., 1996; John et al., 2002; Larsson et al., 2004; Segü et al., 2005). However, 
many of OHIP's 49 items are apparently unrelated to TMD and would compromise its utility 
as a measure of TMD treatment outcome. Empirical attempts have been made to produce a 
TMD-related version by removing apparently items not related to TMD and by adding items 
that are considered relevant (Murray et al., 1996). That work, however, was not based on a 
strong scientific basis. Validated methods are available to distil long instruments, and have 
been used to derive condition-specific versions of OHIP, such as that designed for edentulous 
patients (OHIP-EDENT) (Allen and Locker, 2002). 
The main thrust of this present work was to derive a TMD-specific version of OHIP 
using a rational process, taking into consideration the time-frame identified in Study One and 
Study Two. Having developed a prototype of the instrument, some aspects of its validity and 
reliability have been explored. 
The present project completed the principal stage of the development of a TMD quality 
of life outcome instrument. Further work is needed to examine sensitivity to change with 
treatment of the proposed short form, to explore whether items additional to OHIP are needed 
and to establish the psychometric properties of the final product. 
Chapter 2. 
Review of the literature 
Chapter 2. Review of the literature 
2.1. Introduction to the literature review 
This review consists of five sections. It starts with a section on the definition of the 
temporomandibular disorders (TMD) and their position within other chronic illnesses. The 
section introduces the concept of assessing these conditions taking into consideration 
psychological and psychosocial factors as well as the physical element of the illness. 
Examples of instruments used for the assessment of TMD are presented with a report on the 
lack of specific quality of life related measures. 
Section two looks at TMD and other chronic disorders from a wider angle. It considers 
these conditions under the general umbrella of health, and stresses the need to assess these 
conditions within the multidimensional concept of health and illness. This section expands 
more on the importance of patient-based assessment of own health and on the concept of 
quality of life. It outlines the different dimensions under which treatment outcome should be 
evaluated, especially in chronic pain conditions. 
Section three illustrates the different patient-based methods of health assessment. Both 
qualitative and quantitative methods are considered, including their advantages, disadvantages, 
proper applications and psychometric properties. 
Timing of outcome assessment is an essential element in the success of such assessment. 
Section four examines the importance of two time periods in relation to outcome assessment: 
the optimal time to conduct this assessment (the Review Period) and the time-frame used in 
the assessment (the Reference Period). This section also reports the lack of validated review 
and reference periods for TMD. 
The last section reviews the literature for available measures of oral health-related quality 
of life (OHrQOL), with a brief examination of their types and applications. This is followed 
by a detailed review of the Oral Health Impact Profile (OHIP), the instrument used in this 
project. 
This review is concluded with a summary of the identified key points. 
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2.2. The Temporomandibular joint and its disorders 
2.2.1. Temporomandibular joint (TMJ) and masticatory system 
The TMJs provide the articulation of the mandible with the cranium (Figure 2.1), more 
specifically between the mandible condyle and the squamous part of the temporal bone, which 
are separated by a thin fibrous disc (Okeson, 2003). Movement of the mandible around the 
right and left joints is provided by means of a complex system of muscles and nerves. In 
addition, both the mandible and the disc are supported with ligaments to limit their 
movements. Teeth also play an important role in determining the path of the joint movements. 
This complex system of bones, discs, teeth, muscles, ligaments and nerves is referred to as the 
masticatory system. 
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The anatomical complexity of the joint provides compound functions. It enables the 
mandible to perform a large number of "food-free" movements such as opening, closing and 
excursion; and food-related (or masticatory) functions including incision and mastication. 
This is all regulated by the coordinated function of the muscles surrounding the mandible. 
Two types of movements are facilitated by the double-faced articulation of the disc, namely 
rotation of the condyle against the disc, and translation of the disc against the temporal bone. The 
TMJ is therefore classified as a hinge joint with a movable socket. 
Normal structure and function of this inter-correlated system are maintained through the 
harmoniously co-ordinated function of its parts. However, with this high level of complexity 
both in anatomy and function, it is not uncommon for "incidents" to occur, where some parts 
become affected by external factors. Not only may these components start to malfunction, but 
other parts of the system may become affected indirectly, often leading to a complex 
manifestation of signs and symptoms referred to as Temporomandibular Disorders (TMD). 
2.2.2. Temporomandibular disorders (TMD) 
The first article on TMD appeared in 1934, when James Costen, an otolaryngologist, reported 
"A Syndrome of Ear and Sinus Symptoms Dependent Upon Disturbed Function of the 
Temporomandibular Joint" (Costen, 1934). Since then a vast amount of research has been 
carried out on the TMJ and disorders of the masticatory system. But, because of the various 
conditions affecting these structures, workers, having come from different clinical and scientific 
backgrounds have failed to reach a consensus on nomenclature and definition. In this thesis I 
have chosen that of the American Academy of Orofacial Pain (McNeill et al., 1993): 
"Temporomandibular disorders (TMD) is a collective term embracing a 
number of clinical problems that involve the masticatory musculature, the 
temporomandibular joint (TMJ) and associated structures, or both ". 
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TMD presents clinically with different symptoms (Figure 2.2) including pain, clicking or 
grinding sounds in the joint; dysfunction and limitation in mouth opening and other movements. 
The pain is sometimes localised in the joint and/or the masticatory muscles, and at other times 
radiates to neighbouring areas to produce earache, headache, toothache and pain in the face 
and neck. 
TMD often co-exists with other craniofacial and orofacial pain disorders. It is considered 
a sub-classification of musculoskeletal disorders, including arthritis and fibromyalgia (Feine 
and Lund, 1997; Aaron et al., 2000) 
Figure 2.2. A sketch of the most common signs and symptoms in TMD* 
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1lcadpain 
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Side 
Back 
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* From (Suvinen et aL, 2005) 
Epidemiological studies on TMD are contradictory about its prevalence because of 
disagreement on the descriptive terminology, assessment and data collection methodology 
(Dworkin et al., 1990; LeResche, 1997b). A review of epidemiologic studies of TMD has 
estimated that 28-75% of the general population exhibit at least one sign e. g. joint noise or 
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tenderness to palpation and 33% have at least one symptom (Rugh and Solberg, 1985). These 
authors, however, reported that only 5% of the general population are in need for treatment. 
More recent studies have explored the prevalence of individual TMD signs and symptoms as 
opposed to that of TMD as a distinctive condition. Various signs and symptoms were found to 
differ in prevalence both amongst the patient and the general population (Dworkin et al., 
1990; Goulet et al., 1995; LeResche, 1997b). For example, amongst those seeking treatment 
for TMD, pain was found to be the most prevalent symptom (97%) compared to 43% 
presenting joint clicking and 20% exhibiting limited mouth opening (Dworkin et al., 1990). 
These signs were less common, but still exist in subjects without a clinical diagnosis of TMD. 
For example, the same study reported pain prevalence in the TM region (TMJ and relevant 
muscles) in 12% of the general population and joint clicking in 25%. Other joint sounds, i. e. 
crepitus and "grating" were found far less common both in the patient and general population 
(Dworkin et al., 1990). A more recent study on the prevalence of TMD signs and symptoms 
found that jaw pain, restricted jaw opening, and jaw clicking are the most common presenting 
symptoms amongst TMD patients, but reported different prevalence (Pow et al., 2001) (see 
below). 
While authors agree that signs associated with TMD occur quite commonly in the general 
population, they note that only 5-7% of the population seek evaluation and care (Rugh and 
Solberg, 1985; Schiffman et al., 1990; McNeill et al., 1993; Goulet et al., 1995). These 
figures seem to be inconsistent across different populations. For example, the data from the 
USA reported above are higher than recent findings in a Hong Kong Chinese population. In 
the latter only 1% reported TMD-related jaw pain of moderate or severe intensity and 
frequent occurrence, and only 0.6% had sought treatment for jaw pain, impaired jaw opening, 
or joint clicking that occurred often in the previous year (Pow et al., 2001). 
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Prevalence of signs and symptoms in men and women varies between the general and 
patient populations. While the ratio of women to men is reported to be 1: 1 in the non-patient 
population (Helkimo, 1974b), studies on subjects seeking treatment showed that this ratio is 
between 3: 1 and 9: 1 (McNeill et al., 1993; LeResche, 1997b; Johansson et al., 2003). In 
relation to age, TMD sufferers are reported to be primarily young and middle-aged adults 
(McNeill et al., 1993; LeResche, 1997b). 
Although TMD is usually a self-limiting condition, a significant number of patients 
develop a chronic pain syndrome (Dworkin eta!., 1990; McNeill et al., 1993). This is defined 
as pain persistent for more than six months with associated behavioural and psychosocial 
factors (McNeill et al., 1993). 
2.2.3. Temporomandibular disorders -A multidimensional model 
Chronic pain patients respond to pain differently from acute pain patients (McNeill et al., 
1993). Ongoing (chronic) pain perception is exacerbated by other psychological factors 
including social situations, emotions (anger, fear) and attitudes (Kerns et al., 1985; Dworkin 
and LeResche, 1992; Turk, 1997; Crombez et al., 1999; Holroyd et al., 1999; Dworkin et al., 
2002a; Turk et al., 2003; Suvinen et al., 2005). The psychosocial dimension of chronic pain is 
well documented in the literature, and is covered in more detail in section 2.3.4. 
Accumulated evidence indicates that TMD shares the major characteristics of other 
chronic pain conditions such as headache and back pain (Dworkin and Massoth, 1994). 
Increasing attention has been given to the importance of studying TMD using the same 
biopsychosocial model used for common pain conditions (Dworkin and Massoth, 1994; 
Suvinen et al., 2005). The model encompasses three dimensions: the physical, psychological 
and psychosocial element (Figure 2.3). The need for this broad model to measure health and 
treatment outcomes is explored in more detail in section 2.3. The remainder of section 2.2, 
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however, reviews the various methods for the assessment of TMD patients within this model. 
Available instruments for assessment of the condition and treatment outcomes are discussed 
under the respective physical, psychological and psychosocial dimensions. 
Figure 2.3. Summary of the bio-psychological concept of TMD 
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* From (Suvinen et aL, 2005) 
It should be noted, however, that while this model is extensive, it does not take into 
consideration the recent recognition of the role of genetics as an internal factor explaining the 
variations among patients in pain perception (Diatchenko et al., 2005). 
The following sections review the literature on the assessment of TMD. While 
measurement of pain in general and in relation to TMD is reported elsewhere (sections 2.3.4 
and 2.4.4.4), pain-related impact on patients' lives is reported here. 
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2.2.4. TMD assessment - the physical dimension 
This section concerns the first dimension of the ternary model previously described. It reviews 
instruments used to diagnose TMD and monitor outcomes in terms of physical signs, functional 
ability and functional limitation of the masticatory system. 
2.2.4.1. TMD diagnostic systems 
Diagnostic systems provide either Case Definitions (i. e. classification and diagnostic criteria) 
or Examination Protocols, or both. Numerous TMD diagnostic systems have been developed 
since Bell first published his taxonomy in 1970 (Bell, 1970): 
1. Bell's classification of TMD (Bell, 1970) 
2. Farrar's taxonomy for TMJ Dysfunction Syndrome (Farrar, 1972) 
3. Helkimo's Dysfunction Indices (Helkimo, 1974a) 
4. Block's classification of craniofacial-cervical pain (Block, 1980) cited by Dworkin and 
LeResche (1992) 
5. The American Academy of Craniomandibular Disorders' classification (McNeill et al., 
1980; McNeill, 1983) 
6. Eversole and Machado's classification of "TMJ musculoligamentous derangements" 
(Eversole and Machado, 1985) 
7. The Craniomandibular Index, CMI (Fricton and Schiffman, 1986) 
8. The TMJ Scale (Lundeen et al., 1986; Levitt and McKinney, 1994) 
9. The American Academy of Head, Neck, Facial Pain, and TMJ Orthopaedics (AAHNFP& 
TMJO)'s classification (Talley et al., 1990) 
10. The Clinical Diagnostic Criteria, CDC (Truelove et al., 1992) 
11. The International Headache Society Classification (McNeill et al., 1993) 
12. The Research Diagnostic Criteria, RDC (Dworkin and LeResche, 1992) 
13. The Temporomandibular Index, TMI (Pehling et al., 2002). 
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Different attempts have been made to review and evaluate these systems, e. g. (Dworkin 
and LeResche, 1992; Clark et al., 1993; Okeson, 1997). The most comprehensive of these 
reviews is that conducted by the group who later established the RDC (Dworkin and 
LeResche, 1992). The scope of that review was to determine the performance of existing 
systems at that time with the final aim to establish a scientific diagnostic system that is valid 
for research purposes. The authors firstly decided the features that a scientific TMD classification 
system should have. These criteria consisted of methodological considerations and clinical 
applications (Table 2.1 below) and were used to examine existing diagnostic systems. In 
addition, the team took into consideration the comprehensiveness of patient assessment, 
predictive value of making a diagnostic assignment, and implications for choice of treatment. 
Nine diagnostic systems were included in the RDC review. These were systems that had 
a specific classification of TMD as their purpose. Systems that were not oriented toward TMD 
particularly (i. e. toward diseases or pain in general) or not formulated to collect the information 
which met RDC requirements (i. e. standard of evaluation or TMD diagnostic criteria) were 
excluded. 
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Table 2.1. Assessment criteria for T\1 I) diagnostic systems'}` 
Criterion Description Rating 
Methodological Considerations 
Case-series vs case control 
Sample method Study design for testing diagnostic criteria Cross-sectional vs longitudinal 
Prospective vs retrospective 
Population 
Sample type 2 Source of subjects used in testing diagnostic criteria Clinical 
Unknown 
Research suitability Whether criteria are stated in measurable terms 
Yes 
No 
Inter-rater reliability 
IRR for evaluation methods, according to whether 
internal-full 
Internal-partial 
(IRR) method 3 
data are provided by the proponents of the system and External-full 
whether all evaluation methods have IRR support External-partial 
Specificity 
Whether diagnostic criteria of a system detect 
" " 
Acceptable 
Unacceptable 
in a non-patient population disease Unknown 
IRR diagnosis 
IRR for whether different judges would make the 
Acceptable 
Unacceptable 
same diagnostic assignment unknown 
Clinical Considerations 
Biological 
Whether the system is compatible with current 
Strong 
Moderate 
anatomical, behavioural, and physiological knowledge Minimal 
Exhaustive 
Whether the system can classify all known clinical 
All 
Major 
presentations Minor 
Yes 
Multiple diagnoses Whether multiple diagnoses are allowed No 
Unknown 
Decision making 6 
Whether system is organized to facilitate decision Good 
making Poor 
* From (Dworkin and LeResche, 1992) 
If assessed as "None": study method is not identified 
The term "None" is used where no particular sample is used in the study 
Acceptable IRR are granted when a Kappa statistic was 6.0 or above. "Unknown IRR" is given to measures 
which have no IRR or are insufficiently operationalized 
4 The value of 0.75 determined whether or not the specificity is acceptable, and the "Unknown" term is used to 
describe lack of data 
5A Kappa value of 0.6 is used to determine the reliability. The term "Unknown" is given when data were not 
available 
6 Systems must meet the following to facilitate decision making: 
I. To be organized in a decision-tree concept 
2. Essential clinical characteristics required for assessing a diagnosis are clear 
3. A distinct diagnosis can be obtained through the criteria of each diagnostic category. 
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Based on the above-mentioned assessment criteria the RDC team found that: 
1. All systems, except Truelove's, contain statements which are not essential for the final 
diagnosis, which lead to a difficulty in the use of these taxonomies 
2. There were differences among diagnostic systems in classifying each TMD entity in the 
context of each system. Furthermore, there were contradictions among systems in 
determining specific TMD entities. RDC gives as an example behavioural phenomena such 
as "parafunctioning" 
3. RDC defined four problems regarding the terminology of TMD entities. These were: 
a. The lack of anatomical or physiological support for some hypothetical terms used in 
some systems. Examples for that were "Contracture " and "Myospasm " 
b. The use of statements that have causal implications to describe some terms (e. g. muscle 
splinting) 
c. The internal inconsistency between how a disorder is defined and what the stated 
essential criteria are 
d. The use of non-descriptive terms for some disorders (e. g. Arthritis) in a number of the 
diagnostic systems 
4. All diagnostic systems lacked the psychological assessment of patients. Nevertheless, the 
RDC recommended the need for further efforts to determine the essential variables in 
evaluating the psychological "dimension" of TMD patients, to classify these variables, and 
to agree on the best instrument for assessing this dimension 
5. The RDC team believed that aetiology, prognostic statements and implications for 
treatment are critical issues in assessing nomenclatural systems. Yet, since there is lack of 
knowledge in these domains, diagnostic systems cannot be judged properly. 
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In this project, I derived the physical diagnostic criteria from the RDC, and the 
examination form from the Temporomandibular Index TMI (Pehling et al., 2002). Details 
about these two systems are presented. 
2.2.4.2. The Research Diagnostic Criteria (RDC) 
RDC or RDC/TMD (Dworkin and LeResche, 1992) is one of the best known TMD diagnostic 
systems internationally (Yap, 2002). Unlike other diagnostic systems, both diagnostic 
components, i. e. case definitions and examination procedures are considered in the RDC. 
These diagnostic criteria are proposed for clinical and epidemiological research purposes, but 
not necessarily for clinical practice aims (Dworkin and LeResche, 1992). In addition, RDC is 
the only system that considers the psychological dimensions of TMD. Its examination 
procedures include two axes: assessment of the physical condition (axis I) and of pain-related 
disability and psychological status of the patient (axis II). 
The RDC product was first published in 1992 by a team headed by Samuel Dworkin and 
Linda LeResche (Dworkin and LeResche, 1992). It represented an interdisciplinary effort as 
its team comprised of recognised researchers and experts in different domains ranging from 
basic biological sciences to clinical dental and bio-behavioural sciences. Since they first 
published their original paper (Dworkin and LeResche, 1992), the RDC team have been 
revising and updating their work by testing the validity and reliability of several components 
of the physical examination and the psychological element. To further enhance the RDC, a 
web site' has been established to publish all studies related to the RDC. In addition, this site 
presents the RDC's history-taking questionnaire and evaluation forms in several languages2, 
with the aim of using it to collect multi-national data (Yap, 2002). 
I http: //rdc-tmdinternational. org/ 2 Fourteen languages up till March 2003, and additional 3 languages presented by December 2006. 
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The scope of the original RDC project was multiple: 
1. To critically assess the TMD diagnostic systems in use 
2. To critically appraise reliability and validity of TMD examination methods 
3. To standardize TMD examination procedure and measures 
4. To establish research diagnostic criteria for TMD 
5. To assess pain related disability and psychological status in TMD patients. 
The physical component of the RDC (Axis I) 
The RDC diagnostic protocol contains three major elements: 
1. The evaluation forms including a history-taking questionnaire, physical examination and 
psychological assessment forms 
2. The examiner guidelines that aim to maximize the inter-examiner reliability of the RDC 
examination procedure and to standardize the pain - psychological scoring process 
3. The diagnostic criteria (case definitions) and algorithms allowing the diagnosis to be made 
from components of the RDC history and examination information. 
RDC categorises TMD physical diagnoses into three groups according to the common 
clinical findings (Table 2.2). Other TMJ disorders, which are uncommon, or have no reliable 
criteria or examination methods, are excluded. 
Table 2.2. Research diagnostic criteria for TMD (RDC/TMD) 
GROUP I: Muscle disorders 
Myofascial pain 
Myofascial pain with limited opening 
GROUP II: Disc displacements (DD) 
DD with reduction 
DD without reduction with limited opening 
DD without reduction without limited opening 
GROUP III: Arthrides 
Arthralgia 
Osteoarthritis 
Osteoarthrosis 
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A subject can be allocated one muscle disorder at the most, but each joint can be assigned 
a diagnosis from either the second or third group or both. Therefore, a number of diagnoses 
can be given to one person at one time, ranging from zero (no TMD diagnosis) up to five 
diagnoses. However, it is uncommon to assign more than three diagnoses to one patient. 
Several pages in the original article describe the algorithms for the physical diagnosis. 
Some essential features required to make the diagnosis are mentioned in the history form and 
others in the examination guidelines. For these reasons, I summarised the key criteria of each 
category of RDC/TMD (Appendix 1) to make the diagnostic process easier. The derived form 
was adopted to make the diagnosis for all patients recruited in this project. 
The psychosocial component of the RDC (Axis II) 
Axis II concerns pain-related disability and psychological status. It consists of three scales 
integrated in the History Questionnaire of RDC. These are the Jaw Disability Checklist, the 
Symptom Checklist 90 Revised (SCL-90-R) and the Graded Chronic Pain Scale. These are 
covered later in the following sections. 
Main advantages of the RDC system 
1. The dual, physical and psychological axes of the instrument 
2. The detailed examination form 
3. The comprehensive history-taking from, although some questions appear superfluous to 
making a diagnosis 
4. The examination guide that standardises the examination procedure among examiners, in 
particular: 
a. Patient's position during examination 
b. Patient's instructions and explanations 
c. Amount of the force used to palpate muscles and joints 
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d. Consideration of the vertical incisal overlap when measuring mouth opening 
e. Similarly, consideration of any midline deviation in the rest position when assessing 
excursive movement 
f. The recommended repeated measurement (e. g. evaluating mouth opening and clicks) 
to maximise reliability 
g. The "international style" of the history form which enhances the international 
application of the instrument and the comparison of multi-centre data. 
Main disadvantages of the RDC system 
1. The complicated layout of the criteria and examination forms 
2. Although the RDC team criticized other instruments for including superfluous questions 
and examinations which can mislead the examiner, it incorporates, itself, many items which 
provide no information to make a diagnostic decision. Furthermore, some of these items 
appear to lack reliability. For example: 
a. Assisting patients in opening their mouths 
b. The differentiation between fine and coarse crepitus 
c. The determination of three degrees of muscle tenderness: mild, moderate and severe pain 
3. The examination form excludes non-masticatory muscles. Moreover, the dental 
examination is ignored completely. There is no recognition of any correlation between teeth, 
occlusion and TMD. 
4. Although RDC is perhaps the most translated TMD diagnostic instrument, not all 
translations seem to follow scientific translation methods such as the Forward-Backward 
Translation method used for example to produce the German version (John et al., 2006a). 
Some versions are rather based on personal efforts. In particular, the Arabic version, with 
which the author of this thesis is familiar, is poorly made and was clearly written by a non- 
native speaker. Examples of statements from this version are presented in Appendix 1. 
Further work is needed to produce an Arabic version using validated methodology. 
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2.2.4.3. The Temporomandibular Index TMI 
This measure of the severity of the TMD signs was published in 2002 (Pehling et al., 2002). 
The authors based their index on the RDC's classification, but worked to improve its 
examination form, to allow it to be used an outcome measure, a use for which it was not 
originally designed (Pehling et al., 2002). The examination form of RDC was replaced by the 
previously published Craniomandibular Index CMI (Fricton and Schiff nan, 1986) which allows 
for such measurement. 
The new examination form (Pehling et al., 2002) improves that used in the RDC, and 
covers almost all the information required to make an RDC diagnosis. However, the index 
suffers from some shortcomings such as: 
1. It gives equal weights to different problems, for example, a patient with four tender 
muscles can obtain the same score (four points) as a patient with two tender muscles and a 
reproducible closing click in each joint. According to the RDC, the first subject has 
Myofascial pain, while no RDC diagnosis can be made for the second subject 
2. The TMI also endeavours to achieve an overall score for each subject. Again, this score is 
clinically meaningless as it could result from any combination of conditions and makes 
untested assumptions regarding the impact of each condition. The improvement or deterioration 
of this total score is consequently of dubious value in monitoring treatment outcomes 
3. The actual wording on the form is ill-defined for some items. For example, the examiner is 
required to differentiate between fine and coarse crepitus. This could mislead the examiner 
and lead to a reduction in inter-examiner reliability. 
In order to overcome these shortcomings and to simplify the "crowded" form, I produced a 
new form based on that by Pehling et al. (2002). This is presented in Appendix 1. 
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2.2.4.4. Measuring functionality of the masticatory system 
Speech, laughing, yawning, chewing and other mouth functions are known to be impaired by 
temporomandibular disorders (Kropmans et al., 1999). Mouth function is usually assessed by 
means of measuring mouth opening principally in the vertical dimension but occasionally in 
the horizontal level, i. e. extent of excursion movements (Pehling et al., 2002). 
In addition to the physical measurement of mouth opening, a few instruments were 
developed to explore the TMD associated limitations of mouth functions. For example, 
Stegenga et al. designed a Mandibular Function Impairment Questionnaire (MFIQ) which 
contains 17 items (Stegenga et al., 1993). Also, the RDC product has as part of its Axis II a 
Jaw Disability Checklist (Table 2.3) (Dworkin and LeResche, 1992). 
Table 2.3. Jaw disability checklist 
What activities does your present jaw problem 
prevent or limit you from doing? 
No Yes 
Chewing 0 1 
Drinking 0 1 
Exercising 0 1 
Eating hard food 0 1 
Smiling / laughing 0 1 
Sexual activity 0 1 
Cleaning teeth or face 0 1 
Yawning 0 1 
Swallowing 0 1 
Talking 0 1 
Having your usual facial appearance 0 1 
Measuring functioning of the masticatory system is not limited to questionnaire-based 
instruments. Various devices have been proposed and used to examine the masticatory system 
"objectively". Among these are electromyography and jaw tracking devices. The validity and 
reliability of these devices have not been supported, however (Mohl et al., 1990; Lund et al., 
1995). It is beyond the scope of this review to consider these devices in more detail. 
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2.2.5. TMD assessment - the psychological dimension 
The second dimension in the ternary biopsychosocial model of TMD (Dworkin and Massoth, 
1994; Suvinen et al., 2005) is the psychological dimension. This section reviews the literature 
for the role psychological factors play in TMD and reports the instruments that have been 
used to evaluate the psychological component of TMD. 
There is now considerable evidence to support the importance of psychological factors in 
the aetiology and management of TMD. It is not yet clear, however, whether these factors 
cause TMD or reflect the impact of TMD on the patient (LeResche, 1997a; Suvinen et al., 
2005). It is recognised that the majority of TMD patients cope adequately with their 
symptoms, but there is a group of sufferers with psychological dysfunction who cannot cope, 
showing higher rates of depression, somatization and health care utilization (Dworkin and 
Massoth, 1994; Yap et al., 2002). For example, Yap et al. reported that 39% of TMD patients 
are clinically depressed, and 55% have moderate to severe somatization (Yap et al., 2002). 
The authors also found that severe somatization may be associated with an increase in jaw 
disability (Yap et al., 2004). 
Based on strong evidence of the role of psychological traits in TMD, some workers have 
argued that TMD patients should be routinely screened for psychological and psychosocial 
dysfunction in order to tailor treatment to their needs and to avoid failing management, often 
resulting in a longer chronicity of the condition (Rudy et al., 1995; Turk, 1997; Dworkin et 
al., 2002b; Suvinen et al., 2005). 
The Symptom Checklist 90 Revised (SCL-90-R) (Derogatis and Cleary, 1977; Hardt et 
al., 2000) is a scale of psychological dysfunction, which measures both somatization and 
depression. Somatization refers to preoccupation with physical disturbance (Dworkin and 
LeResche, 1992). While the RDC team do not actively encourage the use of this vague term, 
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they favoured SCL-90-R over other measures of psychological status, such as the Beck 
Depression Inventory (Beck et al., 1961), because it covers both somatization and depression. 
Some workers have suggested that patients can be subdivided into groups based on the 
results of psychological tests. Butterworth and Deardorff (1987) were the first to present such a 
taxonomy of TMD patients. Using the SCL-90-R (Derogatis and Cleary, 1977) Butterworth and 
Deardorff suggested three subtypes of TMD: psychologically normal, moderately distressed, 
severely distressed (Butterworth and Deardorff, 1987). In 1989, Rudy et al. used the the 
Multidimensional Pain Inventory (MPI) (Kerns et al., 1985) (Appendix 8) to categorise TMD 
patients into three subtypes: adaptive copers, interpersonally distressed and dysfunctional (Rudy 
et al., 1989). At a later stage, the Temporomandibular Pain Dysfunction Questionnaire 
(Suvinen et al., 1997c; Suvinen et al., 1997b) was proposed and used to classify TMD cases 
into three subtypes: simple, intermediate and complex TMD (Suvinen et al., 1997a). 
2.2.6. TMD assessment - the psychosocial dimension 
The psychosocial dimension of TMD is the third component of the biopsychosocial model of 
TMD introduced earlier (Dworkin and Massoth, 1994; Suvinen et al., 2005). It is difficult to 
draw a clear boundary between the psychological and psychosocial dimensions. This section 
reports instruments that have been used to examine the impact of TMD on patients' quality of 
life and well-being including physical and emotional functioning. Sections 2.3.3 and 2.3.4 
explore in more detail the theoretical frameworks and dimensions of quality of life and health- 
related quality of life with particular emphasis on chronic pain disorders. 
The impact of TMD on quality of life (QOL) was first demonstrated in 1989 (Reisine and 
Weber, 1989). It has since received increasing recognition (Murray et al., 1996; John et al., 
2002; Larsson et al., 2004; Segü et al., 2005). TMD sufferers have been found to have low 
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quality of life (QOL) in comparison with the normal population especially in relation to 
worries, sleeping, feeling tense and depressed. 
Attempts to quantify the psychosocial impact of TMD have mostly relied on generic 
instruments as opposed to oral-specific or even TMD-specific. Workers who have used generic 
instruments argue that these instruments are better than specific measures in that they allow 
comparisons between different conditions (Di Fabio, 1998), while those in favour of condition- 
specific measures claim that these measures are more accurate and sensitive (Hill et al., 1996; 
Turk et al., 2003). Further exploration of this issue is presented in sections 2.3.4.2 and 2.4.3.3. 
2.2.6.1. Generic instruments 
Numerous standardised instruments have been used to measure pain-related disability in TMD 
(LeResche, 1997a). Some of these are specific to one dimension of pain, for example, 
perceived pain intensity or pain-related depression, while many other tools are multidimensional, 
which measure disability in relation to both physical and emotional function (LeResche, 
1997a). Listed below are eight instruments used to measure pain-related disability in TMD. 
It is worth mentioning that some of the studies using these instruments did not differentiate 
between patients with TMD and those suffering from other orofacial pain conditions. 
1. McGill Pain Questionnaire (MPQ) (Melzack, 1975) is a widely used measure of pain. It has 
been validated and used extensively in pain research. In addition to measuring pain MPQ 
measures pain-related disability (LeResche, 1997a). Both MPQ and its short form (Melzack, 
1987) have been used to measure pain and related disability in a number of orofacial pain 
conditions including TMD (Rudy et al., 2001; Van Wijk and Hoogstraten, 2002). 
2. The Symptom Checklist 90 Revised (SCL-90-R) (Derogatis and Cleary, 1977; Hardt et al., 
2000) is a measure for both somatization and depression. It has been used as part of Axis II 
of the RDC (Dworkin and LeResche, 1992; Dworkin et al., 2002a) but has also been used as 
an independent measure (Yap et al., 2004). 
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3. The Multidimensional Pain Inventory (MPI) was first published in 1985 (Kerns et al., 
1985) (Appendix 8). The instrument has been validated and used extensively in pain studies 
including research on TMD. It is also considered "the gold standard" multidimensional self- 
report instrument for pain (Newton-John, 2002). Furthermore, it is recommended as one of 
the best two indices in pain trials (Turk et al., 2006). As reported earlier, MPI has been used 
as a diagnostic tool to distinguish between TMD patients with different levels of psychosocial 
suffering (Rudy et al., 1989; Dahlstrom et al., 1997; Dahlstrom et al., 2000) and to generate 
pain profiles in chronic disorders (Turk, 1997). The MPI questionnaire comprises 52 six- 
point items divided into three groups: Part 1 (20 items) is related to the impact of pain on 
the patient's life, Part 2 (14 items) on the support the patient receives from spouse and close 
relatives, and Part 3 (18 items) on general functioning such as doing house-hold chores. 
4. The Medical Outcomes Study (MOS) (Tarlov et al., 1989) and its 36-item short from (SF- 
36) (Ware and Sherboume, 1992) have been used in studies on TMD and orofacial pain 
(Kohlmann, 2002; Ta and Dionne, 2004). Di Fabio has also derived a new 17-item short 
form (MOS-17 ) to compare disabilities and health status associated with TMD to other 
musculoskeletal disorders (Di Fabio, 1998). 
5. The Graded Chronic Pain Scale (Von Korff et al., 1990) (Appendix 1) is a seven-item scale 
that measures perceived intensity of pain and interference of pain with general activities. It 
has been widely used in TMD research, especially as part of the RDC's Axis II. More recently, 
it has been used to produce pain profiles of TMD patients in primary health care (Forssell et 
al., 2005) that are similar to those produced by the MPI (Rudy et al., 1989). 
6. The Pain Disability Index (PDI) (Pollard, 1984) has been used in orofacial pain research 
(Bush and Harkins, 1995; Auerbach et al., 2001). 
Another two generic pain-related disability indices have also been used, but in a modified 
form made suitable for TMD: 
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7. A modified version of the scale for measuring the Activities of Daily Living (ADL). This 
has been used in patients with craniomandibular disorders (List and Helkimo, 1995). 
8. A pain-related Limitations of Daily Function in the TMD Questionnaire (LDF-TMDQ) 
(Sugisaki et al., 2005). This questionnaire is still under development, and contains a number 
of instruments to cover the multidimensional nature of TMD. 
The RDC team reported in their comprehensive review (Dworkin and LeResche, 1992) 
three of these measures: the MPI (Kerns et al., 1985) (Appendix 8), the Graded Chronic Pain 
Scale (Von Korff et al., 1990) (Appendix 1), and the pain index part of the Medical outcomes 
Study MOS-PI (Tarlov et al., 1989). The authors of that review did not find any of these three 
methods to outperform the others, but opted to use the Graded Chronic Pain Scale as part of 
their History Questionnaire. 
2.2.6.2. Oral health-specific indices 
A large number of oral health-related quality of life (OHrQOL) has been developed. These are 
reviewed in detail in section 2.6. Among these, the Oral Health Impact Profile (OHIP) (Slade 
and Spencer, 1994) is apparently the only one that has been used in the TMD population. 
OHIP has been shown to be able to capture the impact of TMD and orofacial pain on 
sufferers' lives (Murray et al., 1996; John et al., 2002; Larsson et al., 2004; Segü et al., 2005). 
More recently, John et al. have shown a strong correlation between health-related quality of 
life assessed by OHIP and RDC/Axis II measures (John et al., 2007). 
OHIP, however, consists of 49 items, many of which are not relevant to TMD, for 
example, questions related to tooth sensitivity and food catching. Distilling OHIP to a TMD- 
specific subset of items has the potential to improve the instrument utility as an outcome 
measure for TMD. Section 2.6.7 explores in greater detail findings of studies that have used 
OHIP in TMD, and the need to obtain a short form of OHIP that is specific for TMD. 
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2.2.6.3. TMD-specific indices 
There have been only a few attempts to develop TMD-specific instruments that address its 
psychosocial dimension. These are listed below: 
1. The TMJ Scale (Lundeen et al., 1986; Levitt and McKinney, 1994). Like the RDC, this 
scale was designed as a multidimensional instrument. It contains 97 items divided into three 
domains: physical, psychosocial and global. Although psychometric properties have been 
established, it has been rarely used in the TMD literature. 
2. The Research Diagnostic Criteria, RDC (Dworkin and LeResche, 1992). While Axis I 
(physical component) of this tool was designed specifically for TMD, Axis II employs 
generic instruments such as the Symptom Checklist 90 Revised (SCL-90-R) (Derogatis and 
Cleary, 1977) and the Graded Chronic Pain Scale (Von Korff et al., 1990). The social 
impact of TMD on quality of life, however, is not included in this assessment. 
3. The Manchester Orofacial Pain Disability Scale (Aggarwal et al., 2005). This instrument is 
principally designed to measure pain-related disability, and does not have a physical 
component. This scale is not designed for TMD specifically, but is targeted to all orofacial 
conditions. It was established from a pool of patients with orofacial pain including those 
consulting dental casualty and oral medicine clinics. While promising, it has not been 
extensively tested. 
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2.3. Assessing health in chronic disorders - domains of assessment 
Assessing health care outcomes takes place within the wider concept of measuring health 
status. The traditional medical model of health determines treatment as an elimination of a 
disease. It considers the successful intervention the one that leads to the absence of any 
abnormality in the clinical examination and in the results of any complimentary physical tests 
(e. g. laboratory and radiography investigations). This is a limited disease-based view of ill- 
health and is no longer popular. Conversely, a wider paradigm of health has increasingly 
replaced the traditional notion, taking into account the importance of the psychosocial impact 
of illness on the patient's life (Allen and Locker, 1997). 
The psychosocial impact gains even a greater importance when dealing with chronic or 
life-threatening illnesses. Here, the disease is something that the patient has to live with, and 
improving the quality of life becomes more important than merely prolonging survival 
regardless of its quality. Furthermore, it should be noted that patients with such long-term 
diseases will not suffer only from the disease but also from the adverse effects of treatment. 
Sometimes treatment makes an impact on quality of life that is worse than the disease itself. 
For example, chemotherapy in the management of a young lady with an invisible cancer 
causes her hair loss with enormous effect on her appearance and social life. This is why health 
bodies and regulatory agencies require evidence of intervention efficacy in the form of quality 
of life outcome (Johnson and Temple, 1985; National Institute for Health and Clinical 
Excellence, 2006). 
The term "Subjective Health Status" is used in the literature to describe patient-based 
perception of health. It is important here, however, to distinguish this term from the 
clinician's subjective assessment of patients, something considered as personal, not evidence- 
based and therefore unreliable. Based on this definition come the terms Subjective Health 
Assessment and Objective Health Assessment to describe respectively patient-based and 
physical-based assessments of health, medical care and outcomes. 
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2.3.1. Rationale for the use of subjective health measurement 
In the past, researchers have always called for objective measurements such as the pulse rate 
and range of motion. These are often characterized by good levels of reliability and sensitivity 
to changes. Nevertheless, many of these measures still lack content validity. In other words, 
the degree to which a test measures what it is meant to measure is questionable. For instance, 
is it the amount of mouth opening that reflects the presence of a temporomandibular disorder, 
or is it the patient's inability to chew the food that matters? 
The deviation away from using purely objective measures is historically supported by the 
following arguments: 
1. Measuring pain and feelings 
Pain is perhaps one of the most reported symptoms of all diseases or disorders. Yet, with all 
the advancement of medical technology (see section 2.4), pain and other feelings cannot be 
reliably investigated with machines or physiological measurements. Pain is a uniquely 
personal experience. Furthermore, while recent advances in technology make it possible to 
"image pain" (Porro, 2003), this is still research work and technically impractical in daily 
clinical practice. Therefore, until further development of these techniques becomes reasonably 
obtainable, asking patients about their feelings is more practicable than measuring it with 
sophisticated, expensive and time-demanding devices. Moreover, patients' self report of pain 
is considered the gold standard measure in pain research (LeResche, 1997a). 
2. Problems with the validity of objective measures 
These measures reflect the biological status of the body but might be inconsistent with the 
person's perception of this condition. There are various circumstances where patients may 
demonstrate positive objective signs of illness, while they are unaware of their health 
problems or consider the symptoms they experience as part of everyday life. For instance, the 
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prevalence of a disease, such as cholera, in a specific area would makes its inhabitants 
familiar with the disease and consider it as normal. On the other hand, clinical evidence and 
experience describe patients who complain of sickness, but no objective proof supports their 
complaints (Jenkinson, 1994). Furthermore, studies which have investigated the association 
between clinical and subjective (patient-based) measurement of health have found that this 
relation is weak (Locker and Slade, 1994). 
3. The invalidity of the "health care use" and other societal indicators 
"Health care use" indicators have been used to assess treatment outcomes and the need for 
further treatment. They are not a good alternative to objective measures, however, as they do 
not solely reflect the patient's need for further treatment. They are rather influenced by the 
care provider's policies and resources (Bowling, 2005). Other societal tools do assess the 
impact of illness on individuals, including days of restricted activity and work or school 
absenteeism. While these indicators are useful for demonstrating the burden of a given disease 
on the population, they are of doubtful benefit when assessing the impact of this disease at an 
individual-level (Slade, 2002). On the one hand, they are not suitable for those who are not in 
the workforce. On the other hand, people with even severe levels of discomfort may still 
attend work. This is again influenced by the policies in the organisations where they work. 
4. Weakness of the professionals' assessment 
Studies show that health professionals are poor judges of the impact of illness and treatments 
on the patient's everyday life (Sprangers and Aaronson, 1992). This gap between health care 
providers and seekers can be reduced by incorporating the latter's views of their conditions 
and how these change with treatment (Gill and Feinstein, 1994). 
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5. The cost-benefit analysis of health care 
The call for evidence-based medicine has arisen because of the controversy over different 
treatment plans for the same disease, both internationally and nationally (Jenkinson, 1994). 
Moreover, the discrepancy between the rising costs of health care and the escalating levels of 
mortality, morbidity and disability make health care fenders require more evidence on the 
benefit of the medical costs they are paying (Corson et al., 1999). Consequently, they no 
longer accept the medical experts' views of health care and its outcome; instead they want the 
"consumer's perspective" in the issue. For this purpose, a vast number of patient-based 
questionnaires have been developed. These assess and compare the gained quality of life 
using different interventions. Examples of these instruments is the Quality-Adjusted Life 
Years (QALYs) (Nord, 1992). Health care regulators such as the National Institute for Health 
and Clinical Excellence in the U. K., request clinicians to base their treatment decisions on 
these types of questionnaires, known as utility measures (National Institute for Health and 
Clinical Excellence, 2006). 
6. To comply with the World Heath Organization (WHO)'s definition of health 
In 1946 "WHO" stated that "Health is a state of complete physical, mental and social well- 
being and not merely the absence of disease or infirmity" (World Health Organization, 1946). 
This statement highlighted the importance of incorporating the concepts of function, socio- 
psychological contentment and subjective perceptions of satisfaction in any generic concept 
of health. The term "health-related quality of life" emerged as a concept that encompasses the 
spirit of the WHO definition of health by incorporating both personal health status and social 
well-being in assessing the health of individuals and populations (Guyatt et al., 1993). The 
notion of subjective health assessment developed simultaneously. Since that time, health- 
related quality of life data have seen an increase in publication. It has been documented, for 
example, that physicians and researchers have an increasing interest in utilizing the patient's 
view point in planning treatments and monitoring their outcomes (Geigle and Jones, 1990). 
Consequently, measures of health status that fail to incorporate one of WHO's dimensions are 
subject to negative evaluation (Bowling, 2005). 
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2.3.2. Applications of subjective health measurement 
Subjective (patient-based) health measures have been used for different purposes including 
the following (Fitzpatrick et al., 1992a; Gift and Atchison, 1995; Corson et al., 1999): 
For clinical applications and researches 
1. Assessing clinical trials' outcomes 
Interventions designed to improve patients' quality of life, rather than to increase life 
expectancy, are increasingly interested in evaluating treatment outcome using patients' views 
of their daily lives, instead of the physicians' views on their behalf. An example of this type 
of treatment is joint replacement, where the principal aim is to reduce the pain and restore the 
patient's ability to carry out everyday activities. Quality of life measures are most suitable for 
phases II and III of clinical trials, which aim to assess the effect of treatment on the 
participants (Osaba, 2005). 
2. Providing physicians with a comprehensive picture about their patients' status 
As clinicians endeavour to treat the patient and not the disease, patient's perception of illness 
and its changes during the course of treatment are indispensable auxiliary tools in medical 
practice. Furthermore, understanding patients' needs and incorporating them in making 
decisions about their illness management enhances their co-operation and response to 
treatment instructions (Bowling, 2005). 
For resource allocation decision-making 
3. Rationalizing the cost-utility balance of medical interventions 
Limited resources along with rising health care costs make health care funders and authorities 
adopt the quality of the patient's life as a basis in making rationing decisions. Therefore, the 
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impact of interventions on patients' health status and quality of life has been used to justify 
the choice of treatment (Fitzpatrick et al., 1992a). 
4. Population studies 
Subjective health assessment has been successfully used to inform health authorities about the 
population health status and needs (Kelly, 2000; McGrath and Bedi, 2003a). Studies might 
involve the whole population or a population of specific characteristic, e. g. TMD patients 
(Dworkin et al., 1990; Dworkin and LeResche, 1992). Data obtained by these sorts of studies 
can help as normative references for comparison between definite groups, e. g. how do 
diabetics' scores differ from healthy individuals. 
2.3.3. Health components and indicators 
Health, and similarly health-related quality of life, has different components. There is, 
however, a lack of consensus amongst researchers over the definitions and measurements of 
these components, and these are often used interchangeably (Bowling, 2005). The most 
widely-used concepts in the literature are: functional ability, positive health, social health, 
subjective well-being, and quality of life. The literature records an increase in the use of broad 
health status and health related quality of life indicators over the past 20 years (Bowling, 2005). 
There is also a large emphasis on establishing indicators that measure health positively 
rather than negatively. In other words, indices that assess healthiness and good quality of life 
as opposed to deterioration of health and the consequent impact on quality of life (Bowling, 
2005). Realistically, with the lack of an operational definition of health, it is difficult to 
establish such "positive" measures, and the negative approach still dominates most current 
health indicators. There is a need for broad health status scales that adopt the positive concept 
and measure health as a continuum rather than measuring the deviation away from the healthy 
status (Bowling, 2005). 
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The focus of this review is on the measurement of patient-based health-related quality of 
life. Numerous batteries of instruments have been developed to assess health both objectively 
and subjectively, i. e. from the clinician's and patient's perspectives. But it is beyond the scope 
of this project to review clinical indicators and non-biological indicators such as length of 
hospital stay, time to return to work and hospital readmission rates. 
The measurement of patient-based health-related quality of life (HRQoL) is typically 
achieved by evaluating the different domains of health including physical function, mental 
health, emotional state, social well-being and life satisfaction (Bowling, 2005). Patient-based 
HRQoL measures are built on conceptual frameworks that encompass these domains (e. g. 
physical functioning) and test them through their dimensions (e. g. mobility). These 
conceptual frameworks have been developed in oral health (Locker, 1988; John et al., 2004a; 
Bagewitz et al., 2005). 
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2.3.4. Core outcome domains for chronic pain research 
This section reviews the literature on the measurement of health in chronic pain conditions 
within the broader picture of health and its domains. The focus here is on the definition of 
pain, the subjective nature of pain and dimensions of pain. 
The International Association for the Study of Pain (IASP) defines pain as "an unpleasant 
sensory and emotional experience associated with actual or potential damage, or described in 
terms of such damage"(Merskey et al., 1994). Pain has often been regarded as a passive 
warning signal of an underlying disease process. However, it has been increasingly argued 
that persistent pain, which lasts beyond the expected period of healing, is a disease entity by 
itself (Siddall and Cousins, 2004). These last authors argue that accumulated evidence 
suggests that persistent pain has its own pathology, signs and symptoms and meet all the 
criteria to be considered and treated as a disease entity. They believe that the sole focus on 
removing the primary underlying pathology that triggered the persistent pain without 
recognising the secondary pathology and consequences simply fail to obtain satisfactory 
outcome. In this respect, treatment decisions as well as outcome assessment should address 
the many consequences of chronic pain (Siddall and Cousins, 2004). 
Undoubtedly, the personal experience is a core issue in measuring pain, and despite the 
technological advancement that allows an "objective assessment" of pain (section 2.4), it is 
widely believed that patients' self-report of the pain experience is the gold standard in pain 
research (LeResche, 1997a). 
Dimensions of pain 
IASP's definition of pain recognises the personal nature of pain but highlights also its 
multidimensional nature. As with the concept of health, there has been long debate about the 
dimensions and components of pain. 
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In 1968, Melzack and Casey suggested a three dimensional model of pain: sensory 
(discriminative), motivational (affective: motivating the organism into activity aimed at 
stopping the pain), and cognitive (evaluative) (Turk and Melzack, 2001). In this model, the 
three dimensions interact with one another to inform the brain about the noxious stimulus and 
to motivate the body toward acting against this effect based on past experience and 
knowledge about this stimulus. 
Other researchers (LeResche, 1997a; Newton-John, 2002) have suggested a wider 
multidimensional concept of chronic pain, which incorporates the individual perception of 
pain as well as the psycho-social dimension of the disease (chronic pain). These authors 
recommend that the subjective (patient-based) assessment of pain should consist of a battery 
of the following domains: 
1. Perception of pain: intensity, quality, duration and location 
2. Physical functioning: localised to the diseased area; generic concerns about the daily 
activities; and social role functioning 
3. Emotional functioning: depression, anxiety, anger 
4. Cognitive appraisal of pain: pain-coping; and beliefs about pain e. g. ability to control pain 
and catastrophising 
5. Behavioural pain including expressive behaviour, pain-related limited activities and health 
care usage 
6. Personality 
7. Family support 
8. Improvement and satisfaction with treatment. 
More recently a group of 27 authors from academia, governmental agencies and the 
pharmaceutical industry launched an initiative to establish a consensus about the core 
domains of chronic pain that must be considered when assessing outcomes in clinical trials 
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(Turk et al., 2003). The project, which was called IMMPACT (Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials), suggests six domains of chronic pain 
treatment outcomes. These are: 
1. Pain (i. e. perception of pain) 
2. Physical functioning 
3. Emotional functioning 
4. The individual's ratings of improvement and satisfaction with treatment 
5. Symptoms and adverse events 
6. The participant's disposition (adherence to the treatment regimen). 
While this work is an advanced, multi-authored project, and is close to the views of both 
LeResche and Newton-John (above), it just reflects that there is still a lack of consensus over 
pain domains, and that these are still been used interchangeably. 
In relation to quality of life in chronic pain patients, the IMMPACT team found in their 
review that only two main domains in HRQOL (physical functioning and emotional 
functioning) gain sufficient consensus to be considered in the assessment of clinical trials 
(Turk et al., 2003). This conclusion supports results of other studies (De Gagne et al., 1995; 
Holroyd et al., 1999; John et al,, 2004a) where factor analysis was used to identify the main 
domains of the pain's impact on quality of life. 
In the light of these recommendations, it is necessary to consider the perception of pain, 
physical functioning and emotional functioning in more detail. 
2.3.4.1. Perception of pain 
Measuring patients' perception of pain comprises the examination of its intensity, quality, 
frequency, duration and location (LeResche, 1997a). The change in intensity is perhaps the 
most frequently used measurement of treatment outcomes. In contrast, while pain quality, 
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duration and location are essential to making a diagnosis, they are rarely used to measure 
treatment outcomes (LeResche, 1997a). 
Self-report instruments are considered the gold standard in pain studies (LeResche, 
1997a). The most common of these are Visual Analogue Scales (VAS), the McGill Pain 
Questionnaire (MPQ) and its short form The Descriptor Differential Scale (Turk and Melzack, 
2001). These instruments are discussed in more detail in section 2.4.4.4. 
2.3.4.2. Physical functioning 
One of the oldest and most common methods of assessing treatment outcomes is the patient's 
ability to perform daily tasks. Functional ability is considered "the domain which has the most 
face validity for the patients themselves as it points to the ways in which the pain has changed 
their daily lives" (Newton-John, 2002). 
Several models of disability exist; among these is the widely-used WHO's classification 
of functional disability: the International Classification of Impairments, Disabilities and 
Handicaps (ICIDH 1980) (World Health Organization, 1980). This model defined three 
concepts or degrees of disability: impairment, disability and handicap. An example of this 
model is shown in Table 2.4. 
Table 2.4. An example of WHO's classification of functional disability* 
Disease or Disorder Impairment Disability Handicap 
Blindness Vision Seeing Orientation 
* From (Bowling, 2005) 
In this model, impairment relates to the biological function of the body, whereas 
disability focuses on the effect on activities and performance resulting from the impairment. 
Handicap relates to the social consequences of impairment and disability. 
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In 2001, WHO developed a broader classification of functioning and disability: the 
International Classification of Functioning, Disability and Health (ICF) (World Health 
Organization, 2006) which adopts a positive approach to health. In other words, the new 
model does not give the disability a formal definition. It considers disability as a limitation of 
function and focuses on the different domains of function (body function, activities and 
participation in life situations) (Bowling, 2005). 
Scales measuring this broader view of functioning and ability are available in two types: 
generic and condition-specific (section 2.4.3.42.4.3.3). Generic measurements such as the 
widely-used short form 36 (or SF-36) (Ware and Sherbourne, 1992; RAND, 2006) assess 
whole body function and have been used in a large number of conditions including TMD (see 
section 2.2.6.1 ). Condition-specific instruments, on the contrary, are designed to evaluate the 
impact of a specific condition such as TMD, on quality of life. Examples of these scales are 
presented in sections 2.2.6.3 and 2.4.3.3. 
It is argued, on the one hand, that generic instruments may not capture changes in the 
disorder itself (Hill et al., 1996; Turk et al., 2003), and therefore disease-specific measures are 
more likely to reveal these changes in much more detail. On the other hand, these specific 
measures may fail to reflect on the overall impact of the disease on QOL, where generic 
instruments will be useful and needed. The use of generic and specific measures in 
combination was then recommended to achieve the best assessment in clinical trials (Patrick 
and Deyo, 1989; Turk et al., 2003). It has been also suggested that engaging in social 
activities is of less importance in clinical trials and thus social role functioning is not a core 
domain in treatment outcome measures (Turk et al., 2003). 
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2.3.4.3. Emotional functioning 
While cognitive aspects of pain have rarely been used as primary outcomes, many studies 
aimed at modifying pain-related cognitions for chronic pain problems (LeResche, 1997a). 
Moreover, different instruments have been developed to assess pain-coping including the 
Coping Strategies Questionnaire (Rosenstiel and Keefe, 1983). 
The assessment of behavioural pain is a multi-axial model itself. It comprises assessing 
expressive behaviour such as facial expression of pain; pain-related modifications of activities 
e. g. guarded movement; and health care usage both for medication and clinical attendance 
(LeResche, 1997a). 
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2.4. Assessing health in chronic disorders - methods of assessment 
As noted earlier, assessment of health is performed using objective or subjective measures. 
After a brief summary of objective measures, this section reviews the literature on subjective 
(patient-based) methods of health assessment. It covers their types, uses, advantages and 
disadvantages, and properties. Examples of some pain measures are presented at the end of 
this section. 
Objective measures of pain include physical and biological tests, such as sweating, heart 
rate, blood pressure, respiration, oxygen saturation and endorphins levels. Recent developments 
in imaging techniques have also made it possible to "image pain" (Schweinhardt et al., 2006). 
In other words, to measure changes in the Central Nervous System (CNS) during pain. Most 
of these measures are more appropriate for acute pain and experimental pain studies than 
chronic pain research. Moreover, the validity and reliability of many of them are still under 
investigation. Other objective measures include behavioural and function measures, but it is 
beyond the scope of this review to explore the vast variety of these methods in more detail. 
Patient-based reports of health can be obtained either through interviews or by means of 
self-report (or self-administered) instruments including diaries, questionnaires and scales. 
While the interviews yield qualitative data, self-report measures are capable of producing both 
quantitative and qualitative data. 
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2.4.1. Interviews 
Interviewing patients provides a rich source of data for researchers interested in the patient's 
perception and assessment of health. These, along with other methods such as Focus groups, 
Delphi Panels, and Observation are known as Qualitative Methods, or Qualitative Research. 
In such cases, the data are not numerical, but textual, usually in the form of direct quotes, 
ideas or descriptions. Qualitative research is very important in pain research because of the 
personal nature of pain and its complexity, which can sometimes be difficult to be explored 
using quantitative methods. In particular qualitative research is a very useful tool to 
understand the lived experience of pain. 
2.4.1.1. Qualitative research 
Qualitative methods play an important role in clinical research, in particular in social medical 
research. Although qualitative research is not as common as quantitative research, both types 
are linked with one another, and often findings from qualitative research establish the 
foundation for quantitative research. For example, patient-based health questionnaires are 
often derived from statements given by patients, which are then transformed into questions. 
An example of this approach is the derivation of the Oral Health Impact Profile (OHIP) 
(Locker and Slade, 1993; John et al., 2002). 
Qualitative research is essentially exploratory. It aims to understand and explain a 
particular phenomenon using questions like "what? ", "why? " and "how? " as opposed to "how 
many? " or "how frequently? " often used in quantitative research (Gantley et a1., 1999). 
In health research, qualitative methods are often used for three purposes (Gantley et al., 
1999): 
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1. To explain the process (of an illness or particular course of action for example) 
2. To understand ideas and beliefs of the participants (for example behavioural attitudes in a 
given community) 
3. To generate a hypothesis or a theory about a specific phenomenon. 
2.4.1.2. Advantages and disadvantages of qualitative research 
The differences between the quantitative and qualitative approaches are important, and an 
appreciation of the strengths and weaknesses of qualitative research is essential. A summary 
of these is provided in Table 2.5. 
Table 2.5. Summary of strengths and weaknesses of qualitative research* 
" It is possible explore further the meanings that the participant attaches to a specific answer 
an 
" This research is open ended: participants' own priorities are allowed to lead the data collection 
" Small samples allow rich and detailed data to be obtained 
" Data is context specific and cannot be generalised to other contexts 
" The researcher has an impact on the data: 
o By influencing the respondent's answers 
3 
o Through personal and inaccurate interpretation of the data 
" Sensitive topics are difficult to discuss; participants may not provide the most accurate information 
" Small samples are used 
* From (Britten, 1995; Gantley et aL, 1999) 
Qualitative methods such as interviews have other disadvantages, which have to be taken 
into consideration. Among these is the cost for recruiting skilled interviewers, the expense of 
commissioning data transcription, and if necessary, the costs and skills required to use special 
data analysis software packages. In this section I am going to limit the review only to 
interviews, as these are the most relevant techniques to this thesis. 
2.4.1.3. Types of interviews 
Interviews are categorised under three groups (Britten, 1995): 
1. Structured interviews. In this form of interview, also known as Quantitative Interviews 
(Britten, 1995) trained interviewers administer pre-designed questionnaires which have 
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structured or fixed-choice questions such as "How is your health: excellent, good, fair, or 
poor? ". The responses have numerical codes and are subject to statistical analysis, thus this 
form is considered a quantitative approach. 
2. Semi-structured interviews. Here a flexible framework (a topic guide) is provided to the 
interviewer, which defines the area of interest but allows for further exploration with the 
interviewee. Often open-ended questions are used in this type that permits the interviewee to 
give more details. For example: "What do you think good health is? " 
3. In-depth interviews. These interviews are less structured than the previous. They often 
cover a few topics but in much greater detail. They start with defining the topic of the 
interview (research) but the interviewer poses questions based on what the interviewee has 
said. For example, the opening question might be: "Can you tell me about your own health 
experiences and what you think of your health? " 
The term Qualitative Interviews is often used interchangeably with "interviews" in the 
literature. However, it refers to semi-structured and in-depth interviews. This term is used in 
this thesis to describe these two types of interviews. 
2.4.1.4. Sampling in qualitative interviews 
Unlike quantitative studies, statistical representativeness and numerical generalisation are not 
normally sought in qualitative research. Instead, conceptual analysis is more important 
(Fitzpatrick and Boulton, 1994; Mays and Pope, 1995). Sampling strategies are determined by 
the purpose of the interview (Britten, 1995), which "allow the researcher to claim either that a 
full range of opinions or experiences have been investigated or that the data have provided the 
grounds for theoretical development" (Gantley et al., 1999). These sampling strategies are 
known as Theoretical Sampling (Fitzpatrick and Boulton, 1994), Purposive Sampling or 
Purposeful Sampling (Gantley et al., 1999). Compared to the Random Probability Sampling 
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often used in quantitative research, the sample size is often small in qualitative research. As 
noted in Table 2.5, the largest qualitative studies may recruit only 50 subjects (Britten, 1995). 
It should be noted, however, that there is no reason why random probability sampling 
cannot be used in qualitative research (Mays and Pope, 1995). For example, a random sample 
of patients could be interviewed to explore their satisfaction about a given treatment. 
2.4.1.5. Considerations in data collection in qualitative interviews 
There are certain basic but important issues that have to be taken into consideration in 
interview-based research. These include: 
1. The interview settings have to be convenient for both the conduct of the interview and for 
the interviewee. For example, the interview should be conducted in an environment that 
does not allow for external interruption or noise, or for overhearing what the interviewee is 
saying. They also have to take place at a time that suits the interviewee (Britten, 1995). 
2. The immense volume of data yielded during interviews makes it difficult for the 
investigator to take accurate notes of what the interviewee has said. This might also interfere 
with the interviewing process. For these reasons audio recording of the interviews is 
preferred (Britten, 1995). This, however, brings certain ethical issues, including the 
possibility of recognising the voice of the interviewee, and how and for how long audio 
records should be kept so confidentiality is maintained. 
Issues such as confidentiality and anonymising of the study participants and bias in the study 
are common amongst all methods of patient-based assessment of health. These are further 
explored in section 2.4.6. 
2.4.1.6. Analysing qualitative interviews data 
In contrast to quantitative analysis that involves manipulation of numerical data, qualitative 
analysis consists of manipulation of concepts. Conceptual analysis involves identifying issues 
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of interest to the study participants and developing concepts of underlying patterns 
(Fitzpatrick and Boulton, 1994). 
Different approaches are available to analyse data from qualitative interviews including: 
the Analytic induction, the Framework approach, Grounded theory and the Narrative analysis 
(Gantley et al., 1999). Each method has its advantages and disadvantages, and specific 
indications. The common denominator among these methods is the iterative nature of the 
analysis (Bryman and Burgess, 1994). In other words, the investigator starts analysing the 
data (first interviews) by identifying the main issues emerging in the interviews. He or she 
tries then to come up with a hypothetical explanation (concept) for the investigated 
phenomenon. As more data are collected, the investigator may need to refine the developing 
concepts or add new subjects to the study sample to further investigate some issues. This 
involves going back and forth between developing concepts and the raw data emerging from 
each new interview (Bryman and Burgess, 1994; Gantley et al., 1999). 
Computer-assisted qualitative data analysis software (CAQDAS) 
Technological advancements have made it possible for qualitative researchers to benefit from 
computers in analysing qualitative data. A large number of data analysis software packages 
are available for different purposes and stages in the qualitative data analysis (Murphy et al., 
1998). These include: text retrievers, textbase managers, code and retrieve programmes, code- 
based theory builders, and conceptual network builders. Examples of these packages are: 
Ethnograph, ATLAS/ti, and NUD*IST. 
The major role these packages play in qualitative research is facilitating handling 
qualitative data sets and improving the rigour of the analysis by helping the search for 
falsifying evidence (Murphy eta!., 1998). Despite these major advantages, it should be noted 
that qualitative data analysis is not an algorithmic process. Therefore, these computerised 
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analysis packages can only facilitate the organisation of data. They do not carry out 
qualitative analysis on behalf of the human analyst (Murphy et al., 1998). 
2.4.1.7. Rigour in qualitative research 
Qualitative research is sometimes criticised for lacking of rigour methodology. Mays and 
Pope (1995) have listed three sources for this criticism: 
1. Some accused qualitative research of being merely a collection of anecdote and personal 
impressions that is strongly subject to the researcher's bias 
2. Others argue that this type of research lacks reproducibility. In other words, there is no 
guarantee that different researchers would be able to reach the same conclusions 
3. Qualitative research is also criticised for lacking generalisability. 
Mays and Pope (1995) argue that qualitative and quantitative researches are not of different 
types, and that basic strategies governing the quality of quantitative research should be 
employed in qualitative research to ensure rigour. These strategies include: systematic and 
self conscious design, data collection, interpretation and communication (Mays and Pope, 
1995). In the authors' opinion, it is not the qualitative research that should be criticised; but 
rather qualitative workers who fail to communicate their assumptions and methods. 
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2.4.2. Diaries 
A diary (also called Health Diary) is a method of self-report assessment that is based on 
repeated momentary measurements. It asks patients to repeatedly record their experiences of 
the condition at the moment of assessment or over a brief time period (Stone and Shiffman, 
2002). Unlike other self-report instruments that rely on retrospective assessment of the 
condition, the diary provides what is called an Ecological Momentary Assessment (EMA) 
(Stone and Shiffman, 1994). In other words, it captures the particulars of the experience as it 
is lived by the patient rather than relying on recall of past experience (Stone and Shiffman, 
2002). 
Since the 1940s, diary instruments have been used extensively in social, psychological 
and physiological research (Verbrugge, 1980; Bolger et al., 2003). Examples from medicine 
include research on chronic pain, mood, asthma, coronary heart diseases, diabetes and cost- 
effectiveness (Goossens et al., 2000; Gendreau et al., 2003; Aaron et al., 2004). Diaries were 
also employed in TMD research (Forssell et al., 1985; LeResche et al., 2003; Aaron et al., 
2004; Wassell et al., 2004; Wig et al., 2004). 
Diary methods are suitable for research that examines in detail the personal experience of 
the condition. These research types are summarised in three categories (Bolger et al., 2003; 
Gendreau et al., 2003): 
1. Obtaining an aggregate value of the experience over time 
2. Exploring temporal patterns of changes in the experience, i. e. changes with time 
3. Examining factors affecting changes in the experience. 
For each type of topic, diary data can be examined on the person-level and for between- 
person variability. For example, chronic pain diaries help: 
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1. To obtain an aggregate value for the pain experienced by each patient (person-level) and to 
compare between patients (between-person variability) 
2. To explore pattern of changes in pain level with time (within-person variability) and to 
compare different patterns of changes (between-person variability) 
3. To conduct a causal analysis of within-person changes over time, and individual differences 
in these changes. 
2.4.2.1. Advantages and disadvantages 
It is important to understand and consider both the advantages and disadvantages of diary 
methods when designing the research protocol. 
The most important advantages of diaries are the quantity and quality of generated data. 
These are extensive and more accurate than those obtained with traditional survey or 
interview methods. Diaries "reduce the likelihood of retrospection encountered in 
questionnaires and interviews by minimizing time elapsed between an experience and the 
account of this experience" (Bolger et al., 2003; Gendreau et al., 2003). Studies of pain show 
that aggregate values for discrete diary data are better than retrospective summary measures 
that rely on-recall (Stone et al., 2000). Retrospection leads to a bias that results from 
emphasising recent incidents. This type of bias is called "State-Congruent Recall" (Bower, 
1981). Research on pain shows that pain experiences are heavily affected by numerous 
factors, such as respondents' current emotional state, level of anxiety and underlying disease 
processes (Eich et al., 1985). Patients often tend to give more weight to a combination of 
peak-pain and pain proximal to the recall ratings than reflecting on a simple average of all 
momentary pain reports (Redelmeier and Kahneman, 1996; Stone et al., 2000). 
On the other hand, diaries place a remarkable burden both on the participant and on the 
researcher. Participants suffer the inconvenience of completing the diary repeatedly and 
sometimes at inconvenient times (as is the case with random-scheduled diaries - see below). 
49 
Chapter 2. Review of the literature 
The researcher needs to train the participants and establish their understanding and co- 
operation. In addition, the high volume of data requires more work to insert, verify and 
analyse these data. Furthermore, to guarantee participants' compliance, these need to be 
prompted and "monitored" constantly. For example, a diary study on TMD patients 
(LeResche et al., 2003) prompted the participants with regular telephone calls and with a total 
of $125 (given in instalments at different stages in the study). 
Other problems include the participant forgetting, being unable, or even unwilling to 
complete the diary on time, leaving it with missing entries or fabricated retrospective records 
(Stone et al., 2002). The participant may also wish not to complete the diaries (at least on 
time) when personal or sensitive matters are the subject of the diaries, and when these can be 
accessed by others (Bolger et al., 2003). 
Finally, some argue that completing a self-assessment diary itself has an effect on the 
participants and on treatment outcomes, but this issue is controversial (Cruise et al., 1996; 
Aaron et al., 2005). 
2.4.2.2. Types of diary designs 
Diary protocols can be classified into two main types: Time-Based (Time-Contingent) and 
Event-Based (Event-Contingent) (Bolger et al., 2003). 
Time-based protocols require patients completing the diary at predetermined fixed 
intervals (Interval-Contingent) or when prompted by a signalling device (Signal-Contingent). 
The prompting device can be programmed to generate signals at fixed intervals, random 
intervals or a combination of both. The fixed intervals are usually of hourly or daily 
frequency, e. g. patients are asked to report their pain each hour or at the end of the day. 
Selection of the schedule (fixed or variable) and of intervals is based on the phenomenon 
being investigated. But generally, a rational decision is needed as to how long the interval 
should be between assessments and when these assessments should take place. 
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In this context, signal-contingent protocols have the advantage of allowing the researcher to 
select times for assessment. In other words, much as with sampling design for subjects, sampling 
of moments can be designed to address the particular research question (Gendreau et al., 2003). 
Time-based protocols are most suitable for studies of within-person changes in ongoing 
processes. Event-based protocols, on the other hand, are most suited for the study of rare and 
isolated events. In these designs, patients have to report at every instant they have experienced 
the phenomenon of interest, e. g. only when they get pain. This design overcomes the 
drawback of the time-based one which can miss these isolated events with its restricted 
schedule. A clear definition of the triggering event is essential to ensure that the subject does 
not report unwanted incidents or miss those required. A combination of both time- and event- 
based protocols is 'also possible (Bolger et al., 2003; Gendreau et al., 2003). 
2.4.2.3. Types of diary technology 
The first and simplest type comprises Paper and Pencil Diaries. With its simplicity and 
convenience for lay people, this type has several shortcomings (section 2.4.2.1), which were 
addressed and partly overcome by new advancements in technology. Augmented Paper 
Diaries, for example, help to solve the problem of forgetfulness to complete the paper diary 
and the consequent problems of dealing with missing data (Broderick et al., 2003). This is 
achieved by alerting respondents to complete the diary, usually by means of electronic devices 
such as pagers that signal at predetermined times. While this technology maintains the same 
simplicity of paper diaries and overcomes one of its disadvantages, it is costly and can be 
disruptive of participants' routines. Furthermore, while it eliminates the problem of participants 
forgetting to complete the diaries, it does not guarantee their compliance once they remember 
(Broderick et al., 2003). 
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Over the last decade, Electronic Diaries have appeared, which yield significant 
improvements. These are handheld computers equipped with diary programmes. They do not 
merely prompt participants, but can also monitor their compliance by recording entry time, 
thus identifying "false" late entries (Stone et al., 2002; McCracken et al., 2005). For example, 
in a study on patients' compliance, this was found to be 94% for electronic diaries in 
comparison to 11% for paper diaries (Stone et al., 2002). These equipments can also be 
programmed to accept entries within a margin of time, thus preventing entries being made 
retrospectively. 
In addition, electronic diaries have the flexibility of posing the research questions with 
different presentations. They can change questions' contents and sequence according to 
changes in the condition, thus avoiding unnecessary repetition and cumbersomeness. 
Furthermore, these diaries are a means of data collection themselves. Data inserted by 
participants can be transferred directly to the researcher's computer, hence saving time and 
the error of data insertion at later stages. 
Undoubtedly, these technological innovations come at a cost and have limitations. First, 
the costs incurred by buying and maintaining these devices, designing and installing the 
programmes, and training the participants. Other limitations include participants' computer 
literacy and worries about expensive computer equipments being stolen. Open-ended 
questions can be problematic with these devices as response entry becomes difficult (Bolger 
et al., 2003; Gendreau et al., 2003). 
Newly emerging technologies in diaries include voice recording and recognition which 
allow for open-ended questions to be asked and answered by voice. In addition, Web-based 
questionnaires (both traditional and mobile-accessed) enable interactive contacts between the 
researcher and respondents with an increased compliance. Finally, future devices are expected 
to record both self-report, biological and physiological data (Bolger et al., 2003). 
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2.4.3. Questionnaires 
Questionnaires are important tools in the measurement of patients' perception of health, 
health care, and health economics. Extensive research has been undertaken to develop and 
validate these instruments in health research. By definition, a questionnaire is "an instrument 
consisting of a series of questions and/or attitude-opinion statements designed to elicit 
responses which can be converted into measures of the variable under investigation" (Franklin 
and Osborne, 1971) cited by McColl et al. (2001). 
2.4.3.1. Modes of administration 
There are four major modes of administration for questionnaires: self-completion 
questionnaires, face-to-face interviews, telephone interviews and computer-assisted 
questionnaires. Table 2.6 lists major advantages and disadvantages of these methods. 
Self-completion questionnaires are the most widely used in health research as they are 
cheaper and require less specialised resources than interviewing. They are criticised, however, 
for being limited to literate respondents and for failing to provide explanations to the 
respondents (McColl et al., 2000). Hence, they are most suitable for collecting factual data 
such as age. They are subject to error when used to measure attitudes and beliefs where the 
interpretation of the wording of the question might play a role (Bowling, 2002). On the other 
hand, questionnaires that are facilitated by an interviewer are also prone to bias (Bowling, 
2002). The results might be affected by the interviewer's explanation. Also, lack of 
anonymity may influence response when it comes to sensitive topics such as personal issues 
or opinions about treatments. In addition, they are time and resource consuming. 
Self-completion questionnaires can be administered directly in paper or electronic form, 
or sent to the population of interest by post. Electronic questionnaires are now increasingly 
used (Yap et al., 2001; Couper, 2005). They have some advantages over the paper form 
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including the elimination of the data entry stage removing an essential source of potential 
error. Nevertheless, they require the participants to be computer literate and arguably may 
incur additional costs to the research (Yap et al., 2001). 
Table 2.6. Advantages and disadvantages of the main modes of questionnaire administration 
Self-Administered Interviews 
On-Site Paper-and- On-Disk 
Mailed Pencil or Disk (on-site or mailed) Interactive Telephons In-Person 
Characteristics Respondents use Respondents use Respondent answers Respondent uses a Can be done with Can be done with a 
paper and pencil paper and pencil or directly onto the computer that is written script or be written script or be 
respond directly into computer disk linked into a computer assisted computer assisted 
the computer network or the 
Internet 
Advantages Can reach large Information is Can reach large Can reach the world Can explore answers Same as telephone 
geographic areas obtained immediately geographic areas almost instantly with respondents 
If supervisor is Order of questions Can give respondent Can assist 
present, confusing can be an explanation of respondent with 
survey questions can preprogrammed unfamiliar words unfamiliar words 
be clarified as needed and help with 
Only "legal" difficult questions 
answers are accepted 
Data can be 
automatically 
entered and analyzed 
Disadvantages Need motivated Umited to responses Computer may quit Need access to Need trained Need trained 
respondents to return from just those who system (like Internet) interviewers interviewers 
survey are on site or can get Respondent must be 
there willing to use the Respondent must be Need to make sure Must find a suitable 
Respondents must be computer to willing to use the respondent is home place to conduct 
able to read, see, and Respondents must be complete a survey computer to interview 
write able to read, we. and complete the survey If using computer- 
write assisted interviews, 
System can go down will need technical 
expertise to program 
them 
Special needs Up-to-date address Space and privacy Programmer Software engineer or Up-to-date phone If on site, need space 
list for respondent to programmer numbers and privacy 
complete the survey 
Follow-up mailings Schedule for May be difficult or 
reaching respondents dangerous to go to 
Incentives person's home 
May need a k 
sampling expert for 
random digit dialing 
Costs Printing, paper, Printing, paper. Computer. Mainly technical Training, incentives, Training, spam 
envelopes, stamps, incentives, survey* programmer. (e. g., software telephones and travel, incentives 
incentives supervisor, and incentives engineer), incentives telephone charges, 
possibly space for computers and 
respondent to work technical expertise, 
sampling expert 
* From (Fink and Kosecoff, 1998) 
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Postal questionnaires have the advantage of being easier to administer on a large scale. In 
contrast to directly administered questionnaires, however, they suffer from a lower response 
rate and arguably higher costs. They also do not guarantee that the person who completed 
them is the one they are claiming to be. This is important when the help and opinions of 
others might affect the results. Furthermore, the researcher has no control over the completion 
of the questionnaire in areas where the questions' order matters. 
The focus of this section is on self-administered questionnaires, and in particular the 
"Pencil & Paper" form. The section uses as a source of information a comprehensive 
systematic review of questionnaires design and use in health research by McColl et al. (2001). 
Interviewer-administered questionnaires have been previously covered in the section about 
interviews (section 2.4.1). Ultimately, none of questionnaires' modes of administration shows 
superiority in all criteria. Choice of a particular mode is mainly based on the circumstances of 
the research (i. e. study topic; volume and complexity of data to be collected) and on the 
available resources (McColl et al., 2001). 
2.4.3.2. Questionnaire designs 
Unlike interviews where open questions are often used to allow the respondent and the 
interviewer to expand more on particular points, questionnaires use usually a fixed frame of 
questions with pre-set response choices (Bowling, 2002). The strength of questionnaires comes 
from the fact that they produce unambiguous answers, and yield quantitative data that are 
relatively easy to collect and analyse. On the other hand, pre-set choices limit the respondents 
and might force them to choose an answer that does not exactly represent their views. 
Question wording 
Posing the question is an art in itself. It has an important role in optimising completion rates 
and providing the most accurate information. To begin with, simple, jargon-free language 
55 
Chapter 2. Review of the literature 
should be used. The questions should also avoid words with more than one meaning, and 
leading statements. Long questions and double-barrelled questions (those with "and / or") are 
best avoided (McColl et al., 2001). 
In their systematic review of the design and use of questionnaires in health studies, 
McColl et al. (2001) suggested that the question should be accurate, avoid negatively phrased 
attitudinal sentences, and forgo the combination of direct and indirect questions in the same 
questionnaire. They also suggested that the use of open-end questions should be kept to a 
minimum in self-completion questionnaires (McColl et al., 2001). 
Question sequencing 
The context in which the question is posed does have an effect on the response (McColl et al., 
2001). Numerous recommendations are available in relation to questions order when designing 
a new questionnaire. If a pre-designed questionnaire is being used, the researcher is advised to 
use the same outline and frame. 
Questionnaire appearance 
The questionnaire appearance plays an important role in enhancing the response rate, 
especially when the questionnaire is self-completed and designed for visually-impaired 
participants. Appearance includes response format; layout and pagination; paper colour and 
quality; and length of the questionnaire. Small font and crowded pages will discourage the 
respondent from completing the questionnaires. McColl et al. (2001) listed a number of 
recommendations to improve the quality: 
1. The cover design must present the title of the research and the identity of the organisation 
conducting it 
2. The font should lies between 10 -14 points, but larger fonts could be used for visually- 
impaired respondents 
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3. The format of the questionnaire should be maintained consistently throughout 
4. The whole question has to appear on one page 
5. Similarly, linked questions are better kept on one page 
6. Enough space should be provided in open-ended questions 
7. Options (answers) for rating questionnaires should lie horizontally, and options for other 
closed-ended questions are better sorted vertically. 
Covering letter 
This letter is a very important part of the questionnaire, especially when this is administered 
by mail. The design and careful wording of this letter plays an important role in promoting 
respondents to take part in the study and provide as accurate and honest answers as possible 
(McColl et al., 2000). 
Piloting 
Careful piloting of the questionnaire is a crucial and an indispensable stage during design, 
especially if this is a questionnaire that has not been used before. It is also equally important 
to pilot an existing questionnaire when this is being used in a different environment, e. g. a 
different population of respondents. Issues of interest during piloting include the clarity of the 
questions, participants' reaction to specific questions, and time needed to complete the 
questionnaire (Boynton, 2004). 
2.4.3.3. Classification of questionnaires 
Health questionnaires in general are classified by their target as generic or specific (Guyatt et 
a!., 1993; Fitzpatrick et al., 1998; Garratt et al., 2002). These are described in detail below. 
Generic instruments include health profiles and utility measures, while specific instruments 
are concerned with, for example, particular QOL dimensions, diseases, sites (in the body), or 
they may be individualised. 
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1. Health profiles 
Generic measures are used to measure illness regardless of the cause or site. They usually 
measure several health domains presented in the form of multiple-item questionnaires such as 
the Short Form-36 (SF-36) Health Survey Questionnaire (Ware and Sherbourne, 1992). 
2. Utility measures 
Other types of generic measures have been developed for economic purposes. These tools are 
not designed to measure quality of life per se, but to evaluate the improvement to health- 
related quality of life gained by a particular intervention. Most of these tools produce a single 
index which is used by health policy makers to compare and justify different interventions 
based on the number of units of quality of life these treatments can provide (Bowling, 2001). 
An example of these tools is the Quality-Adjusted Life Years (QALYs) that was proposed in 
1976 cited by Nord (1992). In the U. K., the corresponding measure is the Rosser Index of 
Disability (Rosser and Watts, 1972). The Euroqol (Williams, 1990) is also gaining popularity. 
It has been used recently to enable the estimation of health state values based on other health 
profile questionnaires such as the Oral Health Impact profile (Brennan and Spencer, 2006). 
3. Dimension specific measures 
These are concerned with particular aspects of health such as psychological well-being. They 
are usually scales and produce a single score. An example of these measures is the Beck 
Depression Inventory (Beck et al., 1961). While pain is not considered a dimension on its 
own, some authors argue that it is, and thus classify pain specific measures in this category 
(Fitzpatrick et al., 1998). An example of these instruments is the McGill Pain Questionnaire 
(MPQ) (Melzack, 1975). 
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4. Disease (condition or population) specific measures 
As the name suggests, these target particular disorders or diseases and may explore all health- 
related effects, for example The Arthritis Impact Measurement Scales (AIMS) (Meenan et al., 
1980). 
5. Site specific measures 
These are designed exclusively for certain areas of the body, or for a certain medical 
speciality. Examples are The Oxford Hip Score (Dawson et al., 1996) and the Oral Health 
Impact Profile OHIP (Slade and Spencer, 1994). 
6. Individualised measures 
These tools allow respondents to nominate aspects of their own life, which they consider to be 
the most important, and to weight the importance of these aspects. They have been developed 
in response to the argument that psychometric testing of scales developed at the expense of 
the relevance of the scales to the individual (Bowling, 2005). An example of these instruments 
is the Schedule for the Evaluation of Individual Quality of Life (SEIQOL) (Browne et al., 
1997). Some authors argue, however, that the hypothesis that these instruments have better 
psychometric properties than the standardised measure is unproven (Fitzpatrick, 1999). 
2.4.3.4. Uses for health measurement questionnaires 
Questionnaires can be classified by the purpose of the study as predictive, discriminative, or 
evaluative instruments (Kirshner and Guyatt, 1985). 
1. Predictive tools 
This type of instrument is used to "classify individuals into a set of predefined measurement 
categories when a gold standard is available" (Kirshner and Guyatt, 1985). These indices are 
often used as a diagnostic or screening tool to "predict" which specific individuals have or 
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will develop the condition or outcome of interest (Kirshner and Guyatt, 1985). These tools are 
employed to replace the gold standard measure which might be costly, difficult to use, or 
cannot be used in the early course of a disease. For example, the gold standard method to 
evaluate tooth loss is to examine the mouth. Alternatively, the predictive instrument might be 
asking the participants to report missing teeth on a questionnaire form (Worthington, 1998). 
In quality of life, however, there are no gold standards (Guyatt et al., 1993). Therefore, the 
focus in the remainder of this section is on the other types of questionnaires, the 
discriminative and evaluative. 
2. Discriminative tools 
These are used to distinguish between individuals or groups on an underlying dimension; for 
example, to identify sufferers of a given disease from the normal population. Their main use 
is in cross-sectional surveys, with the aim of quantifying the illness burden across different 
groups. An example of these instruments is the short form OHIP-14 (Slade, 1997b). 
Discriminatory measures do not contain items with high prevalence in the general 
population, since these items are common and may compromise the instrument's ability to 
distinguish between groups with severe and less severe impacts (Juniper et al., 1996). 
3. Evaluative instruments 
These instruments are designed to measure longitudinal change in the condition of interest, 
and can be therefore used to assess treatment outcomes (Rogers et a!., 1998; Allen and McMillan, 
2003). These tools are often used in clinical trials and cost-utility research (Slade, 1998). 
Evaluative tools should be able to reflect the specific goals of the intervention of interest 
(Guyatt et al., 1986). Moreover, they should contain items reported as the most important to 
the respondents (e. g. patients) (Juniper et al., 1996). In this context, items with high 
prevalence in the population should be included, which allow for small changes in the 
condition to be reported (Locker and Allen, 2002). On the other hand, items used in the 
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discriminative tools, reflecting severe impact and low prevalence in the population are less 
amenable to change with intervention. These should not be used to evaluate treatment 
outcomes. For example, a question about pain severity asked to patients with orofacial pain 
will fail to discriminate between those with toothache, sore gum or mouth, or pain in the TMJ. 
However, this question can be successfully used to evaluate changes in pain severity when 
posed to the same patient on different occasions. 
It is clear that the instrument's design and psychometric properties vary according to its 
purpose. These are summarised in Table 2.7 and explained in more details in section 2.4.5. 
The use of an instrument for a purpose other than what it was designed for might well 
compromise the results (Worthington, 1998; Locker and Allen, 2002). If a previously 
established instrument is to be used in a context other than that it was originally designed for, 
it is crucial that the instrument's properties are re-examined in the new context (Locker and 
Allen, 2002). The same applies when attempting to distil a lengthy instrument (Guyatt et al., 
1993), as discussed later. 
Table 2.7. Major considerations in index construction and validations 
Discriminative criteria Predictive criteria Evaluative criteria 
Item selection -tap jmportant components of the -statistical association with -tap areas related to change in 
domain criterion measure health status 
-universal applicability to -responsiveness to clinically 
respondents significant change 
--stability over time 
Item scaling -short response sets which 
facilitateiniform interpretation 
-response sets which maximize -response sets with sufficient 
correlations with the criterion gradations to register change 
measure 
Item reduction -internal scaling or consistency 
-comprehensiveness and 
reduction of random error vs 
respondent burden 
Reliability large and stable intersubject 
variation: correlation between 
replicate measures 
Validity -cross-sectiönal construct validity. 
relationship between index and. 
external measures at a single 
point in time ;.. 
Responsiveness --not relevant 
-power to predict vs respondent -responsiveness vs respondent 
burden burden 
-stable inter and intrasubject 
variation: chance corrected 
agreement between replicate 
measures 
-criterion validity. agreement 
with criterion measure 
-stable intrasubject variation: 
insigni cant variation between 
replicate measure' 
---longitudinal construct validity: 
relationship between changes in 
index and external measures over 
time 
-not relevant 
* From (Kirshner and Guyatt, 1985) 
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Different formats of questionnaires are proposed to measure changes over time, but there 
is no universal consensus over what method to use (Locker, 1998; Slade, 1998; Allen, 2003). 
The various types are: 
1. Comparisons of "before" and "after". This is the simplest format, where group summary 
scores are calculated for the study participants on two or more occasions. The drawback of 
this approach is that it treats the scores before and after the event of interest as independent, 
and does not allow for "within-subject" changes to be calculated. Therefore, in a given 
intervention, responders and non-responders cancel each others' scores. 
2. Computing individual change scores. This is done by subtracting the baseline score from 
the follow-up score for each individual, allowing for identification of those whose scores 
improved or lowered. 
3. Global transition judgment. This is the patient's (respondent's) retrospective assessment 
of overall changes in their condition during the study period. This method is considered 
better than the previous as it allows the respondent to decide their own reference points, i. e. 
before and after the event of interest (Slade, 2002). It is criticised, however, for being a 
retrospective assessment that is prone to bias (see section 2.5.1) and which does not take 
into account fluctuation of the condition over time (Dolan et al., 1998). 
4. Retrospective judgement of extent of change. This is an extension of the previous 
method, where respondents rate the extent of change numerically rather than just report its 
occurrence or direction. 
5. Categoric enumeration of change (Slade, 1998). In this method, within-subject changes 
are considered as in method two. The author argues that domains of quality of life do not 
necessarily change in the same direction. Therefore changes may cancel each other even 
within the same individual. Slade (1998) exemplifies this by a person who lost some teeth 
which reduced pain but introduced difficulty in chewing. He recommends categoric 
enumeration of change by considering both increment and decrement in scores. 
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2.4.3.5. Shortening lengthy questionnaires 
Lengthy questionnaires are deemed to be too costly in large national surveys, inappropriate 
for compromised or aged participants, subject to large item non-response in cohorts with 
specific disorders, and difficult to use in clinical practice (Locker and Allen, 2002). For these 
reasons, shorter versions of composite measurement scales have been developed either to 
replace long versions, or to make them more specific for certain disorders or populations. 
Shorter versions designed as condition-specific measures have better responsiveness than 
the original long questionnaire (Allen and Locker, 2002; Allen, 2003). Also, the 
administration of short versions of the questionnaire is easier. While this is a benefit, it can be 
argued that reducing the number of items may adversely affect measurement. Obviously, the 
content validity of the short-form measures is compromised (Locker and Allen, 2002). In 
addition, the reliability of an existing questionnaire tends to decrease as items are eliminated 
(Nunnally and Berbstein, 1994). 
Various approaches have been developed to produce shorter versions of composite 
measurement scales while maintaining psychometric characteristics. Different methods, 
however, maintain different psychometric properties. The decision about which approach to 
use depends on the purpose and required properties of the short-form version (Guyatt et al., 
1993; Juniper et a!., 1997; Locker and Allen, 2002). 
For discriminative instruments, the aim is to produce a shorter version which is able to 
classify respondents (patients) in a similar way to the original. Therefore, the researcher 
should examine the extent to which variance in scores in the full instrument is explained or 
predicted by scores of the short-from (Guyatt et al., 1993). If the intention, however, is to 
produce an evaluative short version, psychometric properties of concern should be the 
instrument's validity in the new context and its responsiveness to change with treatment in 
comparison to those properties of the full version (Guyatt et al., 1993). 
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The literature reports three popular approaches for item reduction: the Item-Impact 
analysis (Juniper et al., 1997), the Regression Analysis and the Factor Analysis (Coste et al., 
1997). The three methods and their favoured applications are described below. 
The item-impact analysis (Juniper et al., 1997) identifies items that are most important to 
the respondents (Locker and Allen, 2002). In this method, respondents (e. g. patients) are 
given a pool of statements (in this case the long form instrument) and are asked to indicate the 
items which they have experienced over a given period of time, and to rate these items on a 
Likert-type scale of importance. The item-impact score for each item is calculated by 
multiplying the proportion of respondents experiencing this item by its mean importance 
rating (Juniper et al., 1997). As an example, this method was used to derive a population 
specific short form of the 49-item Oral Health Impact Profile (OHIP) (Allen and Locker, 
2002). 
Regression analysis is a "method for describing the relationship between two or more 
variables. It estimates the impact of one variable on another" (De Vaus, 2001). In other words, 
it evaluates how much of the variance in a variable is explained by the variance of another. 
This method has been used to shorten long questionnaires by identifying individual items that 
contribute the most to the full questionnaire. In this context, items which explain most of the 
variance in the total questionnaire are considered important, and those which explain little 
variance are considered redundant and are eliminated. For example, Slade (1997b) used this 
method to shorten OHIP-49 to OHIP-14. 
Factor analysis is a "complex method of reducing a large set of variables to a smaller set 
of underlying variables referred to as factors" (De Vaus, 2001). This analysis can be 
conducted in a number of ways, but they all serve the same purpose, and that is to identify the 
underlying factors of a large set of variables, e. g. questionnaire items. For example, this 
method has been used to identify the possible dimensions of oral health-related quality of life 
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(OHrQOL) (John et al., 2004a). The authors identified four dimensions (factors) and derived 
a 21-item short version of the original OHIP-49. 
In a review of the methodology of shortening composite measurement scales (Coste et 
al., 1997), the authors emphasised that the regression and factor analyses are most suitable 
when the original scale is the gold standard for measuring the phenomenon of interest. Here, it 
is essential to optimise the "criterion" validity of the short-form by ensuring a high degree of 
correlation between the shortened and original form. In contrast, when the original instrument 
is not the gold standard, these analyses are inappropriate and other methods are preferred. 
If the short-form questionnaire is evaluative, i. e. is to be used as a treatment outcome 
measure, it is essential that this is based on what patients feel is important (Guyatt et al., 
1986; Juniper et al., 1996). For this reason, the item-impact method is preferred (Locker and 
Allen, 2002) as it is based on patients' ranking of items according to their importance (Juniper 
et al., 1997). Clearly, evaluative instruments should employ items with distinguished 
responsiveness to change with the intervention of interest (the Effect Size), and which have 
low floor effects (see measurement properties - section 2.4.5.3). 
To this end, the performance of two short versions of OHIP has been examined (Allen 
and Locker, 2002; Locker and Allen, 2002); one derived using the regression analysis [OHIP- 
14 (Slade, 1997b)], and another obtained using the item-impact method [OHIP-Edent (Allen 
and Locker, 2002)]. It has been concluded that the item-impact method yielded an instrument 
that is better in detecting change with treatment, and that has lower floor effects. 
How short is short? 
There are no clear guides to how much one can cut down an instrument. It is important, 
though, to maintain the same framework of the original form (Juniper et al., 1997; Slade, 
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1997b; Locker and Allen, 2002). As mentioned before, the shorter the instrument, the weaker 
the psychometric features. 
For health instruments, it has been suggested that each of the index's dimensions needs to 
be represented by three to four items (Juniper et al., 1997). It is also argued that increasing the 
number of items per domain decreases the risk of floor effects (Bindman et al., 1990). On the 
other hand, reducing the instrument to two items per domain would maintain responsiveness 
and reliability of composite measurement scales at an acceptable level, with a trade-off of 
reduced construct validity and increase in sample size requirements (Moran et al., 2001). This 
argument is supported by the fact that some instruments were shortened to two items per 
dimension and were still valid and widely used, e. g. OHIP-14 (Slade, 1997b). 
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2.4.4. Scales 
While many self-administered instruments, e. g. questionnaires, are composed in general of a 
battery of indicators, scales are a more sophisticated and perhaps more informative self-report 
method. Scaling is the assignation of numbers to responses for given questions (Bowling and 
Ebrahim, 2005). This is essential to enable qualitative data to be analysed in a mathematical 
or statistical way. 
Scales can be single or multiple questions posed to respondents on certain attitudes, 
feelings and perceptions. They can be uni- or multidimensional in relation to the number of 
domains they cover. An example of unidimensional scale is a single-item scale of pain 
intensity (see section 2.4.4.4). Multidimensional scales are usually in the form of multiple- 
item questionnaires. Examples of these are presented in sections 2.4.3 and 2.4.4.4). Some 
single-item scales can be used, however, as an alternative for long multidimensional 
questionnaires. These are usually referred to as "Global Self-Rating". 
In global scales subjects respond to a comprehensive question about their perception of 
the phenomenon being investigated. Using this method it is assumed that the respondents will 
interpret the dimensions of QOL that are important to them, make judgement of the impact of 
their condition on these dimensions, and incorporate this judgement into a single score (Slade, 
2002). The validity and reliability of this approach has been addressed in a large number of 
studies on health in general as well as on health related quality of life (Cunny and Perri, 1991; 
de Boer et al., 2004). 
Global scales are very popular in health and its related quality of life research, mainly 
because they are short, simple, and easy to administer and to analyse. Other advantages 
include permitting respondents to assimilate multidimensional experiences and choose those 
which are most prominent (Slade, 2002). Furthermore, they allow for positive ranking of 
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health, as opposed to measuring the extent of illness, something that fits with ICF the 
International Classification of Functioning, Disability and Health mentioned earlier (World 
Health Organization, 2006). It should be noted, however, that detailed multiple-item scales 
are inevitable to obtain a clearer picture of the individual or QOL, which can be masked by 
overall rating. For example, in a study on the impact of dental and other oral disorders (Slade, 
1998), it has been found that while tooth loss may affect chewing, it decreases pain. Reporting 
both improvement and deterioration of health simultaneously is only possible with a detailed 
multiple-item questionnaire, and was not possible with a summary single-item scale. It is 
therefore recommended that multiple-item instruments should be used whenever possible 
(Cunny and Perri, 1991). 
2.4.4.1. Scales' data 
Whether it is a uni- or multidimensional, single- or multiple-item scale, scales' data can be 
categorised in four levels: nominal, ordinal, interval, and ratio (Bowling, 2002; Bowling and 
Ebrahim, 2005). 
1. Nominal and categorical scales 
These scales classify responses into groups and use numbers to distinguish the different 
groups but do not give them any order. A simple example of nominal classification is 
grouping patients by their gender where male patients are coded by 1 and females by 2. These 
numbers do not imply that females are greater or lesser than males. They simply denote that 
patients who have the same number are from the same gender. Data can be dichotomous such 
as in yes/no questions or descriptive (race, eye colour, etc. ). 
2. Ordinal scales 
As the name suggests, these scales order responses in a hierarchy. Items in this type of scales 
are ranked with respect to their importance, severity or frequency from least to most. For 
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example, reported pain can be mild=l, moderate=2 or severe=3. There are no definite 
intervals among the groups, i. e. it cannot be concluded that the difference between mild pain 
and moderate pain is identical to that between the latter and severe pain. Ordinal scales such 
as Likert-type scales, are adopted in a large number of HRQoL instruments. Yet, the optimal 
scoring interval is controversial. A good scale should provide the respondent with an adequate 
number of choices. On the one hand, limited choices such as "Do you agree or disagree" can 
lead to confusion and error in the measurement. On the other hand, redundant options might 
result in meaningless responses. Most of HRQoL instruments offer four to seven options. 
3. Interval scales 
These assign definite intervals among the ordered responses. In other words, numerically 
equal distances on the scale represent equal distances on the attribute of interest. The Visual 
Analogue Scale VAS which is used to measure pain is an example. Patients are asked to 
indicate their pain level on a line of 100 mm length. A score difference of 10 is the same 
whether it is between 60 and 70 or 80 and 90. The absolute value of the attribute, however, is 
either unknown, meaningless, or given arbitrarily. 
4. Ratio scales 
These are the highest level of scales, and the most accurate (Bowling, 2002). They are 
suitable for attributes that have absolute values, for example, the patient's weight. Unlike the 
interval scales, the zero point here is the original value. Thus, a value of zero suggests here 
that the respondent has none of the measured attribute. 
2.4.4.2. Statistical analyses of scales 
From a statistical point of view, analytical options rise with increasing levels of scales. To 
start with, only simple statistics can be performed for nominal data including cross-tabulation 
and frequencies. Non-parametric procedures can be considered at the ordinal level, but these 
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data can only be ranked, not sorted, and cannot be averaged or mathematically manipulated 
(Bowling, 2002). The median is, therefore, the most appropriate statistics to describe the 
central tendency of scores. Optimally, interval and ratio scales can be analysed by parametric 
statistics (Bowling, 2002). Any statistical measure can be used to analyze data from ratio level. 
However, no rating scales achieve ratio scale level (Bowling, 2002). Ideally, for accuracy 
and statistical considerations, measures should be developed using interval or ratio scales. 
Yet, obviously, this is difficult in social sciences. But there are still numerous techniques 
available to help in transforming nominal data into interval and ratio levels (Bowling, 2002). 
2.4.4.3. Scoring scales 
The simplest way to get data from a scale is by summing its items' scores. Some items, 
however, may be of more importance than others and should therefore contribute more to the 
total score. Attributing equal scores to the scale items would lead to assigning the same 
weight to items that might not be of the same importance to the patient. A given score can be 
arrived at in different ways. For instance, someone who is physically disabled, but who has a 
joyful character may score the same as someone else who is mobile but suffers a psychological 
problem. Though this may be meaningful when assessing workload, it has no value in 
assessing the individual's status. In the field of temporomandibular disorders an index has 
been developed to measure the severity of the condition and to monitor treatment outcomes: 
The Temporomandibular Index (Pehling et al., 2002). While this index has some merits, it 
suffers by trying to produce an overall score for the condition. This overall score does not 
provide any meaningful result, as the patient can reach the same score whether he/she suffers 
a disc displacement or a myofascial pain. 
This problem can be avoided by assigning different weights to the items according to 
their importance to the patient. For example, three oral health-related quality of life measures, 
the Dental Impact on Daily Living (DIDL) (Leao and Sheiham, 1996), the Oral Health Impact 
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Profile (OHIP) (Slade and Spencer, 1994) and the UK oral health-related quality of life 
[OHQoL-UK (W)] (McGrath and Bedi, 2001), consist of items with weights. Weighting is 
often based on Thurstone's method of paired comparisons (Allen and Locker, 1997; Slade, 
1997a). 
On the other hand, it is argued that weighting brings some difficulties and complexities, 
and may not be feasible in clinical settings (Streiner and Norman, 1995). These authors 
suggest that weighting might be useful for indices with fewer than 40 items, but those with 
more items may not benefit from this additional procedure. Their argument is supported by 
some research on item weighting in OHrQOL measures (Leao and Sheiham, 1996; Allen et 
al., 2001; Aaron et al., 2004; McGrath and Bedi, 2004). 
2.4.4.4. Examples of scales used for the measurement of pain 
Single-item scales 
Various types of single-item pain scales have been developed (Turk and Melzack, 2001) 
including: 
1. The Verbal Rating Scale (VRS) 
This scale provides a choice of several options, preferably 5-7 (Bowling, 2002) from which 
the patient is asked to select the one that best describes the intensity of their pain (e. g. none, 
mild, moderate, severe, very severe) or its frequency (e. g. never, hardly ever, occasionally, 
often, very often). This type of scales is often referred to as Likert type (Bowling, 2002). 
2. The Numerical Rating Scale (NRS) 
This scale consists of a sequence of numbers (e. g. 0- 10 or 10 - 100) form which the patient 
is asked to circle a choice that corresponds to the degree of suffering. 
3. The Visual Analogue Scale (VAS) 
This is a line, preferably horizontal and 100 mm long (Bowling, 2002), that is anchored at its 
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ends by the extreme limits of the phenomenon being measured, for instance the level of 
suffering "no pain" and "the worst imaginable pain ". Respondents are asked to mark on this 
line the extent of their suffering (e. g. intensity or unpleasantness of pain). The scale score is 
represented by the distance between the start point and the indicated mark. It has been found 
that lines shorter than 10 cm tend to produce greater error variance and that intermediate 
points should not be defined to avoid clustering of scales. 
While the three methods have well established validity and reliability, VAS is the 
favoured instrument (Turk and Melzack, 2001). This is due in part to the observation that 
NRS leads to response clustering. In other words, respondents are derived to choose one 
option (one number) as opposed to giving their exact measure of the phenomenon as the case 
in VAS. By this, NRS imitates Likert-type scales (Wewers and Lowe, 1990). Another 
problem is patient ability to remember previous answers thus leading to a bias (Gendreau et 
al., 2003). Also, the verbal descriptions used in the VRS may be interpreted differently by 
different respondents, thus affecting the validity of the scale (Bowling, 2002). 
The VAS technique, which became widely used in 1970s, has been adopted as an 
alternative for the ordinal scales and as a solution to the scoring debate. While some argue 
that VAS is an ordinal scale, others believe it also meets the criteria of interval and ratio 
scales (Maxwell, 1978; Wewers and Lowe, 1990). 
VAS is often used for assessing clinical symptoms, especially pain (Olsen et al., 1992). It 
has been also used for the evaluation of sleep, functional performance, behaviour and 
affective state, e. g. mood and anxiety. This technique better mirrors the continuous nature of 
feelings and attitudes, has been extensively tested for validity and sensitivity to change with 
treatment in research on feelings (Zealley and Aitken, 1969). 
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It is not surprising that VASs have been used in a large number of TMD research, 
including measurement of pain intensity (Dao et al., 1994; Wassell et al., 2004) and perceived 
improvement with treatment (Dahlstrom et al., 2000; de Boer et al., 2004). 
Multiple-item scales 
McGill Pain Questionnaire (MPQ) (Melzack, 1975) is a well established and widely used 
measure of pain. The author of this instrument argues that assessing pain merely in a 
numerical way is limited and that the nature of pain is an important factor in the experience of 
pain and has to be considered in the evaluation of pain. To measure this nature, MPQ enables 
the respondent to choose from an extensive set of verbal descriptors of pain. These are then 
transformed into numerical codes in order to yield a score. MPQ does not measure pain intensity 
and nature only, but also pain-related disability (LeResche, 1997a). Both MPQ and its short 
form (Melzack, 1987) have been used to measure pain and related disability in a number of 
orofacial pain conditions including TMD (Rudy et al., 2001; Van Wijk and Hoogstraten, 2002). 
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2.4.5. Psychometric characteristics 
Researchers agree that self-report instruments have to meet certain criteria before they can be 
used in research. Most importantly they have to be valid and reliable, but other measures are 
also important. 
2.4.5.1. Validity 
In simple terms, a valid instrument is one that measures what it is supposed to be measuring. 
Validity is not a single feature. It has several aspects that are listed below (Litwin, 1995; 
McColl et al., 2000; Fayers and Hays, 2004) 
1. Face validity 
The questions asked here is "whether on the face of it" the instrument is measuring what it is 
supposed to measure. This is only a primary step and is usually examined by asking a group 
of ordinary non-specialised people to check if the instrument items appear appropriate. 
2. Content validity 
This type of validity explores if the content of the instrument, e. g. the questionnaire items, 
covers everything it should, and does not include irrelevant elements. This is assessed by a 
panel of informed people including specialists and members of the target population, e. g. patients. 
3. Construct validity 
This is the most rigorous approach to establishing validity (Guyatt et al., 1993), which 
investigates if the results obtained by the instrument confirm expectation. Two methods are 
used to assess this aspect of validity. 
In the first method the results of the target group are compared with another group that is 
expected to produce different results e. g. patients against healthy controls. This method is 
known as Known-group validity, group validity or discriminant validity and it is suitable to 
validate instruments with discriminative purpose (Guyatt et al., 1993). 
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The second method, multi-trait multi-method analysis (Campbell and Fiske, 1959) 
involves examining the behaviour of the investigated instrument against another 
simultaneously administered instrument of known validity (McColl et al., 2000). High 
correlation is expected amongst instruments that are measuring the same phenomenon or 
conception (Convergent Validity). Weak correlation is expected between instruments 
measuring dissimilar concepts (Divergent Validity). Different methods are available to 
measure the correlation coefficients depending on the data type. Pearson's correlation 
coefficient "r" is appropriate when at least one of the variables is at the interval (continuous, 
numerical) level, while Spearman's rho correlation coefficient "r3" is the test of choice for 
ordinal data. 
To validate an evaluative instrument, changes over time detected by this tool should 
correlate to those measured by another instrument of established properties, given that both 
instruments are measuring the same phenomenon (Guyatt et al., 1993; Worthington, 1998). 
The correlation between variables (e. g. instruments) using either Pearson's or Spearman's 
correlation coefficients varies between -1 and +1, where the sign indicates the direction of 
correlation, i. e. positive or negative. The values between 0 and the absolute 1 and their 
meanings are presented in Table 2.8 (Riffenburgh, 2006). 
Table 2.8. Values of Pearson and Spearman's correlation and their interpretation 
0 No relationship 
0.10 to 0.29 or -0.10 to -0.29 Small 
0.30 to 0.49 or -0.30 to -0.49 Medium 
0.50 to 0.99 or -0.50 to -0.99 Large 
1 or -1 Perfect 
4. Criterion validity 
This type of validity is considered as a special case of construct validity (Fayers and Hays, 
2004). It examines the inter-correlation between the investigated instrument and a gold 
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standard measurement of the same concept applied concurrently on the same group. An 
example of this is testing a self-reported statement of high temperature against the measurement 
on a thermometer. HrQoL suffers, however, from a lack of gold standard measures. Hence, 
the assessment of the validity of HrQoL measures is mainly limited to content and construct 
validity (Fayers and Hays, 2004). 
Nevertheless, when testing the validity of a new shorter instrument that has been derived 
from an original one, the "mother" version is considered the gold standard (Coste et a!., 1997). 
2.4.5.2. Reliability 
A reliable instrument is one that measures the concept of interest in a consistent or 
reproducible manner. As with validity, there are different aspects of reliability (McColl et al., 
2000; Fayers and Hays, 2004): 
1. Stability or test-retest reliability 
This analysis explores the reproducibility of the obtained results when the instrument is 
administered to the same person on two occasions within which the condition being 
investigated was "relatively" stable. 
There has been considerable debate in the literature regarding the most appropriate 
choice of the reliability coefficient (Streiner and Norman, 1995). One method to assess this 
reliability is to calculate the correlation coefficient CC (or Pearson's coefficient) between the 
two stages' data (Worthington, 1998). In essence, the correlation test examines the ratio of 
between-subject variance to total variance, which includes both between- and within-subject 
variance (Guyatt et al., 1992). The reliability, denoted "r", is considered good if r values > 
0.70 (Litwin, 1995). Streiner and Norman (1995) argue that Intraclass Correlation Coefficient, 
ICC is a better measure of reliability than Pearson's r both technically and mathematically. 
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While correlation coefficients measure the strength of the association between the two 
variables, another analysis is needed that determines whether the change in scores between 
the test and retest is statistically significant. A paired t-test can be used for numerical 
normally distributed data, while Wilcoxon is the nonparametric equivalent test for ordinal 
data (Pallant, 2005). 
Testing the stability of a scale is challenging in the clinical settings because the interval 
between the two occasions has to be long enough to avoid memory effect, i. e. patients 
recalling their initial answers, and not too long so the condition does not change. 
The test-retest reliability for established instruments must be re-examined when they are 
used in a different population than that they were originally tested on (Litwin, 1995). 
2. Inter-rater reliability and intra-rater reliability 
These are special cases of the test-retest reliability. Inter-rater reliability is also known as 
inter-observer, between-observer, or between-interviewer reliability and refers to whether 
different examiners will reach the same assessment for the same observation (e. g. patient) 
given no changes in the condition. Inter-rater reliability for agreement on ratings is measured 
by Cohen's Kappa (Cohen, 1988; Riffenburgh, 2006), which evaluates agreement in excess of 
that is expected to occur by chance. Kappa of 0 implies no agreement better than chance, 
while 1 implies perfect agreement. Other values and their interpretation are given in Table 2.9 
(Landis and Koch, 1977; Cohen, 1988). Different formulae to calculate Kappa have been 
developed to allow the assessment of agreement between two or more assessors; for two or 
more categories (Riffenburgh, 2006). 
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Table 2.9. Values of Cohen's Kappa and their interpretation 
0 No agreement 
< 0.2 Poor 
> 0.2 >0.4 Fair 
> 0.4 > 0.6 Moderate 
> 0.6 > 0.8 Good 
> 0.8 >I Very good 
1 Perfect agreement 
Intra-rater reliability, also known as intra-observer, within-observer, or within- 
interviewer reliability refers to whether the observer can obtain the same results from the 
same participant on different occasions, given nothing changed in the meantime. This is 
mostly required for predictive instruments when the purpose is to classify an observation into 
the same category. 
The Intra-rater reliability is assessed by a statistic known as Cronbach's coefficient alpha 
"a" (Worthington, 1998), named after the psychometrician who first reported it in 1951. 
Alpha lies between 0 and 1, but should be above 0.70 for the instrument to be reliable 
(Nunnally and Berbstein, 1994; Streiner and Norman, 1995). 
3. Internal consistency 
This indicator, sometimes named Homogeneity, reflects the harmony between the 
instrument's elements. In other words, it investigates if all the questions of a questionnaire are 
measuring the same or a related phenomenon, thus achieving results that are inter-correlated. 
This consistency is also assessed by Cronbach's a (Litwin, 1995; Riffenburgh, 2006). If the 
instrument's a is low, it can be improved by adding more items or re-examining the existing 
items for clarity. 
Similar to the test-retest reliability, it is essential to measure the internal consistency for 
each new instrument, as well as for existing instruments with established internal consistency 
when used in a population other than that for which they were designed (Litwin, 1995). 
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2.4.5.3. Responsiveness 
1. Sensitivity to change 
This feature is particularly relevant to evaluative instruments. In longitudinal research, it is 
fundamental that the instrument is capable of detecting change (both improvement and 
deterioration) in the condition of interest (Fitzpatrick et al., 1992b). Similar to the test-retest 
reliability, when measuring sensitivity, variance due to real change in the condition has to be 
distinguished from that related to measuring errors (Guyatt et al., 1992). To this end, it is not 
only important to examine the significance of score change pre- and post treatment, but it is 
essential to determine the true amount of change captured by the instrument. This is measured 
by calculating the Effect Size, which results from dividing the mean of score change by the 
standard deviation of the post-intervention score (Fitzpatrick et al., 1992b; Allen and Locker, 
2002). The effect size is considered small, moderate and large if it measures respectively 
< 0.2,0.3 to 0.6, and > 0.7 (Cohen, 1988; Allen and Locker, 2002). Another way to examine 
the sensitivity to change of larger multiple-item instruments is to administer a parallel single- 
item global scale of self-reported change (Dolan et al., 1998; Locker, 1998). 
2. Ceiling or floor effects 
The responsiveness of an instrument can be compromised by ceiling or floor effects (Guyatt 
et al., 1993; Locker and Allen, 2002). That is, patients may report the highest possible scores 
on a measurement of function, while their quality of life is impaired by other factors that the 
instrument failed to show -a ceiling effect. On the other hand, patients reporting lowest possible 
scores in an instrument may feel worse than others, or may get worse with time, yet the scale 
fails to demonstrate this. This is called the floor phenomenon (or effect) (Bindman et a!., 1990). 
It is crucial to employ questions that are responsive to the condition being investigated, 
and to use measurement units that allow the detection of small but clinically important changes. 
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2.4.6. Other methodological considerations 
The researcher has to be aware of other research and ethical issues that are of importance. 
2.4.6.1. Confidentiality 
Whether in-depth interviews or questionnaires are involved, great care should be exercised 
during data collection and handling. These data often comprise personal information and 
opinions and should be treated as confidential. Data forms should always be kept separate 
from any information identifying participants. Only codes can be attached to data forms, 
which can be used when necessary to trace back the respondent. Codes of practice should be 
followed both from national sources, e. g. data protection legislation (The Information 
Commissioner's Office in the UK, 1998); and internal sources, e. g. relevant University and 
Hospital Trust guidelines. 
2.4.6.2. Administering and data handling errors 
Various types of errors can occur during administration of questionnaires and data processing 
including coding and data entering. Every effort should be made to avoid or minimise 
mistakes. It is noteworthy that computer assisted interviews or questionnaires have major 
advantages over traditional methods in this context. 
2.4.6.3. Bias 
Bias can occur at any point of research, especially in the sampling stage. Bias can still occur 
even when both the instrument and the sampling method are valid. An example of this is the 
Auspices Bias seen for instance when patients tend to report higher satisfaction with treatment. 
This is especially the case in interviewer-administered questionnaires. The interviewer has to 
be perceived by the interviewee as neutral with regard to the subject matter of the interview. 
In this context hospital staff are advised not to interview their own patients regarding 
satisfaction of care for example, as this might introduce bias by patients attempting to please 
their hospital staff (Fitzpatrick and Boulton, 1994; Britten, 1995). Similarly, bias can occur 
when respondents may under-report socially undesirable behaviour in what is called Social 
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Desirability Bias. Recall Bias is another type of bias and is observed with questions involving 
memory (McColl et al., 2000). 
2.4.6.4. Sample size 
The sample of the research participants should be designed at the outset so that the emerging 
results can be generalised with confidence. One aspect of this design is the number of 
participants in a study that is required to obtain precise and reliable data. This is often 
controversial. On the one hand, the bigger the number the lesser the standard error. On the 
other hand, increasing the sample size consequently increases costs for data collection, 
processing and analyses. 
Numerous factors control the suitable sample size (Fink, 1995; Bowling and Ebrahim, 
2005). These include the following: 
1. Objectives of the study: the more objectives the study aims to achieve, the more variables 
introduced, with the consequent need for sufficient data. 
2. Number of subgroups of participants: it is important to ensure fair representation for all 
groups in the study. 
3. Type of data: data analysis relies grossly on its type, i. e. qualitative or quantitative. While 
a small number of participants is adequate to generate large amounts of qualitative data, 
statistical analyses of quantitative data often require a greater amount of data to be valid. 
4. Non-response rate: If this is expected to be considerable, over-sampling is often needed to 
obtain the desired response. This is often the case with postal questionnaires which have a 
lower response rate than "in-house" questionnaires, and longitudinal studies where 
participants fail to complete the study. 
5. Administration mode: face-to-face questionnaires are costly in comparison to the self- 
completion ones, and any additional participant will attribute markedly to the total cost of 
the study. 
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Estimating sample size 
The size of the sample should be calculated at the design stage of the study using a power 
calculation. The test power is its probability to detect differences between the investigated 
groups at a given level of significance (Petrie et al., 2002). This power should exceed 80% 
(Crichton, 1993; Petrie et al., 2002). The statistical significance of the study results relies also 
on the true difference between the populations being investigated and the level of 
significance. The level of significance is often selected at 0.05 (Petrie et al., 2002). 
Having determined all the above variables, calculating the desired sample size can be 
performed using Altman's nomogram (Altman, 1991). Alternatively, some statistical software 
packages are available to do this calculation. 
2.4.6.5. Missing data and enhancing response rates 
All self-report measures suffer from low response rates to some degree (McColl et al., 2000). 
This is particularly seen with postal and follow-up surveys where completing the 
questionnaire or the diary relies completely on the respondents' cooperation. The response 
rate may be acceptable sometimes, or considered unacceptable in others. This is when it is 
thought that the non-response rate can affect the validity of the results, while the questionnaire 
itself is a valid instrument. 
There are two types of response rate: Overall (questionnaire) response rate, defined as 
the proportion of respondents to the total number of eligible respondents; and Item response 
rate representing the proportion of answered questions (items) to the total number of items 
(McColl et al., 2000). Different approaches are recommended to improve the response rate 
(McColl et al., 2000; Boynton, 2004): 
1. Minimising the respondents' efforts to complete the survey and to return it, i. e. avoiding 
lengthy and complicated questions and providing pre-paid self-addressed envelopes 
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2. Maximising the respondent's rewards, for instance by emphasising the importance of the 
survey to the patient and all sufferers of the same problem, by personalising the covering 
letter, by expressing appreciation in all communications, and by informing the participants 
of the research results 
3. Establishing trust between the researcher and the respondents by means of establishing the 
credentials of the researcher (e. g. using headed papers in correspondence, naming of 
researchers), and by providing endorsement by well-regarded organisation. 
The latest technologies in obtaining and entering data help to reduce the amount of 
missing data. For example, computer-based questionnaires can be programmed to alert the 
respondent to uncompleted fields, or may even be programmed so they do not allow the 
respondent to proceed before completing all required fields. 
Ultimately, it is not uncommon to have missing data and it is the researcher's 
responsibility to assess the volume of these data and how they affect the outcome of the study. 
If missing data lie within the acceptable criteria set by the research, a decision has to be made 
whether these data are to be excluded or replaced. Replacing missing data is known as Data 
Imputation. Different methods for data imputation are available in current statistical packages 
(Riffenburgh, 2006). 
83 
Chapter 2. Review of the literature 
2.5. Assessing health in chronic disorders - timing of treatment 
outcome assessment 
2.5.1. The review period 
Establishing the time at which treatment outcomes are to be assessed plays a critical role in 
the reliability of the assessment. On the one hand, sufficient time must be allowed for the 
treatment to achieve the desired outcomes. On the other hand, the assessment should not be 
delayed too much, to enable the clinician to change treatment plans within acceptable time 
should the treatment prove unsuccessful. 
The time until assessment, the so called Review Period must be based on evidence and 
not chosen arbitrarily or this might well affect the reliability of the assessment. In TMD, 
however, this period appears to have been derived from clinical experience and expert 
opinion, but with no supporting evidence. For example, to test the sensitivity to changes with 
treatment for a "new outcome measure for TMD" (Pehling et al., 2002), the authors stated 
that "post-treatment testing was completed when the patient and treating doctor determined 
that a healing plateau had been achieved". Their review period averaged around six weeks 
after the start of treatment, but again without supporting scientific reference. 
Two systematic review studies for randomized controlled trials and splint therapy in 
TMD (Forssell et al., 1999; Al-Ani et al., 2004) have found that follow-up periods varied 
between four and 52 weeks (in the reviewed articles alone). To the best of my knowledge 
there is no literature that attempts to identify optimal review periods for TMD treatments. 
The optimal review period is principally dependent on the end point of treatment, ideally, 
the time when a cure has been achieved. However, in the case of chronic disorders, symptoms 
often linger and a cure may not be expected. In this scenario, clinicians will endeavour to 
minimize symptoms and their impact on patients' lives. Therefore, establishing the optimal 
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review period for chronic conditions should be based on the point when acceptable or 
important outcomes are achieved. 
In this context, defining "important outcomes" becomes essential, not only to determine 
the optimal review period, but also to produce potential cut-off points to sort treatment 
responders from non-responders, a measure that is increasingly adopted in clinical trials 
(Farrar, 2000). Furthermore, it constitutes a standard outcome measure to compare different 
clinical trials (Farrar et al., 2000; McQuay, 2005). 
Different attempts have been reported in the literature to define the "Clinically Important 
Difference - CID" in pain treatment outcomes. Unfortunately, there is no consensus, however, 
over what CID means, and what volume of improvement should be considered as CID 
(Farrar, 2000; McQuay, 2005). Firstly, while some studies defined CID as the minimum 
acceptable level of change in symptoms that can be reported as improvement (Todd and Funk, 
1996), others defined CID as the minimum desirable achievement from a particular treatment. 
They used this to draw a cut-off point between improvers and non-improvers (Moore et al., 
1997; Farrar et al., 2000). Consequently, lacking a clear definition of CID lead to disagreement 
about its value. For some (Todd and Funk, 1996) it meant a minimum reduction of 18 out of 
100 mm in the pain intensity as measured by the visual analogue scale. Other workers 
suggested that CID should be based on percentage of improvement (Goldsmith et al., 1993). 
They concluded that "an improvement of at least 36% should be clinically important for 
patients" in rheumatoid arthritis clinical trials. A shortcoming in the methods in the above 
studies is reliance on the professionals' assessment of the patient's pain instead of being 
patient-based (Todd and Funk, 1996; Farrar, 2000). 
The value of CID ranges in the literature between 25% and 75% pain reduction without clear 
rationale (Farrar, 2000). In particular, the 50% threshold has been adopted in different studies 
(Freedman et al., 2003; Mason et al., 2004a; Mason et al., 2004b) yet again there is no justification. 
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Different approaches have been taken to establish CID. A meta-analysis study of 
analgesic clinical trials compared different patient-based outcome measures including pain 
intensity and pain relief. The authors suggested 50% reduction in pain intensity as a cut-off 
point to group patients as "responders" or "non-responders" (Moore et al., 1997). The study 
also suggests that the number of responders compared to non-responders is an important 
outcome measure of clinical trials. Another approach has been used with complex regional 
pain syndrome type one. In this case patients' global perceptions of successful and 
unsuccessful treatment were related to a reduction in VAS pain scores (Forouzanfar et al., 
2003). The results show that a pain reduction of at least 50% and an absolute reduction of 
3 cm on a 10 cm VAS are accurate in predicting successful treatment. 
The concept of using "rescue medicine" has been used to establish the aforementioned 
cut-off point between improvers and non-improvers (Farrar et al., 2000). Rescue medicine is 
an additional drug that patients can take if their routine pain management fails to reduce pain 
sufficiently. As such, it can act as a gold standard for the clinical efficacy of routine treatment. 
This test, which has been used for cancer treatment, produces dichotomous data with clear cut- 
off point (i. e. whether the treatment worked or failed in improving symptoms) against which cut- 
off points from other pain scales can be standardised (Farrar et al., 2000; Farrar et al., 2003). 
To summarize, it is essential to establish the optimal time for treatment outcome 
assessment (review period). Arbitrary decisions about this time may have important effects on 
the reliability of the outcome assessment. Different methods have been suggested to establish 
the review period, however, there is no consensus. The concept of Clinically Important 
Difference, CID, still remains nebulous. Perhaps Pehling's idea (Pehling et al., 2002) of 
delaying post treatment testing until a healing plateau had been achieved offers a good 
outcome. Nevertheless, as with CID, further work is needed to define this more clearly for 
TMD and its sub-diagnoses. 
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2.5.2. The reference period 
Treatment outcome can be assessed by examining signs and symptoms at the time of the 
assessment, or by assessing the patient's experience of these over a past period of time. This 
is especially the case with a self-report instrument, such as a questionnaire, where patients 
will be asked to report their experience retrospectively with reference to a specific period, 
hence called the Reference Period. Determination of this period has to be done in conjunction 
with the outcome assessment timing. It too has to be evidence-based to provide consistency 
across different studies of the same condition. 
The reference period should allow patients enough time to make a meaningful 
assessment of their experience. On the other hand, it should not be too long or it will include 
the time near the start of treatment when no or little improvement had been achieved. It is 
therefore essential that this period allows for a realistic CID to be reached and either 
maintained or exceeded for some time to enable the patient to make a valid assessment of the 
hopefully improved condition. 
If a previously designed questionnaire is to be used, which is not specifically designed 
for a TMD population, the validity of its original reference period has to be established. 
Generalising the same reference period blindly to a population other than the original one may 
well compromise the results. The main questionnaire used in this project, OHIP, has been 
originally designed and used for patients with oral and dental problems in general with a 
reference period of 12 months (Slade and Spencer, 1994; Slade, 1997b). As part of validating 
the German version of OHIP, John et al. (2002) reported that a one month reference period 
had the highest internal consistency. 
Different studies have administered OHIP with a reference period of one month. These 
include research on orofacial pain (Murray et al., 1996; Segü et al., 2005) and on patients 
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with oral rehabilitation needs (Awad et al., 2000). The choice of this period, however, was not 
justified in either study. 
To the best of my knowledge, there is no study in the literature that attempts to establish 
the optimal reference periods to assess TMD treatment outcomes. 
2.5.3. Temporal dynamics 
Some chronic pain conditions are characterised by evident variation in intensity over time, 
e. g. fibromyalgia (Gendreau et al., 2003; Harris et al., 2005). This can occur within the same 
day or from day to day. It is important, therefore, to take these dynamics into consideration 
when assessing treatment outcomes. Most studies assess treatment outcomes at different 
follow-up occasions with fixed or unfixed intervals (Farrar, 2000; Gendreau et al., 2003). If 
this assessment looks only at the variable of interest at the time of the assessment, then it 
clearly misses what is happening between the review points. This is similar to taking snapshots 
of a moving object and expecting to understand how it moves. Some methods overcome this 
drawback by asking the patients to assess the outcome of interest over a period of time (the 
reference period). Yet, they fall into another problem, and that is relying on the patient's 
memory which often yields a bias in the assessment (Redelmeier and Kahneman, 1996). 
Examining the temporal dynamics of a condition will not only enhance the assessment of 
treatment outcomes, but will improve understanding of the condition itself and its progress. 
This point is strongly emphasised by a review study of diaries (Bolger et al., 2003). 
Diaries are the most powerful tools to assess changes in the outcome of interest as they 
are happening (Bolger et al., 2003). While this section aims only to highlight the importance 
of examining temporal dynamics of chronic disorders, assessment methods for these 
dynamics along with their pros and cons are covered elsewhere (section 2.4). 
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2.6. Assessment of oral health-related quality of life (OHrQOL) 
OHrQOL measures concern the impact of orofacial conditions on quality of life. In a way, 
they can bp considered as site-specific self-report measures of health. 
The development of OHrQOL was inspired by the general concept of health-related 
QOL. Historically, OHrQOL was given little attention in comparison to generic HrQOL 
(Cohen and Jago, 1976). It was in 1984 that research was carried out on the societal impact of 
OHrQOL, more specifically the impact of dental diseases on loss of work (Reisine, 1984). 
Subsequent research has demonstrated that orofacial conditions have as serious an impact on 
QOL as other disorders (Cushing et al., 1986; Reisine et al., 1989). 
The earliest attempts to measure OHrQOL used generic HrQOL instruments, for 
example, the Sickness Impact Profile (SIP) (Reisine, 1985). This approach was criticised by 
Locker who argued that while pain impact can be detected, the impact of other conditions 
such as tooth loss cannot (Locker, 1988). The first oral-specific measure of health related 
quality of life was the Sociodental Scale (Cushing et al., 1986). 
It is argued that measuring OHrQOL by generic HrQOL tools has a number of 
advantages over the use of OHrQOL specific measures. For instance, the use of generic 
instruments allows for the comparison between oral-related and other disorders. In addition, 
the psychometric characteristics of these measures are already established. The counter 
argument is that generic instruments often fail to capture subtle differences in oral health 
status (McGrath et al., 2003), and that their discriminant validity and responsiveness to 
changes with treatment is poor (Allen et al., 1999; Allen et al., 2001). Furthermore, OHrQOL 
instruments are condition-specific, and therefore of less burden on the patient. This would 
consequently shorten completion time and improve the response rate. 
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2.6.1. Oral specific health related quality of life instruments 
Similar to generic HrQOL, OHrQOL measures have been developed to measure the impact of 
illness both on the societal level, including days lost to sickness and treatment costs (Reisine, 
1984) and on personal levels. Only the latter is considered here. 
Different approaches and frameworks have been used to construct OHrQOL instruments. 
The conceptual framework based on WHO's classification of impairment, disability and 
handicap (World Health Organization, 1980) is a reasonable starting position (Sato, 1997; 
Allen, 2003). In this concept, any damage in the orofacial structures (e. g. tooth lost or TMJ 
arthritis) is considered as impairment. This can consequently lead to disability (e. g. 
difficulties in performing daily activities such as eating and speaking) and/or to handicap in 
more severe conditions (e. g. absence from work and financial consequences). Based on this 
classification, Locker built a frequently cited conceptual model for measuring oral health 
(Locker, 1988) (Figure 2.4). 
Figure 2.4. Locker's conceptual model for measuring oral health 
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Locker's model forms the foundation for several OHrQOL instruments including: the 
Oral Health Impact Profile (OHIP) (Slade and Spencer, 1994), the Dental Impact on Daily 
Living (DIDL) (Leao and Sheiham, 1996), and the Oral Impacts on Daily Performances 
(OIDP) (Adulyanon et al., 1996). 
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2.6.2. Historical uses of OHrQOL instruments 
OHrQOL tools have been mostly used in descriptive population studies (Locker and Slade, 
1993; Nuttall et al., 2001; McGrath and Bedi, 2003a; Steele et al., 2004; Fernandes et al., 
2006). Some workers established national norms for some of these tools (Kelly, 2000; 
McGrath and Bedi, 2002; John et al., 2004b), while others have investigated the cross-cultural 
differences of OHrQOL (Slade et al., 1996; Allison et al., 1999). 
OHrQOL instruments have also been used as treatment outcome measures (Rogers et al., 
1998) in clinical trials (Awad et al., 2000; Allen and McMillan, 2003; Allen et al., 2006) or as 
predictors for treatment needs (Leao and Sheiham, 1996; Locker and Jokovic, 1996). A few 
attempts have also been made to use these instruments as cost-utility indices (McGrath and 
Bedi, 2003b; Heydecke et al., 2005; Brennan and Spencer, 2006). There is still some development 
work required for the use of such measures for outcome assessment and economic purposes. 
2.6.3. Types of OHrQOL instruments 
OHrQOL, with its different domains and dimensions, can be assessed using either single-item 
global rating question or multiple-item questionnaires. While the former is shorter, easier to 
administer and therefore more suitable for large scale cross-sectional research, the latter, having 
more items, is more accurate in capturing details and more appropriate for longitudinal 
studies. Nevertheless, multiple-item questionnaires have largely been used in surveys involving 
large number of participants (Slade eta!., 1996; Allen and McMillan, 2003; Steele et al., 2004). 
A number of instruments from both approaches (single and multiple-item) have been 
devised and used in the past. Single-item global ratings of oral health have been used as 
indicators of health status (Locker and Jokovic, 1996; Jones et al., 2003). However, these do 
not attempt to measure QOL, for example, "How would you describe the health of your teeth 
and gums? ", which is asked with a five-point Likert type scale (from Good to Poor) (Jones et 
al., 2003). 
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Multiple-item OHrQOL instruments have also been developed, with considerable 
heterogeneity in their focus, length and format (Table 2.10 page 93). For example, current 
OHrQOL questionnaires range in length between three and 56 items reflecting the divergence 
in opinions about definition of QOL and its components. Of these instruments, four allow 
patients to report the positive impact of oral health on QOL (Slade, 1997a; McGrath and Bedi, 
2001; Slade, 2002). These are the Geriatric (or General) Oral Health Assessment Index 
(GOHAI), the Dental Impact Profile, the Oral Health Quality of Life - U. K. and the Oral 
Health QOL Inventory. 
Condition-specific instruments 
While OHrQOL instruments are considered as a site-specific type of the HrQOL instruments, 
even more condition-specific instruments have been developed as shortened versions of the 
general OHrQOL instruments [e. g. OHIP-edentulous (Allen and Locker, 2002)]. However, 
oral condition-specific measures have not all been derived by shortening generic OHrQOL 
tools. Some have been developed as original and independent OHrQOL instruments. 
Examples of these are the Xerostomia-Related Quality of Life Scale (XeQoLS) (Henson et 
al., 2001), the Manchester Orofacial Pain Disability Scale (Aggarwal et al., 2005), and the 
Liverpool Oral Rehabilitation Questionnaire (Pace-Balzan et al., 2006). 
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2.6.4. Choosing an OHrQOL measure 
Choice of the most appropriate OHrQOL measure relies on different considerations including 
the instrument's theoretical framework, purpose, ability to measure positive as well as 
negative impact of health on QOL, derivation method, psychometric characteristics, 
practicality and cross-cultural compatibility. 
To date, no substantive work has been published to compare the performance of the 
different available OHrQOL instruments (Allen, 2003). Some studies, however, have partially 
explored this issue. For example, Strassburger et al. found that OHIP is increasingly used in 
OHrQOL studies, and that it is methodically more sufficient than other OHrQOL instruments 
(Strassburger et al., 2004). 
The instrument of choice should have a sound theoretical basis that is in accordance with 
the domains of quality of life and health-related quality of life. OHIP is structured around 
Locker's hierarchal model of health and its related quality of life (Locker, 1988), which is 
based in turn on the WHO's classification of illness. 
Existing OHrQOL instruments have been developed for various purposes, as discussed in 
section 2.4.3.3. The psychometric characteristics of an instrument are dependent on the 
purpose it was designed for. Therefore, it is essential to choose the instrument for the right 
purpose and with suitable properties. OHIP was originally developed to measure the impact of 
oral disorders on the individuals in epidemiological research. Nevertheless, it has been 
employed successfully in different types of research including its use as a measure of 
treatment outcomes for prosthetics treatments (Awad et al., 2000; Allen and McMillan, 2003), 
surgical interventions (Ross Beime, 2004), orthodontics (de Oliveira and Sheiham, 2004), and 
tooth whitening (McGrath et al., 2005). OHIP has also been used in research on oral 
conditions such as Behcet's disease (Mumcu et al., 2006), periodontal diseases (Ng and 
94 
Chapter 2. Review of the literature 
Leung, 2006) and temporomandibular disorders (Murray et al., 1996; John et al., 2002; 
Larsson et al., 2004; Segü et al., 2005; Wolfart et al., 2005). 
On the other hand, unlike other measures such as the Oral Health Quality of Life - UK 
(McGrath and Bedi, 2001), OHIP only allows for negative rating of health (Locker and 
Gibson, 2006). In other words, it measures deviation from health and the burden of illness as 
opposite to measuring well-being. Also, it measures only frequency of the impact on quality 
of life and not its severity. 
OHIP's major advantage over some other instruments is that it is based on statements 
derived from in-depth interviews with a representative sample of dental patients (Slade and 
Spencer, 1994). This gives it an excellent content validity. In addition, OHIP's psychometric 
properties have been extensively explored and proven in different conditions and populations 
(Slade, 1997b; Slade, 2002; John et al., 2003; Larsson et al., 2004). Furthermore, OHIP 
appeared to be the only OHrQOL instrument tested or used in the TMD population. 
Practicalities 
In the search for a practical and inexpensive measure of OHrQOL, it is particularly important 
that the instrument can be successfully self-administered, thus eliminating the costs and 
resources often needed for the interviewer-administered questionnaires. Robinson et al. 
(2001) compared between OIDP (Slade and Spencer, 1994) and a short version of OHIP-49: 
OHIP-14 (Slade, 1997b) (see section 2.6.6 below). Both instruments were administered in two 
formats, interviews and self-completed questionnaires. The authors found that OHIP-14 
preformed better than OIDP in the self-completed format. In part, this may be due to the fact 
that OIDP was originally designed and tested as an interviewer-administered instrument. The 
completion rate of the self-completed OIDP was particularly low in ethnic minorities, who 
apparently found it difficult to complete the questionnaire (Robinson et al., 2001). 
95 
Chapter 2. Review of the literature 
This conclusion is supported by findings from another study that compared OHIP-14 and 
OIDP in a sample of patients with xerostomia (Baker et al., 2006). However, OHIP suffers a 
limitation in comparison to OIDP, and that is it does not measure severity of the problem but 
frequency. 
When compared to the Geriatric (or General) Oral Health Assessment Index (GOHAI) 
(Atchison and Dolan, 1990), OHIP-14 was found to be as good a discriminative tool, but 
weaker in detecting within-subject change (Locker et al., 2001). This may be explained by the 
way OHIP-14 was derived from the original OHIP-49. The derivation method means that 
OHIP-49 lost a large number of items, and with them it lost part of its psychometric 
properties, as discussed in section 2.6.6. 
In addition, with the increasing international collaboration of medical research, OHrQOL 
instrument that are cross-culturally compatible have advantage on others which are not 
(Bullinger et al., 1993; John et al., 2007). Similarly, instruments which can be used for 
different conditions, allow for cross-condition comparisons, something that is very helpful for 
health bodies and policy makers. 
Partly as a result of its early development and perhaps of its strong theoretical 
framework, OHIP has gained international popularity and has been translated to different 
languages including Chinese, German, Hebrew, Hungarian, Italian, Japanese, Malay, Spanish 
and Swedish. The international popularity of OHIP gives it even more strength as it allows for 
comparisons to be made not only across different nations, but also across the different disease 
populations for which it has been used. For example, Larsson et al. (2004) used the Swedish 
OHIP to compare four conditions: TMD, primary Sjögren's Syndrome, oral mucosal pain and 
skeletal malocclusion. 
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2.6.5. The Oral Health Impact Profile (OHIP) 
OHIP comprises 49 statements structured in seven domains which are matched more or less to 
Locker's model (Locker, 1988). These are functional limitation, physical pain, psychological 
discomfort, physical disability, psychological disability, social disability and handicap 
(Appendix 7). It does not measure, however, the perceived satisfaction with oral health, 
changes in oral health, prognosis or self-reported diagnosis (Slade, 1997a). 
An example of the basic style of OHIP items is: Have you found it uncomfortable to eat 
any foods because of problems with your jaws, teeth, mouth or dentures? Each item is scored 
on a five point scale related to frequency of impact in the following order: Never, Hardly 
ever, Occasionally, Often, and Very often. The reference period in the original OHIP is one 
year, i. e. patients assess their quality of life retrospectively over one year. 
Weights are available for OHIP items based on Thurstone's method of paired 
comparisons (Allen and Locker, 1997; Slade, 1997a). These aim to attribute to the items 
values that are related to their importance. However, it is argued that these weights unnecessarily 
make OHIP scoring more complicated and unfeasible in clinical settings (Allen and Locker, 
1997; Allen et al., 2001). In most current research employing OHIP weights are not used. 
Scoring OHIP 
Calculating OHIP scores is achieved in two ways. The first is to compute summed item scores 
"Sum OHIP". So for a particular individual an overall score is computed by summing item 
scores. For a group, a mean score can be obtained for each independent item across all members 
of the group. Since the scale is ordinal and not continuous, overall scores are appropriate only 
for comparison purposes, and not as summary scores. In other words, a score of 20 represents 
more impact on quality of life than that of 10, but the absolute value itself is meaningless as it 
could refer to different degrees of the impact frequencies. 
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The second method is to count items answered at a threshold level, e. g. fairly often or 
very often (FOVO). Individuals' overall scores are calculated based on the number of items 
that reach this threshold. For a group, the overall score for a'particular item is the proportion 
of respondents reporting this item above the given threshold. Statistically, this is simpler and 
more straightforward to handle than the previous method. However, in many populations the 
distribution of this summary variable may be skewed, with many respondents reporting no 
impact at the defined threshold, restricting the use of parametric statistics (Slade, 2002). 
2.6.6. Short-form versions of OH/P 
Different distilled versions of OHIP have been produced in order to facilitate its use in clinical 
or epidemiological settings, or to obtain disease-specific measures (Allen, 2003). Historically, 
OHIP was first reduced by Slade to a 14-item version, the so called OHIP-14 (Slade, 1997b). 
This was followed by another attempt to derive a 14-item version using a different shortening 
method (Locker and Allen, 2002). These latter authors then produced a condition-specific 
version of OHIP, OHIP-EDENT for the edentulous population (Allen and Locker, 2002). This 
instrument is also known as OHIP-20. 
The simplicity and usefulness of the short versions of OHIP prompted authors around the 
world to produce their own short form including the Chinese OHIP-14S, the Malaysian, the 
Japanese, the Hebrew 14-item OHIP. Recently the Germans introduced three new daughters 
of OHIP: the 5-item, the 14-item and the 21-item (John et al., 2006b). 
Different methods have been used to derive the short forms including regression analysis, 
factor analysis and item-impact analysis (as discussed in section 2.4.3.5). The choice of 
shortening method depends on three factors: 
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1. Whether the original instrument is the gold standard for the condition it measures 
2. Whether the desired short-form is intended to replace the long form in the same context, or 
to be a population (disease) specific version 
3. Whether the intended short-form is desired to act as a discriminative or evaluative tool. 
Slade used internal reliability analysis, factor analysis and regression analysis to reduce 
OHIP and found that the regression analysis yielded the optimum set of items (OHIP-14) 
(Slade, 1997b). Locker and Allen adopted a different approach to obtain a 14-item version by 
using a modified form of the item-impact analysis (Locker and Allen, 2002). In the original 
item-impact analysis (Juniper et al., 1997) each item is given a score, which is obtained by 
multiplying its prevalence in the population of interest by a measure of its importance. The 
modified form used mean score of the item as a proxy for its importance. Items were then 
ranked by their item-impact and the top two items from each OHIP dimension were selected. 
Locker and Allen compared their results with Slade's and found that items derived with 
the regression analysis have a smaller size effect and a greater floor effect than those obtained 
by the item-impact method (Allen and Locker, 2002; Locker and Allen, 2002). They 
concluded that Slade's regression analysis yielded a good discriminatory tool but that was 
weaker in describing the OHrQOL of populations and detecting change with treatment. 
Furthermore, Locker and Allen (2002) reported that both the regression and item-impact 
methods produced indices with good psychometric characteristics, including discriminant and 
convergent validity, internal consistency, and correlation with the full OHIP. While the 
regression analysis did better in some of these tests, the authors argue that any subset of 14 
items of OHIP will have reasonable psychometric properties no matter how they are selected 
(Locker and Allen, 2002). Therefore, the approach of choice to shorten OHIP depends on the 
ultimate use of the index. 
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2.6.7. OH/P as a measure of TMD-related quality of life 
Section 2.2.6 of this review reported the impact of TMD on patients' quality of life, and the 
different patient-based instruments that have been used to measure this impact. Among these 
was OHIP, which was able to capture the impact of TMD and orofacial pain on sufferers' 
lives and to differentiate between TMD sufferers and the general population. (Murray et al., 
1996; John et al., 2002; Larsson et al., 2004; Segü et al., 2005). For example, TMD patients 
reporting frequent or constant function-related problems such as chewing food were four 
times as many compared to those in the community, and nine times more reported 
psychological problems such as depression (Murray et al., 1996). OHIP was also sensitive to 
the differences between different diagnostic groups of orofacial pain (Murray et al., 1996), 
and also sensitive to changes with treatment (John et al., 2002). 
Among these studies, only Murray et al's study used the English language OHIP. Murray 
et al pioneered the use of OHIP in the TMD population providing a very useful insight on the 
extent to which quality of life was compromised in these patients and how this was associated 
with different pain profiles. The significant correlation between OHIP and other pain-related 
measures run in parallel support the validity and reliability of OHIP as a measure of TMD- 
related QOL. 
That study, however, suffered from some design limitations, which were recognised by 
the authors. For example, the patients were selected based on their clinical notes, and were 
mailed the questionnaires prior to their initial appointments. Clinical examination to confirm 
the diagnosis was only available for half of the participants. Moreover, the sample consisted 
of patients with TMD and other neurological pain disorders. According to the authors, these 
groups differ in their quality of life profile (different OHIP domain scores were noted). 
Furthermore, only 30 items of OHIP were used in this study; 21 items were eliminated and the 
choice of these questions was subjective, and two items were added to OHIP: "Taking longer 
to complete a meal " and "Avoiding eating with others" based on previous research 
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undertaken by the authors. Finally, the one-year reference period in the original OHIP was 
changed to one month, with no justification for this time frame. 
In the German version of OHIP "OHIP-G" (John et al., 2002) the authors tested the 
ability of OHIP to differentiate between TMD sufferers and four other groups including a 
group of healthy subjects. They also tested OHIP's ability to capture change with treatment. 
The extensive analysis concluded that OHIP-G was both effective as a discriminative and 
evaluative tool for TMD. The authors also reported a strong correlation between health- 
related quality of life assessed by OHIP and RDC/Axis II measures (John et al., 2007). 
Despite the relatively small TMD patient sample (n = 30) that took part in validating the 
Swedish version (Larsson et al., 2004), the study reported interesting findings. These authors 
added the word `jaws " to the source of patients suffering in the body of OHIP questions. The 
discriminative psychometric properties for OHIP were examined in five groups including 
subjects coming for routine dental check-ups, patients with TMD, primary Sjögren's Syndrome, 
oral mucosal pain and skeletal malocclusion. Additionally, the authors confirmed the stability 
of OHIP in the TMD subgroup. 
The Italian version of OHIP was also validated in a sample of TMD patients (Segü et al., 
2005). The study was to a large extent a reproduction of Murray et al. 's study (1996). The 
authors used the same 30 OHIP items, same one month reference period, and same validating 
pain measures. This work confirmed the findings of the above-mentioned and OHIP was 
found to have good discriminative psychometric properties for TMD. 
All studies that have used OHIP in TMD populations reported that non TMD-related 
items dilute the overall score. They agreed that exclusion of these items would not only 
minimize respondent burden, but more importantly would improve the performance of OHIP 
as a measure of TMD-related quality of life. 
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2.7. Summary of the literature review 
Emphasis has been increasingly given to base the understanding of TMD aetiology, their 
management and outcome assessment on the same biopsychosocial model used for other 
chronic pain conditions (Dworkin and Massoth, 1994; LeResche, 1997a). To this end, outcome 
measures are needed for TMD that encompass this concept and that are based on patients' 
perception of their illness and of their quality of life as opposed to clinician-based measures. 
Currently, most TMD measures concern about the detectable physical signs and 
symptoms. An exception to that is the RDC system (Dworkin and LeResche, 1992), which 
allows assessment of both the physical and psychological dimensions. However, RDC is 
clinician-centred, does not assess the social dimension of TMD and has not been tested as an 
outcome measure. 
Other patient-based non TMD-specific instruments are available, which measure the 
impact of chronic illness in its multidimensional model. However, these generic instruments 
are arguably not sensitive enough to capture subtle differences in health status (Hill et al., 
1996; Turk et al., 2003). In this perspective, balance is required between condition-specific 
instruments that are sensitive to small changes with treatment and generic health instruments 
which permit comparisons across different conditions, a pre-requisite for decision-making in 
health care. To this end, OHrQOL measures provide a reasonable balance and can form the 
basis for the development of a TMD outcome measure. 
Among available OHrQOL measures, the Oral Health Impact Profile (OHIP) (Slade and 
Spencer, 1994) is the most widely used both across various oral conditions and different 
languages. Moreover, OHIP has a strong theoretical framework, has been extensively 
validated and has shown ability to capture the impact of TMD on quality of life. 
OHIP, however, has not been tested as an outcome measure for TMD. Its many non 
TMD-related items might potentially compromise its utility as an outcome measure. 
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Moreover, its one-year reference period, set originally for epidemiologic studies on oral 
diseases, is not suitable for outcome assessment of TMD. 
A research is needed to identify OHIP items that are most relevant to TMD, which 
exhibit sufficient psychometric properties to form the core of a patient-based quality of life 
outcome measure for TMD. An investigation is also required to establish the optimal time to 
administer OHIP to assess TMD treatment outcome and to determine the best reference period 
to be used in this assessment. This background forms the rational for this PhD project. 
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Chapter 3. Aims of project 
The overall aim of this project was to start the development of a quality of life outcome 
measure for TMD. Three linked studies were conducted for this purpose. The aims of each of 
these studies are shown below: 
Study One: Determination of suitable review and reference periods to assess TAMD 
treatment outcomes: Analysis of TAMD pain diaries 
Pain dynamics of patients undergoing conservative treatment of TMD were explored to 
establish optimal review and reference periods for the assessment of TMD treatment outcome. 
Study Two: Determination of suitable review and reference periods to assess TNID 
treatment outcomes: A qualitative approach - Interviews with TAND patients 
This study aimed to triangulate with Study One and verify the previously identified review 
and reference periods. Qualitative methods were used to explore the lived experience of TMD 
throughout treatment, and to understand patients' perception of the process of improvement. 
Study Three: Establishing a quality of life measure of TAND treatment outcomes 
Study three aimed to begin the process of developing an outcome measure for TMD, using as 
a starting point the Oral Health Impact Profile (OHIP). The study aimed to derive a short form 
of OHIP that is potentially suitable as an outcome measure and to explore aspects of its 
psychometric properties. 
105 
Chapter 4. 
Study One: Determination of 
suitable review and reference 
periods to assess TMD treatment 
outcomes: 
Analysis of TMD pain diaries 
Chapter 4. Stucky one - Introduction 
4.1. Introduction 
To conduct reliable and proper assessment of treatment outcomes, sufficient time must be 
allowed for the treatment to work. This is critical when different approaches are being 
compared. In this part of the thesis, Study One, I aimed to determine an appropriate time to 
review TMD treatment outcomes. I called the time at which a meaningful assessment of 
treatment outcomes is made the "Review Point ", and the time between the start of treatment and 
this point is therefore called the "Review Period" (Figure 4.1). In the literature, this period has 
been chosen arbitrarily and varies from one month to one year (Forssell et al., 1999). 
Figure 4.1. A time scale representing review and reference periods 
Re% ie%ý period 
Reference ý--ý 
Review 
Treatment Time scale 
start 123456789 10 11 12 (months) 
The treatment outcome assessment to be carried out, in this project using the Oral Health 
Impact Profile (OHIP), a quality of life instrument, will ask patients to appraise their 
conditions retrospectively over a period of time, called the "Reference Period" (Figure 4.1). 
The concept of reference period appears only rarely in the TMD literature. OHIP, was 
originally designed for patients with oral and dental problems in general and used a reference 
period of 12 months (Slade and Spencer. 1994; Slade, 1997b). However, John et al. (2002) 
found that a reference period of one month provided OHIP with the best internal consistency. 
Some studies that administered OHIP on orofacial pain patients used a one month reference 
period (Aggarwal et al., 2005; Sega et al., 2005). These latter authors, however, did not 
justify their choice of one month. 
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To the best of my knowledge there is no literature that determines when TMD treatment 
outcomes can be measured properly (i. e. the treatment has been given sufficient time to 
work), and I aimed from this study to determine suitable review and reference periods to 
assess TMD treatment outcomes. To achieve this aim I analyzed changes in pain intensity 
with treatment of TMD patients. The data consisted of pain diaries recorded by TMD patients 
during a trial of splint therapy (Wassell et al., 2004). Changes in pain scores throughout the 
treatment were used to draw a general "pain recovery" trend for those who responded to 
treatment. This trend was used then to inform: 
1. The average time taken for TMD treatment to reach and maintain an acceptable outcome, 
i. e. the review period. 
2. The average period before the review point where a clinically significant improvement, in 
relation to the start of treatment, had been achieved and maintained, i. e. the reference period 
(Figure 4.1). 
As will be expected from any clinical trial, not all participants respond to treatment and 
this was the case with patients in this study (as explained later). However, as aforementioned, 
the patients of interest were only those who showed improvement (the Improvers). Therefore, 
I had first to discriminate improvers from non-improvers; and to do so I had to design some 
discrimination rules and compare them against other traditional measures. 
I will call the preparatory study which explored pain dynamics and discriminated between 
improvers and non-improvers: Study ]-A; and the following work which aimed to study the 
pattern of pain improvement in an average improver: Study 1-B. Since the materials (i. e. the 
patient group that provided the pain diary data) are the same for both studies, I will describe 
these first, and then I will give details for the methods and results for each study separately. 
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4.2. Aim 
This study explored pain dynamics of patients undergoing conservative treatment of TMD, 
with the aim of establishing suitable review and reference periods to assess TMD treatment 
outcome. 
4.3. Objectives 
1. Study 1-A: to identify the improvers by: 
a. Assessing characteristics of pain change with time by visually examining pain/time plots 
b. Setting up rules to discriminate patients based on the above characteristics 
c. Testing the reliability of these rules 
d. Comparing these rules against other traditional mathematical measures of improvement 
e. Identifying the definite improvers to inform Study 1-B 
2. Study 1-B: to examine the general pattern of pain improvement, in order to determine: 
a. A suitable review period 
b. A suitable reference period. 
Outline of this study is presented in Figure 4.2. 
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Figure 4.2. Outline of Study One 
I -A 
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Excluding invalid data 
Study One 
1-13 
Determining review and 
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of pain scores ."i 
i Examining the pattern of 
: ssment pain improvement 
Testing and validating the rules 
Determining the Determining the 
Comparing the visual & review period 
review period 
mathematical analyses 
Corroborating results to identify 
definite improvers 
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4.4. Materials 
This is a secondary analysis of data obtained from a previous prospective study of TMD 
management in general dental practice (Wassell et al., 2004). The original study tested the 
effectiveness of stabilization splints in the treatment of TMD. Ninety three patients with 
different types of painful TMD were invited to take part, with 72 completing the trial. Patients 
were randomly allocated to receive either stabilization splints (treatment group SS = 34 
patients) or non-occluding splints (control group CS = 38 patients). The non-occluding splint 
had the same design and shape as the stabilization splint, but without an occlusal surface. 
Treatment time for SS and CS was three months, however, after nine weeks of follow-up, 17 
patients were crossed over from the CS to SS due to poor response to treatment (cross-over 
group CO). These patients were treated for five months. Diagnoses were made according to 
the International Headache Society Criteria (McNeill eta!., 1993). The majority of patients 
had either "muscle" or "muscle and joint" related problems. Only four patients had clinical 
signs and symptoms associated exclusively with the joints. 
Treatment outcomes were assessed by means of daily diaries for pain intensity in these 
72 patients who completed the trial. Patients were asked to complete the dairies at the end of 
each day. The diaries contained the following three questions: 
1. Please mark, on the line below, how bad your jaw pain has been today. The line represented 
a visual analogue scale (VAS), 100-millimetre long, anchored at each end by "No pain" 
and "Unbearable pain" 
2. How many hours of headache have you suffered today? 
3. How many painkillers have you taken today? 
Type of tablets? ---------------- 
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4.5. Study 1-A: Identifying improvers 
Objectives of this study are summarized in page 109. 
4.5.1. Methods 
Pain VASs were measured using a millimetre ruler and scores to the nearest millimetre 
inserted into an Excel spreadsheet. Some of the diaries were not valid for two reasons: 
1. Five patients had more than one diary for the same period of time. These unexplained 
double data were excluded. 
2. Not all patients filled in the diaries regularly, and these were excluded if they had missing 
data for: 
a. More than 10% overall, or 
b. More than 25% missing data within any month (any 30 consecutive days) 
This resulted in a further exclusion of 28 patients. Therefore, 39 patients met the inclusion 
criteria, representing 54% of patients completing treatment. These were 34 females and five 
males with mean age 35 years (ranging from 19 to 65 years). Sixteen of them were in the SS 
group, 13 controls (CS) and 10 were crossed-over from SS to CS. Detailed diagnoses using the 
International Headache Society Criteria (McNeill et al., 1993) are shown in Table 4.1. 
Table 4.1. Diagnoses of patients participating in the original trial in Study One 
Sub-diagnosis Frequency % Sub-diagnosis Frequency % 
None 1 2.6 None 23 59.0 
0 Reflex Splinting 14 35.9 ö Disc Displacement with Reduction 15 38.5 
aR Myofascial Pain 24 61.5 Capsulitis 1 2.6 
y C 
Total 39 100.0 Total 39 100.0 
Thirty nine individual pain/time graphs were drawn which revealed remarkable 
dissimilarity among patterns of pain change with treatment. Some graphs showed a clear trend 
in jaw pain reduction during treatment, others showed no improvement, but only pain 
fluctuation, whilst a third group was borderline between improvers and non-improvers. 
Examples of these graphs are shown in Figure 4.3. 
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A. Improver 
B. Borderline improver 
C. Non-improver 
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Figure 4.3. Different types of pain/time change with treatment 
Chapter 4. Study 1-A: Identifying improvers - Methods 
To identify definite improvers, these pain-time graphs underwent the following analyses 
(detailed outline is shown in Figure 4.4): 
1. Visual assessment, where pain-time graphs were assessed visually; assessment rules were 
set and tested. 
2. Mathematical assessment analysed the reduction of pain scores in relation to the first and 
last months of treatment. 
3. The agreement between these two procedures was tested and definitive responding 
patients identified by combining results from both analyses. 
4. Further analyses were performed to check and further validate the aforementioned 
approach. 
Figure 4.4. Detailed outline for the methods used to discriminate improvers from non-improvers 
Visual assessment 
First assessment 
(joint assessment - setting rules) 
Second assessment 
(individual assessment - adding more rules) 
Third assessment 
(individual assessment - identifying 
improvers "visually") 
Mathematical assessment 
Mean & Maximum 
(pain intensity comparison in first & last 
months of treatment) 
Identifying improvers "mathematically" 
using 50% improvement as a cut-off point 
Area under the curve AUC 
(as an alternative to the "Mean " test) 
Comparing between the visual and the mathematical assessments 
Sensitivity & Specificity of Mean & Maximum against Visual as standard 
Additional tests: 
Analgesics usage analysis 
Examining changes in the mathematical 
cut-off point for identifying improvers 
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4.5.1.1. Conducting and validating the visual assessment 
Graphs plotted for the selected 39 patients were examined by three consultants experienced in 
the management of TMD, two of whom were specialists in Restorative Dentistry and the third 
in Oral & Maxillofacial Surgery. To improve and validate the assessment criteria, this was 
conducted on three separate occasions with two month-intervals to reduce memory effects. 
In the first assessment the assessors jointly examined the pain/time graphs and considered two 
factors: 1- general trend of the graph, 2- heights of the pain spikes (Figure 4.3). 
To determine the inter-examiner reliability of the visual assessment, on the second 
occasion the consultants assessed the graphs individually. Their agreement was measured by 
two sets of Kappa tests. The first considered all three patient categories, whilst the other 
combined the borderline graphs with the non-improvers. Kappa was calculated using the 
statistical package Statat, which was recommended by the faculty statistician Dr Nick Steen. 
Following this assessment the non-agreed cases were discussed and two more rules were 
introduced to conduct the assessment on a third occasion. These new rules took into account 
changes during treatment affecting the apparent frequency of the pain spikes and the apparent 
area under the graph line. 
The third assessment was again performed individually and was subject to Kappa tests. 
Finally, based on the results of the third assessment patients were visually categorised as 
improvers, borderline improvers or non-improvers. This was done by assigning a patient to a 
category if two or all three examiners agreed on the allocation. 
Stata 7, StataCorp LP, 4905 Lakeway Drive, College Station, Texas 77845, USA 
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4.5.1.2. The mathematical assessment 
The second approach to discriminate improvers from non-improvers analysed changes of pain 
scores during treatment mathematically. Two measures were considered: the Mean of pain 
scores over a month and Maximum pain score in a month (Figure 4.5). 
To be considered an improver, a patient must have achieved both: 
1. A 50% reduction of the first month mean pain score at the last month of treatment 
2. A 50% reduction of the first month maximum pain score at the last month of treatment 
These rules were derived in collaboration with the study statistician Dr Nick Steen. The 
agreement between the two rules was measured by means of a Kappa test. Then, the results 
obtained from both mathematical approaches were combined and compared with those 
resulting from the visual assessment. 
Figure 4.5. A plot showing the time periods involved in the mathematical assessment 
of mean pain, AUC and height of maximum spike (an example of one of the improvers assessed visually) 
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Area under the curve as an alternative to the mean pain scores 
The relationship between the "Mean" pain scores and the commonly used measure "area 
under the curve, AUC" was examined. 
To calculate AUC it was first necessary to replace the few items of missing data. The 
statistical software Statistical Package for the Social Sciences (SPSS)' suggests four methods 
to replace missing values, however, two of them, regression and EM estimation (expectation- 
maximization), "depend on the assumption that the pattern of missing data is related to the 
observed data only. This assumption allows estimates to be adjusted using available 
information". These two methods were adopted to replace the missing values. 
For each patient A UC was measured for first and last month, and a 50% reduction in 
A UC (first month compared to last month) was used as a cut-off point to discriminate 
improvers from non-improvers. The Correlation Coefficient (r) was calculated for the 
comparison of the results obtained by A UC and those obtained by the "Mean" test. 
Having replaced the missing values, A UC was calculated using a formula advised by Dr 
ST Kometa, a Computing Officer in the Information Systems and Services at Newcastle 
University (Appendix 2). 
4.5.1.3. Comparing the visual and mathematical assessments 
In the absence of studies validating the clinical relevance of the chosen mathematical 
assessments of TMD pain intensity, the results of the visual assessment were considered the 
standard to which the mathematical ones should be compared. The sensitivity and specificity 
of the mathematical tests were, therefore, examined in relation to the third visual assessment. 
' SPSS help section, SPSS 12.0.1 FOR Windows. Release (11 Nov 2003). SPSS Inc. Headquarters, 233 S. 
Wacker Drive, 11th floor, Chicago, Illinois 60606. 
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4.5.1.4. Identifying the definite improvers 
Since the aim of Study One was to analyse data of definite improvers, only those cases with 
both visual and mathematical evidence of improvement were selected. 
4.5.1.5. Optimum threshold for discriminating improvers from non-improvers 
The 50% threshold of pain reduction to discriminate improvers from non-improvers in the 
mathematical test was chosen as it has been adopted arbitrarily by a number of pain studies. 
To determine the effect of changing the 50% threshold I also used 40% and 60% reductions 
and examined the sensitivity and specificity of each mathematical discrimination against the 
visual one. The threshold providing the highest aggregate sensitivity and specificity was 
identified as optimum. 
4.5.1.6. Analgesics usage analysis 
The approach described above to identify improvers is based on professionals' perception of 
pain data. To help validate this approach I used a measure of patients' response to pain, 
namely consumption of self-prescribed analgesics used as an additional treatment to support 
splint therapy. It was hypothesised that only the improvers group would show a significant 
reduction in the usage of analgesia when comparing the first and last months of treatment. 
Patients were asked to record the type of analgesic and number of tablets taken. 
However, to avoid problems with making comparisons of different self-prescribed analgesics 
I analysed the number of days each patient used analgesics regardless of the analgesic type or 
amount of tablet consumed. 
The number of days when analgesics were used by improvers and non-improvers during 
the first and last months of treatment were compared using the Kruskal-Wallis Test. 
Individual comparisons within groups with time and between groups at each time period were 
performed with Mann-Whitney U Test. The level of significance was p<0.05. 
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4.5.2. Results 
4.5.2.1. Conducting and validating the visual assessment 
The first visual examination of the graphs resulted in the identification of three groups. While 
Appendix 3 presents all graphs, examples of the three groups are shown in Figure 4.3. 
1. Improvers: Patterns where there was a clear trend in pain reduction (20 patients) 
2. Non-improvers: Patterns with no specific trend to reduction or increase, but with major 
fluctuations giving a saw tooth appearance of varying frequency (13 patients) or patterns 
where pain remained constant (one patient) 
3. Borderline improvers: Patterns showing a possible trend to pain reduction but 
accompanied by several spikes of pain (five patients) 
The second assessment, carried out individually, resulted in total agreement in 24 out of 
the 39 cases (61%), and partial disagreement (two out of three examiners agreeing) for the 
remaining 15 cases. Examiners ratings of each graph are presented in Appendix 3. 
Two Kappa tests were performed: Kappa 2-A measured the agreement between the three 
assessors for the three categories; Kappa 2-B measured the agreement between the three assessors 
over definite improvers. In other words, non-improvers and borderline improvers were 
combined in one group as being non-improvers. The results were Kappa 2-A =0.6 and Kappa 
2-B = 0.76. This time 18 improvers, seven borderline improvers and 14 non-improvers were 
identified according to agreement between either two or three examiners. 
The third assessment observed a general improvement in agreement with total agreement 
in 29 cases and partial agreement for 10 cases only (Appendix 3). Similar Kappa tests were 
conducted and the results were Kappa 3-A =0.70 (31d assessment / three categories) and Kappa 
3-B = 0.79 (3`d assessment / two categories). On this occasion 20 improvers, nine borderline 
improvers and ten non-improvers were identified. Table 4.2 compares the results obtained from 
all three visual assessments, and shows a trend to an increase in borderline cases with repeated 
assessment. 
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Table 4.2. Comparison between results from the three visual assessments 
The detailed Kappa analysis showed consistently good agreement for identification of 
improvers and non-improvers, but identification of borderline improvers was much less 
reliable (Table 4.3). 
Table 4.3. Agreement between examiners (Kappa test) for the second and third assessments 
Category 
Improvers 
Borderline improvers 
Non-improvers 
In relation to the type of treatment provided, Table 4.4 shows similar proportions of patients 
in each TMD treatment group classified visually as improvers, borderline and non-improvers. 
Table 4.4. Cross-tabulation of TMD treatment group with visually assessed treatment outcome 
Third assessment 
Kappa 3-A 
0.79 
0.44 
0.79 
Second assessment 
Kappa 2-A 
0.76 
0.26 
0.69 
Improvers Borderline Non improvers 
Trial type 
Control 
Stabilization 
Crossed-over 
Total 
7 2 4 
9 5 2 
4 2 4 
20 9 10 
Total 
13 
16 
10 
39 
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4.5.2.2. The mathematical assessment 
Unlike the visual assessment the calculations did not allow for borderline improvers to be 
assigned, so patients were classified as improvers or non-improvers only. There was only 
moderate agreement between the "Mean" and the "Maximum" tests (Kappa=0.58). 
Combining the results from these tests 21 improvers and 18 non-improvers were identified. 
The "Area under the curve, AUC" test identified exactly the same improvers and non- 
improvers as did the "Mean" test. The correlation coefficient, r, for the correlation between 
A UC and "Mean" was 0.99. Therefore, A UC was not included in further analyses. 
4.5.2.3. Comparing the visual and mathematical assessments 
When examined individually against the visual assessment, the Mean test and the Maximum 
test had sensitivities of 0.9 and 0.84 respectively but the specificity for both was only 0.68. 
When the results of the Mean and Maximum tests were combined the sensitivity remained at 
0.9 but the specificity improved to 0.84. 
4.5.2.4. Identifying the definite improvers 
The corroboration between results from both the visual and mathematical tests resulted in 
the identification of 18 improvers as shown in Table 4.5. 
All the improvers were female, aged between 19 and 59 years with a mean age of 34.5 
years. Nine of them received the stabilization splint, while six were controls and three were 
crossed-over. 
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Table 4.5. Corroboration of the visual and mathematical assessments to derive definite improvers 
Visual Mathematical Combined 
1--- -1 1 
4 4 4 
6 6 6 
10 10 10 
11 11 11 
13 13 13 
14 14 14 
15 15 15 
16 16 16 
17 17 17 
18 18 18 
21 21 21 
23 23 23 
24 24 24 
25 25 25 
26 26 26 
30 30 30 
32 32 32 
33 33 33 
34 34 34 
Definite Improvers 
4 
6 
11 
13 
14 
15 
16 
17 
18 
21 
24 
25 
26 
30 
32 
33 
34 
2 
8 
9 
12 
19 
20 
29 
3 3 
5 5 
7 7 
22 22 
27 27 
28 28 
31 31 
36 36 
37 37 
39 39 
5 
7 
22 
27 
28 
31 
36 
37 
39 
Legend 
Improvers 
Borderline 
Non-improvers 
* Numbers represent patients' trial numbers 
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4.5.2.5. Optimum threshold for discriminating improvers from non-improvers 
Table 4.6 shows the results for the sensitivity and specificity tests comparing the visual and the 
mathematical assessments carried out with different thresholds. The optimum percentage of 
pain reduction used as a threshold to discriminate between improvers and non-improvers was 
50%, above and below which the aggregate sensitivity and specificity of the mathematical 
assessment dropped. This was true for the Mean, Maximum and combined tests. 
Table 4.6. Sensitivity & specificity of the mathematical assessment against the third visual assessment 
with different cut-off points 
Non improver if, compared to 
first month, remaining pain > 
40% 50% 60% 
Sensitivity 0.85 0.95 0.95 
Specificity 0.74 0.68 0.58 
Aggregate 1.59 1.63 1.53 
E Sensitivity 0.80 0.90 0.95 
0 
E Specificity 0.74 0.68 0.63 
x 
Aggregate 1.54 1.58 1.58 
Sensitivity 0.75 0.90 0.95 
Specificity 0.84 0.84 0.74 
Aggregate 1.59 1.74 1.69 
4.5.2.6. Analgesics usage analysis 
Both improvers and non-improvers had very similar numbers of days when analgesics were 
taken during the first month of treatment. Only four improvers and one non-improver used no 
analgesia during the course of the trial. Kruskal-Wallis test demonstrated a significant 
difference (p=0.02) between the four groups (improvers and non-improvers, in the first and 
last month) as shown in Figure 4.6. Patients classified visually as improvers (n=20) showed a 
significant reduction in median number of analgesic days when comparing the first and last 
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months (10 c. f. 3, p=0.01, Mann-Whitney U test). There was a trend to a reduction in 
analgesic days with the non-improvers (n=19) but this was not significant (p=0.09). 
Figure 4.6. Number of days analgesics used during treatment 
30 
25 
* 
20- 
15- 
10- 
5 
0 
ImprowJA Improver_B Non-Improver_A Non-Improve 
A: First month 
B: Last month 
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4.5.3. Discussion 
The original aim of this study was to establish suitable review and reference periods for TMD 
treatment outcome assessment. These periods were necessary to examine the performance of 
the intended quality of life questionnaire (the core of this project - Study 3) as a tool for 
measuring treatment outcomes. The importance of establishing evidence-based review and 
reference periods was highlighted in the literature review (section 2.5 ), but revealed that this 
period had not been yet established for TMD. Clearly, these periods should be based on when 
significant improvement of symptoms can be expected to be achieved and maintained. 
To establish realistic review and reference periods for TMD, I studied pain/time changes 
of TMD patients undergoing splint treatment in a clinical trial to identify the point at which a 
clinically significant reduction of pain had been achieved and at which a meaningful 
assessment of improvement might be made by patients. I was only interested in those patients 
who showed improvement in their symptoms, the so called Improvers. If I had not separated 
out the improvers, the pain/time responses of the non-improvers would have masked how 
much improvement could be expected and how long it took. 
It was first essential to find a valid method to identify these improvers (Study I -A). At a 
later stage, data of an average improver was examined in detail (Study 1-B) to establish the 
review and reference periods. 
To discriminate improvers from non-improvers, pain/time graphs from 39 patients were 
visually analysed. Criteria were set to identify the graphical characteristics of improvers, and 
were tested for validity and enhanced. The raw data were then re-examined mathematically in 
order to express the visual criteria in arithmetical terms that are often used in reporting 
treatment outcomes. Having identified the improvers, more analyses were carried out to 
validate the results. This involved triangulating the results with the proportion of improvers in 
the treatment groups and with analgesic use. 
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In this study, I analysed daily changes in pain intensity and considered the full course of 
treatment. I favoured this approach over relying on discrete measures weeks or months apart 
because in chronic conditions these are unreliable. In chronic conditions such as TMD, pain is 
often fluctuating from day to day (Gendreau et al., 2003). Discrete measurements, therefore, 
often mislead as they may capture high or low points on the graph that are not necessarily 
representative. This point was highlighted in published recommendations to avoid bias in 
VAS analysis (Gendreau et al., 2003). Indeed, discrete measures simply represent snapshots 
of a continuous fluctuating course of changes. To compensate for this drawback, some studies 
tend to assess the pain over a retrospective period of time. But these measures are in turn 
prone to bias due to distorted recall memory effects (Eich et al., 1985; Bolger et al., 2003). 
This is why pain diaries are the favoured tool to capture changes in self-reported pain in a way 
that is closer to real time than other methods (Stone and Shiffman, 1994; Bolger et al., 2003). 
In discussing the results two caveats must be emphasised in relation to TMD. Firstly, 
TMD consists of a variety of sub-diagnoses the most common of which are myofascial pain 
and disc displacement with reduction. These conditions are well represented in the present 
sample (Table 4.1). For sub-diagnoses occurring less frequently (e. g. disc displacement 
without reduction and TMJ arthritis) the pain/time characteristics may well be different. 
Secondly, in determining overall treatment response for TMD, as for other musculoskeletal 
problems, outcomes other than pain intensity need to be considered. These include clinical 
findings (e. g. muscle and joint tenderness, clicking, and limitation of opening), quality of life 
measurement, analgesic consumption and the need for rescue medication (Farrar et al., 2003). 
4.5.3.1. The visual assessment 
To achieve robust results, strict criteria were implemented to exclude cases with unacceptable 
missing data that might affect the assessment. Following that, 39 graphs were plotted, which 
revealed major variations not only between patients, but also for individual patients on a day 
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to day basis. These findings agree with those reported in studies looking at fibromyalgia 
(Gendreau et al., 2003; Couper, 2005). 
Experienced clinicians are in a unique position to make informed judgements about what 
pattern of pain dynamics constitutes a meaningful improvement, particularly in the context of 
a condition that they treat regularly. The ability of clinicians to agree independently is a pre- 
requisite though. Criteria for visual assessment were refined to optimise agreement between 
observers as determined by Kappa. The simple general trend (slope and diminishing area 
under the curve) of the graph was neither adequate to fully describe a pattern of response, nor 
sufficient to obtain good agreement between the assessors. Additional criteria included 
apparent frequency and height of pain spikes. Reduction in pain spikes has been 
recommended recently as part of the core outcome measures in chronic pain (Aaron et al., 
2005). The final criteria yielded the best agreement between the three assessors (Kappa = 
0.79). 
The assessors were relatively consistent in identifying the same improvers and non- 
improvers. However, the borderline improvers were more challenging. These cases showed a 
comparably poor level of agreement between the assessors (Table 4.3), which noticeably 
affected their overall agreement (Kappa). 
4.5.3.2. The mathematical assessment 
In this assessment I measured mean pain scores, maximum pain score and area under the 
curve (AUC) for first and last month of treatment. This helped express the visual criteria in 
mathematical terms that are often used in reporting treatment outcomes. The first and last 
month of treatment were chosen to simplify analysis; some patients had taken three months or 
less to show clinically significant improvement, whilst others had taken up to five months of 
treatment. In relation to the overall length of treatment a one month sampling period provided a 
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satisfactory measure of pain/time reduction at the end of treatment. It is worth mentioning 
here that the monthly period suits TMD, but might not be appropriate for other disorders. 
The Mean value represented an aggregate value of pain changes over the one month 
period. This method has been used often in pain research and is better than asking patients to 
retrospectively assess their pain over a period of time to avoid memory effects (Bolger et al., 
2003). Changes in the Mean were expected to represent the graph slope. 
A UC, which has also been used before (Gendreau et al., 2003), was expected to represent 
the corresponding visual criteria, i. e. "apparent area under the curve". AUG is believed to be 
more meaningful than the Mean pain score, and possibly is so when there is a considerable 
amount of missing data as it interpolates between existing data. In this study, however, when 
strict rules were applied to exclude subjects with missing data, the A UC and mean pain values 
identified exactly the same improvers and non-improvers. Therefore, A UC was not included 
in further analyses. 
Finally, maximum pain score was chosen to represent the level of highest spike. Neither 
the "Mean" nor the "Maximum" test alone was sufficient to describe and report the process 
of pain reduction assessed visually by expert clinicians. 
4.5.3.3. Comparing the visual and mathematical assessments 
By combining results from the Mean and Maximum mathematical tests I achieved optimum 
agreement with the visual assessment in terms of specificity and sensitivity. These results 
confirm that statistical analyses should be used carefully and only within a clinically relevant 
frame to be meaningful. 
As regards the best cut-off point, I found that a 50% reduction in mean and maximum 
pain was the best threshold to discriminate improvers from non-improvers. By establishing 
this cut-off point I have established the "Clinically Important Difference" CID for TMD 
disorders (see section 2.5.1). 
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4.5.3.4. Further validation - the analgesic consumption test 
In order to further validate the judgement from a patient's perspective it is possible to 
triangulate the definition of success against an objective proxy for the patient's pain 
experience. In this case analgesic intake was used as a patient-based measure. Although a 
fairly blunt instrument, a significant reduction in analgesic usage was found in the improver 
group (p=0.01). The trend to a reduction in analgesic days in the non-improver group suggests 
that some of this group were also showing signs of improvement, even though the pain levels 
had reduced by less than 50%, but as this included some cases originally classified as 
borderline it is perhaps not surprising. In order to minimise the risk of type two errors, a strict 
definition of improvement is appropriate and it was this that underpinned the grouping of 
borderline cases with non-improvers. 
It was possible to use analgesic days as a separate measure of pain experience in this 
group as 87% of patients were regularly using analgesics at the start of treatment. In other 
patient populations where subjects may avoid analgesia this type of comparison would not be 
possible. Nevertheless, the consumption of `rescue medication' has been used as an outcome 
measure in clinical trials (Farrar et al., 2000; Bolger et al., 2003). 
4.5.3.5. Further validation - comparing with trial results 
Another factor in support of the validity of the visual definition was the similarity in the 
proportion of improvers in each of the splint groups. During the clinical trial there was no 
significant difference between the splint groups for any of the clinical outcome measures 
(Wassell et al., 2004). 
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4.5.3.6. Strengths and limitations 
The main strength of this study is that it challenged the traditional methods to identify 
improvers. I have closely observed the full course of pain changes throughout treatment and 
have used various outcomes (including a form of rescue medicine) to propose a new method 
to discriminate improvers from non-improvers. 
Identifying improvers was critical not only to establish the review period, but also to 
comply with the recent trend in the medical literature. Analysis of pain measurements in 
clinical trials has moved away from consideration of mean pain changes of treatment and 
comparison groups, which can be misleading, towards comparing the proportions of patients 
in such groups who have shown a clinically significant improvement (Farrar et al., 2000). 
The argument is that "group mean differences could reflect large changes in a few patients, 
small changes in many patients, or any combination of these outcomes" (Farrar et al., 2000; 
Gendreau et al., 2003). 
Furthermore, this study enables the estimation of CID (the clinically important 
difference) for TMD using a different approach to that used in the medical literature. This 
could potentially support other research on CID for chronic pain conditions. 
Although reported for the management of TMD, this approach is straightforward and 
could be applied to any condition where there is a risk of daily variation in the recovery 
period. This study does not advocate simply using clinical judgement as an outcome in clinical 
trials, but proposes applying clinicians' judgements to reliable patient data to make sure that 
any statistical definition of success has some clinical meaning, rather than being arbitrary. 
On the other hand, this study was limited firstly by the lack of true pre-treatment data. 
Ideally, in any pain study the base-line evaluation of pain should take place before any 
intervention. Unless waiting lists are used constructively for this purpose however, there are 
ethical difficulties in withholding treatment to facilitate measurement. In this study pain 
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diaries were issued after the initial consultation which occurred two weeks prior to starting 
splint treatment. Whilst it is tempting to label this period `pre-intervention', in reality the 
initial interaction between patient and clinician may have influenced pain perception so these 
were not truly pre-treatment measurements. 
Secondly, the study was limited by the return of adequately completed pain diaries. In 
this study 54% of the 72 patients who finished treatment had adequately completed diaries. 
This provided sufficient data for the purpose of this methodological study; however, it would 
have been a disappointing result if the original trial (Wassell et al., 2004) had relied entirely 
on the diaries as the sole outcome measure. Much better compliance with pain diaries has 
been reported by other workers (LeResche et al., 2003; Aaron et al., 2004). LeResche paid 
her patients to participate and also telephoned them as a reminder to complete the diaries. 
Aaron used electronic diaries to prompt patients to complete the diaries and to monitor their 
compliance. Clearly, if pain diaries are to be adopted as a principal outcome for chronic pain 
trials considerable efforts will be needed to ensure adequate compliance. Indeed, the lack of 
reporting of patient compliance and the impact of missing data have been raised as significant 
issues affecting the quality of many clinical trials of pain management. 
Thirdly, the original study used paper type diaries. In contrast to electronic diaries that 
have become available recently, paper diaries suffer not only from lower compliance but from 
retrospective completion. This exposes the diaries to the risk of recall bias, the very drawback 
they have been used to avoid (Bolger et al., 2003). One way to reduce this risk is to ask 
patients to submit their diaries at each follow-up visit. This study and others have used this 
method (LeResche et al., 2003), nevertheless, the electronic diaries are still favoured in that 
they log time for completion, and can allow a pre-defined margin of delay (Bolger et al., 
2003; Gendreau et al., 2003). 
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Fourthly, while the original study used different pain outcome measures, all were uni- 
dimensional. In other words, they all concerned pain intensity but not other pain measures 
such as verbal description, unpleasantness, coping, etc. 
Finally, data about the rescue medicine (i. e. analgesic usage in addition to splint 
treatment) were available and were used as a secondary outcome to confirm previous findings. 
However, I was not able to use this as a gold standard. This is because assessment of pain was 
made at the end of the day. Patients' scores. for "how bad your pain was today" can be 
interpreted as the overall level of pain before or having taking the medicine. Other workers 
have asked their patients to assess pain just before they take the rescue medicine (Farrar et al., 
2000). The challenge of using rescue medicine data in chronic disorders was indeed highlighted 
by one of the review studies (Farrar, 2000). 
4.5.4. Summary 
I examined the full course of TMD pain changes throughout conservative treatment. 
Different patterns of changes of pain scores were described. Some showed improvement 
while others did not or were not conclusive. 
I established and validated methods to identify improvers using pain graphs and 
traditional statistics. Fifty percent reduction in pain was found to be a suitable cut-off point [or 
clinically important difference (CID)] to discriminate between improvers and non-improvers. 
Eighteen improvers were identified when combining the visual and mathematical 
assessments. Data of the patients will be examined in the following study to determine the 
best time for outcome assessment. 
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4.6. Study 1-B: Examining the general pattern of improvement 
The purpose of this study was to determine the review and reference periods for TMD treatment 
outcome. Having established patients showing improvement in Study ]-A, I examined in 
Study 1-B the pattern of pain changes for an average improver to identify a point where 
clinicians can make a meaningful outcome assessment (review point), and the period over 
which patients might make a retrospective assessment of their condition (reference period). 
The review point was based on the time when improvement reached a plateau. The same 
concept has been used in TMD before (Pehling et al., 2002), but without a clear definition of 
"improvement". The reference period is the time extended from the review point backward, to 
which patients will refer when making a self-report assessment. This period should be long 
enough for the patients to make meaningful assessment of their conditions. On the other hand, 
it should not extend too long so it reaches the stage when a clinically important improvement 
"CID" had not been achieved. 
4.6.1. Methods 
Two methods were used to examine the combined improvers' data. In the first I plotted the 
average daily pain (the mean daily pain scores across all improvers). The second method 
involved a regression analysis of the improvers' data, in an attempt to obtain a general trend 
of improvement. 
It was first necessary to convert the VAS scores for each patient into a percentage of the 
pain at the treatment start (the first score). This allowed percentage of improvement (change 
of pain) for each individual to be examined rather than the actual pain score. This conversion 
was approved by the study statistician. 
The period over which the mean pain improvement was calculated started from the first 
visit two weeks before the splints were fitted (Figure 4.7). Since treatment periods were not 
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exactly the same for all participants, means were calculated up to the point when 80% of the 
patients had completed treatment which was 126 days, i. e. four months. Data after this period 
were excluded to avoid corrupting results with the data from a few exceedingly slow 
responders. 
Figure 4.7. Pattern of daily pain changes for an average improver 
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The second approach, advised by the statistician, was to derive a best fit pain/time 
response involving factorial regression analyses including different models (linear, cubic and 
quadratic). The linear regression was ruled out as it did not fit the likely curved plot. The 
other models were plotted (Figure 4.8 A and B) using the following functions: 
Y= -2.4583*X+0.0274216*X*X-0.000115*X*X*X+102.6108 for the cubic term 
Y= -1.505424*X+0.0071877*X*X+93.13249 for the quadratic term. 
However, the curve fit at the latter part of the plot did not make clinical sense showing 
negative or increased values of pain. The simpler approach of using means calculated for 
selected time periods was therefore adopted. 
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Figure 4.8. Regression analyses of pain scores for an average improver 
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I decided therefore to continue the analysis with the simple plot representing aggregated 
improvers' data. Means were calculated using Microsoft Excel taking into account cells in the 
spreadsheet with missing data. The mean percentage of change for the 18 improving patients 
was plotted: 
1. On a daily basis (Figure 4.7) 
2. On a weekly basis (Figure 4.9) 
3. On a fortnightly basis (Figure 4.9) 
The daily graph was considered too spiky for the determination of the review and reference 
periods. On the other hand, too much detail was lost on the 2-weekly graph. As a result, I 
opted to complete the study with the weekly graph. 
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To check the graph's accuracy, standard errors of the weekly means were calculated and 
confidence limits of the mean were drawn (Figure 4.10). 
Figure 4.9. Pattern of pain changes for an average improver on a weekly and fortnightly basis 
Weekly Means 
100 
i 
80 
6O 
0 
0 
2.40 
20 
0 
0123456789 10 11 12 13 14 15 16 17 18 
Time Scale (Weeks) 
Fortnightly Means 
100 
80 
C 
g 60 
0 
w 0 
" 40 
20 
0 
0 2468 10 12 14 16 18 
Time Scale (2 weeks) 
Figure 4.10. Weekly means and standard errors of means for improvers 
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The weekly graph was examined to determine the time at which improvement had 
leveled out, and this was chosen as the earliest possible review point (Figure 4.11). The 
reference period is the time before the review point over which the patients will be asked to 
appraise their conditions. In setting the reference period either weeks or months can be used. 
However, I chose months because it seems more sensible to ask patients how they have been 
over the last month or two months rather than over the last three, five or seven weeks. To 
determine this period I adopted a criterion. That was during this period at least 75% of 
improvers would have achieved and maintained more than 50% reduction of original pain. 
Figure 4.11. Concept of the review and reference periods 
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4.6.2. Results 
4.6.2.1. The review period 
The graph of the combined data from the 18 improvers (Figure 4.12) shows that mean pain 
reduced to 40% of the original level after five weeks of initiating treatment, including the 
period between taking the impressions and fitting the splints. Another 20% reduction occurred 
up to week 12. From then onwards, the mean pain level flattened around a value of just below 
20% of original pain. I therefore defined 12 weeks as the "earliest review point". An "ideal 
review point" should allow extra time to maintain improvement. 
Figure 4.12. Pain reduction with treatment for an average improving patient 
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4.6.2.2. The reference period 
To determine the effect of varying the reference period, two scenarios of one and two months 
were examined. When theses scenarios were applied from the earliest possible review point of 
12 weeks (Figure 4.13), it was found that: 
1. For a reference period of one month patients would consider their condition from the end of 
week eight onwards, a point at which almost 80% of improvers would have achieved > 50% 
of pain reduction; and an average responder would have achieved 66% reduction in pain. 
2. For a reference period of two months patients would consider their condition from end of 
week four onwards, at which point only 56% of all improvers would have achieved > 50% 
of pain reduction; and an average responder would have achieved less than 50% reduction 
in the original pain. 
Figure 4.13. Determination of the reference period 
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4.6.3. Discussion 
This study aimed at establishing optimum review and reference periods for TMD treatment 
outcome assessment. In the medical literature these periods have been chosen arbitrarily (see 
section 2.5). It was essential to determine these periods before developing and testing the 
intended quality of life instrument. For this, I examined the full course of pain changes for an 
average improver until improvement had stabilised. 
I started by converting patients' scores to percentage of original score. This was 
necessary to adjust for the inter-subject variability in initial pain scores. It is also consistent 
with recommendations by other authors (Price et al., 1983; Farrar, 2000). 
As discussed previously in the development of the method, regression analysis gave 
results which did not made clinical sense. For that reason I excluded this approach and 
continued with the simpler method of calculating mean pain score for the improvers. 
The period over which the mean pain improvement was calculated started from the first 
visit two weeks before the splints were fitted. The reason for this was that patients received 
counselling on the first visit; hence, some form of treatment started at this time. In addition, 
some of the individual graphs showed that pain reduction occurred before fitting the splints. 
Empirically, means calculated on a weekly basis presented the best indication of change 
of pain intensity with time. The relatively low standard errors show I have made a reliable 
assessment of mean pain/time change and in particular the relatively high rate of change in the 
earliest part of treatment up to week five. 
A reduction of 80% was achieved at week 12 and maintained afterwards. This suggests 
that the earliest review point should be after three months of treatment when, for the average 
responding patient, no more reduction of pain is expected. The latest review point should not 
be made much later than four months or it could compromise the initial management of non- 
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responding patients who may benefit from being seen sooner. The ideal point lies between the 
two limits. I chose 15 weeks, representing 3.5 months, as the ideal review period. Clearly, for 
a study of TMD outcomes it would have been impractical to have used either the six or twelve 
months reference period often used with OHIP. 
To determine the optimum reference period I applied the two scenarios (i. e. one and two 
months) from the earliest possible review point (12 weeks). This is the most critical in setting 
the reference period because at the start of the period it would include more patients with a 
high level of pain than would a later review point (Figure 4.13). It was clear from this analysis 
that the two month-period's data do not meet the criterion previously defined, that is at least 
75% of improvers would have achieved and maintained more than 50% reduction of original 
pain during this period. Furthermore, the retrospective assessment made with the two month- 
period will allow for a bigger recall bias than restricting this to one month (Redelmeier and 
Kahneman, 1996). Therefore, a reference period of one month was determined to be the best. 
This result is in agreement with the recommendations of the team who validated the German 
version of OHIP (John et al., 2002). It is also in agreement with the reference period used in 
previous research using OHIP in TMD (Murray et al., 1996; Segü et al., 2005); where the 
choice of one month was based on the authors' clinical experience. 
4.6.3.1. Strengths and limitations 
This study is the first to suggest evidence-based review and reference periods to assess the 
outcome of TMD treatment. Deriving these periods was based on consideration of continuous 
data about pain changes throughout treatment as opposed to taking one or two "snapshots" of 
the full course of treatment. The study is limited, however, by the same factors reported for 
Study 1-A. Another limitation is the fact that I have considered here only improvement in 
pain. While this is the most reported symptom, other dimensions of the disorders should be 
assessed. The next study (Study Tivo) considers these domains. It is also important to mention 
that these results are limited to conservative TMD treatment, and that further work is needed 
in relation to other modalities of treatments. 
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4.6.4. Summary 
I examined pain changes for patients reporting improvement with conservative treatment of 
TMD to establish suitable review and reference periods for outcome assessment. The 
assessment time for clinical trials should allow a clinically significant reduction in pain to be 
confirmed and maintained. For an average improver, a review time of 3.5 months was 
considered ideal. In addition, a one month reference period was more suitable than two months. 
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4.7. Conclusions of Study One 
1. (Objective 1. a) - In chronic pain studies, different patterns of pain response to treatment 
can be encountered, representing improvers, non-improvers and including borderline cases. 
These distinct patterns could be used as an outcome measure on their own. 
2. (Objectives I. b, & 1. c) - This work clearly shows that clinicians can make reliable 
qualitative assessment of chronic pain intensity. While this is a clinician-based 
interpretation of treatment outcome, it is potentially more representative than using a few 
snapshot measurements of pain and applying statistical tests blindly at intervals. 
3. (Objective 1. d) - When using visual analogue scale (VAS) no single statistical method can 
be guaranteed to give a clinically valid outcome to determine improvers and non-improvers. 
The systematic approach described could be used to provide clinical validity to traditional 
statistical methods when measuring episodic chronic pain. 
4. (Objective 1. e) - Study 1-A identified 20 improvers whose data were analysed in 
Study 1-B. 
5. (Objective 2. a) - Assessment of TMD treatment outcome should allow sufficient time for 
improvement to be noted and maintained; it is recommended that initial outcome is measured 
at least three months after the start of treatment, and preferably not to exceed four months. 
6. (Objective 2. b) - The reference period to be used at the review point should not exceed one 
month. 
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Chapter 5. Study two - Introduction 
5.1. Introduction 
The overall aim of this project was to develop a quality of life instrument to evaluate TMD 
treatment outcomes. One important consideration when designing such an outcome measure 
is the time at which it will be applied after the start of treatment, referred to here as "the 
review period'; a time which allows treatments to achieve outcomes noticeable by patients on 
their everyday lives. The other important consideration is the time frame of the individual items 
(questions); the reference period. While Study One analysed pain data to determine these two 
periods, Study Two had the same aim but used a different approach. 
Qualitative in-depth interviews were undertaken in this study to explore perceived 
improvement and its time scale. This would allow for aspects of patients' suffering other than 
pain to be explored, which might be of significance to the sufferers. It would also allow for a 
triangulation of data from both quantitative and qualitative resources. 
It was hypothesised that although pain is a major problem in TMD patients' lives, other 
symptoms may also play an important role. It is essential to take these symptoms into 
consideration when assessing the progress of the patient's condition with treatment, as 
different symptoms may require different times to resolve. In this context, interviewing TMD 
patients who are responding to treatment will offer a broader understanding of their 
experience of symptoms and perception of improvement with treatment compared to a series 
of visual analogue scale scores. 
Although qualitative interviews have been used to develop measures of the psychosocial 
impact of oral health on quality of life such as the Oral Health Impact Profile (OHIP) (Locker 
and Slade, 1993; John et al., 2002) and the Manchester orofacial pain disability scale 
(Aggarwal et al., 2005), no study has explored the lived experience of TMD and its 
resolution, especially in relation to time. Only a few studies have considered patients' own 
accounts of the impact of other forms of oral pain such as toothache and burning mouth on 
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quality of life (Pau et al., 2000; Anderson and Thomas, 2003; Hakeberg et al., 2003; 
Anderson, 2004). In the medical literature, however, there are many qualitative studies 
covering the experience of pain, and probably the most relevant to this research are those 
investigating the lived experience of fibromyalgia and recovery from fibromyalgia (Raymond 
and Brown, 2000; Menghoel and Heggen, 2004). 
While the original aim of this work was to verify the review and reference periods 
previously identified in Study one, great care was taken to understand the lived experience, 
and this produced findings with implications well beyond its original purpose. 
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5.2. Aim 
To use qualitative methods to explore the lived experience of TMD patients throughout 
treatment, specifically including the process of improvement. The results will be used to 
verify the review and reference periods previously identified in Study One. 
5.3. Objectives 
1. To use qualitative data to explore the rate of recovery from different TMD symptoms as 
experienced by the patients. 
2. To use qualitative data to establish the specific time scale of the recovery process. 
As the interviews progressed a third objective was added to reflect both the need for additional 
data to understand recovery, and to explore the emerging themes. This objective was: 
3. To explore the patients' journey through the process of suffering and treatment. 
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5.4. Methods 
5.4.1. Subjects 
The study used a purposive sampling method. Of twelve patients approached, ten were 
interviewed including nine females and one male reflecting the gender ratio for the condition 
(Table 5.1). They presented with different categories of chronic TMD according to RDC Axis I 
(Dworkin et al., 2002a)'. All had been treated in the Restorative Department of the Newcastle 
Dental Hospital (NDH) by a combination of conservative treatment approaches. These included 
counselling, remedial jaw exercises, soft and hard occlusal splints, and in two cases, occlusal 
adjustment. Patients were included in the study if at review, after a minimum of three months 
of treatment they reported having less than 50% of pain in comparison with the start of treatment. 
Overall, 10 patients who met the inclusion criteria and agreed to participate were interviewed. 
Table 5.1. Characteristics of the patient sample in Study Two 
Number Gender Age Diagnosis Last treatment ° Treatment period ° 
1 F 65 MFP', DDWR', 
Arthralgia 
Glucosamine, stabilizing splint 6 months 
2 F 35 MFP, Osteoarthritis Exercises, soft & stabilizing splints, 
physiotherapy 
12 months 
3 F 59 Osteoarthritis Exercises, soft splint, analgesics 3 months 
4 F 37 DDWR, Arthralgia Exercises, soft 
& stabilizing splints, 
occlusal adjustment 
4 months 
5 F 52 MFP, Arthralgia Exercises 9 months 
6 F 54 MFP, DDWR Exercises, soft splint 4 months 
7 F 34 DDWR Exercises, NSAIDs 3 months 
8 F 47 MFP Exercises, soft splint 4 months 
9 F 33 MFP Exercises, 
hard splint, Amitriptyline, 
occlusal adjustment 
12 months 
10 M 38 MFP Exercises, stabilizing splint 4 months 
2 MFP: Myofascial pain 
3 DDWR: Disc displacement with reduction 
4 Last treatment in Newcastle Dental Hospital (NDH) 
1A summary of the RDC criteria and the examination form used in this project are in Appendix I 
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5.4.2. Preparatory stage 
This study was conducted in collaboration with Dr. Catherine Exley, Centre for Health 
Services Research, Newcastle University. Advice was sought during the planning and analysis 
stages on detailed methodological considerations. 
Approvals were sought from both Newcastle NHS Trust and the Local Research Ethics 
Committee LREC (Newcastle and North Tyneside). The study was registered in LREC under 
Ref. 2003/38. 
Before taking part in the study, all participants were provided with a specifically 
designed information sheet and gave informed consent (see Appendix 4). The consultant in 
charge of the clinic was always informed about the interview to ensure a clinical reference 
point should any clinical issues be raised during the interview that required further 
investigation. 
5.4.3. The interviews 
A series of semi-structured interviews was conducted until all expected themes were explored 
and the full range of experiences had been investigated (10 participants). The interviews were 
conducted by the researcher and an experienced interviewer, Mrs Jill Smith using a pre- 
designed topic guide (Appendix 5) to define the broad themes to be considered during the 
interview. In order to avoid any bias in the data, for example, "auspices bias ", seen when 
patients tend to report higher satisfaction with treatment to avoid upsetting the treating 
doctors, the interviewers had not been involved in the treatment of any participant, and the 
interviews were undertaken in a quiet office within the Dental Hospital away from the clinical 
environment. 
On average, the interviews lasted about 25 minutes, and were recorded using an audio 
digital recorder, backed-up with a traditional tape recorder. The audio digital files were 
149 
Chapter 5. Study two - Methods 
transcribed verbatim by a specialist company (T)peFast 2000)'. Digital record files and the 
magnetic tapes will be destroyed on completion of this higher degree. 
Records' transcription and preliminary analysis were conducted immediately after each 
interview, which helped to identify emerging themes and to feedback and modify the topic 
guide. Only minor amendments were deemed necessary. For example, two sentences were 
added to the guide to encourage participants to give more details about their perception of 
improvement and about the time-line. 
5.4.4. Data analysis 
Data for this study consisted of direct quotations abstracted from the transcripts. Ideas 
emerging during the interviews were arranged within themes and were supported by the 
relevant quotes (Appendix 6). 
The method used to abstract and analyse data in this study was the Framework method. It 
involves five separate but highly interconnected stages summarised below (Bryman and 
Burgess, 1994; Gantley et al., 1999). 
1. Familiarisation. At this initial stage the analyst familiarises him/herself with the data 
through reading and re-reading the transcripts. Initial listing of key issues and themes 
emerging from the transcripts takes part at this stage. 
2. Identifying a thematic framework. At this stage the analyst builds a framework or an 
index based on the identified key issues and themes. This index is developed and refined 
using data from a few transcripts, and is designed to store data emerging from the remaining 
interviews. 
3. Indexing. The developed index is systemically applied to each transcript to abstract all 
relevant data. 
' Horseshoes, Cobgate, Whaplode, Nr Spalding, Lincolnshire PE12 6TD, info@typefast2000. co. uk, 
http: //www. Mefast2OOO. co. uk. 
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4. Charting. This is the stage at which data are combined from all interviews in one chart or 
matrix. This chart is devised from the previously established framework. It allows making 
comparisons between different respondents within the same "heading", i. e. theme; and also 
allows reading a summary of one respondent's data across all themes. 
5. Mapping. Here pieces of the data set can be mapped together and analysed as a whole in 
order to make general interpretations and to address the a priori research objectives. 
Data abstraction and analysis were conducted concurrently by two independent 
researchers, the author and one of the supervisors (JS), who then collaborated to develop a 
common thematic framework for final analysis. 
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5.5. Results 
Four themes were expected from the topic guide and another one emerged from the interviews 
(Table 5.2). The first one, "length of suffering before seeking treatment and main reasons for 
seeking treatment", was a direct result of the topic guide, included to give some context to the 
subsequent interview, but was not considered as a core theme for this project. Detailed data from 
all five themes are presented in Appendix 6, but only themes b to e are presented here. 
Table 5.2. Expected and emerging themes obtained from the interviews 
Expected themes based on the topic guide 
a. Length of suffering period before seeking treatment and main reasons for seeking treatment 
b. Range of symptoms 
c. Impact of TMD on quality of life (QOL) including functional and psychosocial disability 
d. Perceived improvement and temporal characteristics of improvement 
Emerging themes 
e. Perception of care (primary and secondary) 
In the topic guide, perceived improvement and its temporal characteristics were explored 
as one theme separately from other themes about suffering. However, for a better presentation 
of the results, improvement of symptoms and quality of life are presented along with the 
accounts of their corresponding sections. This is followed by a separate section on the 
temporal characteristics of improvement. 
5.5.1. Symptoms of TMD and their improvement 
This section describes TMD symptoms both in terms of their significance to participants and 
their characteristics. This is followed by an outline of symptom improvement. 
5.5.1.1. Range of symptoms 
While participants were not asked specifically to rank their symptoms in order, the order of 
the list of symptoms they reported was noted. A broad range of symptoms was reported. 
However, participants appeared to suffer most from orofacial pain and headache, and least 
from clicking/locking. 
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1- Pain and headache 
All participants in the study reported facial or jaw pain. The characteristics of pain, however, 
varied noticeably. It was mostly, but not always, the first complaint reported. Headache was 
also one of the chief complaints, and in some cases the first to be reported. 
The severity of pain and headaches ranged considerably amongst the interviewees, and 
with it the impact on quality of life differed. The pain on some occasions reached extreme levels: 
"I was in just so much pain; I didn't want to get out of bed... it's the worst 
pain you can ever experience and I had two children and it's just the worst 
pain I could ever experience in me life, it was awful. Constant pain ". 
(Participant 2, Female) 
"In fact I had a permanent headache and my face was feeling as if it was 
going to split open with the pressure. Because it was the pressure on the eyes 
and it was really, really painful, that was what was the worst ". (P5, F) 
"The pain was to a point where it started being all down one side of my face 
to a point where the pain as that bad that my face was like paralysed... It's a 
pain that I never knew could exist. The type of pain even where there's times 
that I wished I was dead because the pain was just so unbearable ". (P9, F) 
The interviewees gave specific descriptions about their symptoms, and while it was not 
the aim of this study to investigate this issue, these data were recorded and may potentially be 
used in future analyses. Table 5.3 summarises the range of locations and pain characteristics. 
The periodical and fluctuating nature of TMD, especially the associated pain, was 
highlighted by many participants. Some even used to ignore the condition when they were 
having no pain from it: 
"The pain changes from time to time... it was having relapses where the pain 
would ease. It would ease down to maybe 4-5 (out of 10) and then within a 
couple of days it would shoot backup to about 10 ". "The pain can vary daily 
or... it can actually vary throughout the day. (P9, F) 
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"Probably just discomfort because I find when I'm at work it's fine. Because 
I'm working, it's off your mind... probably because you 're working it doesn 't 
seem to bother you ". (P 10, M) 
The need for taking medication including painkillers and antidepressants, was used by 
participants as a measure of the condition's severity as well as of the treatment success. The 
majority of participants needed painkillers on a different frequency according to their pain. 
"I had morphine patches and pethidine and ... which weren't touching the 
pain... I was on a lot of medication for my complaints, what I've been through, 
but nothing, nothing took the pain away. Nothing at all ". (P9, F) 
"I'd take 8a day when it was very painful... (but now) not half as much, not 
hardly any actually ". (P2, F) 
Table 5.3. Participants' own accounts of jaw pain and headaches 
Difficult to pinpoint or to localise 
Pain, ache, or toothache in the jaw 
Cheeks were sore 
Location In the side of the face/mouth 
Pain from the ears, pressure on the eyes 
Pressure in/round the face 
Radiating towards the neck and the arms 
The jaw pain: The headaches: 
Unpleasant ache/discomfort Bad heads 
Aching jaw Dull headaches 
Jaw feels sore Pressure 
Jaw is painful 
Toothache 
Characters 
Periodicity 
Pulling sensation 
Awful, agonising, horrible 
Shooting pain when it happens 
Excruciating pain 
The worst pain you can ever experience 
Festering sensation 
Debilitating pain 
Intermittent 
Constant 
Constant but worse some times 
Periodical 
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2. Non painful joint-related symptoms 
In general, joint-clicking seems not to have an important impact on the quality of life. Five 
participants reported having clicking in their jaw joints. However, they reported it low in the 
list of their symptoms, at least third following pain and headache. Only one participant 
complained of clicking before she mentioned other symptoms. She, and some other 
participants, could not, however, distinguish between clicking and locking. In other words, it 
was not clear whether they were describing Disc Displacement without Reduction, or Disc 
Displacement with Reduction. Similar to the pain symptoms, participants gave specific 
descriptions to joint-related symptoms, and these are summarised in Table 5.4. 
"My jaw was clicking a lot, it felt like it was locking". (P7, F) 
I feel that it ... as if your bones are all being 
breaking". (P5, F) 
"When I opened my mouth there was a tightness on the jaw and I used to feel 
that if I didn't manoeuvre it, it just cracked ". (P 1, F) 
"Kept locking on the one side, on the right hand side "... (and eventually) "It 
made its way back over the.. to same position ". (P2, F) 
Table 5.4. Participants' own accounts of non painful joint-related symptoms 
Clicking 
I nn4inn 
Cracking 
Funny noise 
Tightness on the jaw 
Catching 
Participant needs to "manoeuvre" or to "wobble" the jaw to avoid it catching 
Grinding 
Crepitus Jarring 
Breaking bones 
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3. Muscle-related symptoms 
While non-painful joint-related symptoms were of slight impact on quality of life and did not 
occupy much of the interview, muscle-related symptoms were numerous, reported more often 
and had a greater impact on everyday life. These are summarised in Table 5.5. 
Table 5.5. Participants' own accounts of muscle-related symptoms 
"/ used to wake up.. /felt tired and my mouth was tired" (P I, F) 
Tiredness and " The muscles would be tired" (P4, F) 
weakness "That side's not the same as that side. just weaker or something" (P6, F) 
"Jaw felt so heavy and tired" (P4, F) 
"You can imagine when people are having strokes their facial muscles all go, well that's Paralysis and what it felt like " (P8, F) 
stroke 
appearance "My 
face was like paralysed... I felt I couldn't move it... I looked as though I'd had a 
stroke " (P9, F) 
"Some mornings I would get up and my jaw was so sti it took me ages to get it working 
Stiffness and My jaw fell tight" "There was a tightness on the jaw " 
tightness " The muscles here always felt really tense " 
"The muscles running down the front of me face always felt like they were strained" 
Clenching "Sometimes when / woke I would be aware that I had ... my jaw was clamping really 
and grinding tightly shut". (P4, F) 
In addition to stiffness and weakness of the muscles resulting from hyperactivity or 
parafunction, one particular problem seemed to have additional impact on participants, and 
that was grinding the teeth and creating an aesthetic problem (see section 5.5.2.1). 
5.5.1.2. Symptom improvement with treatment 
One of this study's objectives was to explore how symptoms improved and how long each 
symptom required to improve. Reported here are characteristics of improvement. The time 
scale of improvement is presented later in section 5.5.3. 
It was the reduction of pain and headache that participants reported as most important, 
consistently reporting this first and talking about improvement predominantly in terms of pain 
reduction. The pain was reported generally to have improved in terms of intensity, durability 
and frequency. For example one participant told of her experience: 
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"Before I came here if my jaw locked I would maybe have say 2-3 weeks of 
like toothache and pain in my jaw. But once they explained about the exercise 
I would say maybe about 3-4 days down the line I would start to feel... 
(Before the treatment the problem) (It) would go away and it would be okay 
for a month. But once they showed me the exercises... I would maybe go 
maybe a couple of months again where I was fine ". (P7, F) 
For some participants, pain has not been completely solved with treatment. Despite this, they 
found that the treatment helped them to cope better with their conditions than they did before: 
"I think I'm coping a lot better than what I was coping with the pain ". (P 10, M) 
"I wouldn't say 1'm feeling better every day, but I'm feeling that what I've got 
I can cope with better". (P5, F) 
The improvement of muscle-related symptoms was also important and was consistently 
linked with well-being more than improvement of the clicking and locking. This included having 
freedom of mouth opening, relaxation and more movement in the face, reduction of the stiffness, 
reduction of tooth grinding and clenching, feeling the jaw was secure and looking better: 
"I've got more movement in my face... I feel better... My face feels more 
relaxed. There's been an improvement across my face ". (P5, F) 
"I think I felt happier plus I was sleeping better... You know, I wasn't' 
grinding me teeth as much as I was ". (P 10, M) 
In parallel to symptom reduction, the participants considered the decrease in using the 
treatment an improvement on its own. This included taking fewer painkillers, decreasing the 
use of the occlusal splint and less need to visit the Dental Hospital for a follow-up. 
"Very much improvement... I don't have the pain at all and my jaw doesn't 
click you know, I can open my mouth freely, you know, and 1 don't live on 
painkillers ". (P 1, F) 
"I've managed to go six or seven weeks without having to come up (to the 
hospital)... which to me is, a move forward ". (P9, F) 
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5.5.2. The impact of TMD on quality of life and its improvement 
5.5.2.1. The physical impact 
The physical impact of TMD was far reaching, with oral function, everyday activities, work 
and sleeping all being affected. 
The oral dysfunction involved eating, talking, yawning, and even smiling. Almost all 
participants experienced problems with eating, but this ranged from avoiding certain types of 
food to having extreme difficulty in taking any sort of food. Two types of food were 
particularly mentioned by participants; those that need a lot of time to chew such as meat and 
hard foods such as apples and toast: 
"I couldn't eat nothing. I had to eat soup and drink pop all day ... 
I couldn't hardly open me mouth" (P2, F) 
"I used to have to just pick, you know, pick certain foods that I didn't need to 
chew because my jaw used to click quite a bit... (But) it just wasn't worth the 
hassle, you know, it was an easy option, not to eat meat". (P 1, F) 
"Well I'm aware of what I eat.. Opening my jaw for an apple or something is 
a bit, you know, If 1 want to get a bigger bite ". (P6, F) 
Difficulties were also encountered by some participants when opening the mouth during 
yawning, to receive dental treatment or even just to talk. One lady, a switchboard receptionist, 
suffered to the extent that she asked to be moved to another job: 
"I worked as a receptionist and I found that if I'd been talking a long time, 
speaking a long time on the telephone it was really painful by the end of the 
evening ... and I actually asked if I could move off the switchboard. I was that 
concerned about having to speak for a long period of time ". (P8, F) 
"I found when I had to go to the dentist ... she couldn't get in to do any 
treatment. She couldn't get in me jaw ". (P 10, M) 
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Tooth grinding with resulting aesthetic problems were also experienced by one 
participant. She was aware of a link between the grinding and TMD symptoms, but was most 
distressed with the lack of confidence in her smile: 
"I used to have nice teeth and the deterioration from that was drastic. 
When I looked in the mirror it sometimes doesn't reflect me. 
It changed my appearance so much. My teeth were changing and it was 
changing my whole face really... and my appearance ". (P 1, F) 
The impact of TMD on everyday activity was markedly different amongst the 
interviewees. For the majority, it did not affect their daily life, but for others there was a 
dramatic affect: 
"Well it didn't stop me doing anything... I still was working". (P3, F) 
"No it wasn't affecting my daily life ". (P6, F) 
"I just wanted to lie in bed all the time I was in just so much pain; I didn't 
want to get out of bed ". (P2, F) 
One lady (P9), who appeared to be the most suffering person in the sample because of her 
long experience of unsuccessful multi-referral, reported the consequences of her pains: 
"It stopped me doing everything. I've been off work for over a year" 
"I couldn't even do shopping. I was confined to the house really" 
"I was having to live with me mum and dad because the pain was that bad I 
couldn't look after my little boy. I couldn't look after myself '. (P9, F) 
In addition to the daily suffering, almost all participants experienced sleep difficulties 
ranging from sleep disturbance to waking up at night or in the morning with pain or 
headaches: 
"I've always been a good riser on the morning but I was very sluggish, you 
know, I would wake up with this headache ". (P 1, F) 
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"It did affect you sleeping, I think more difficult really - It wasn't all the time- 
but it wasn't anything I could say I'd be worrying about ". (P3, F) 
, "Sleep was impossible. The pain was so intense. 
I think the only time I went 
to sleep was when I think my body was just so run down and knackered with 
the pain I could sort of cat nap ". (P9, F) 
"I can't really sleep on this side because it's just an ache. So I ... 
I tend to 
sleep on that side anyway ". (P 10, M) 
5.5.2.2. The psychosocial impact 
The psychosocial impact of TMD varied considerably across the participants, not only in 
presentation but in severity as well. For some, it was a lack of self-confidence, which was 
linked mainly to pain but also to the appearance in one participant. For others, it was mood 
alteration such as depression, desire to stay alone, distress, anger, and despair. 
"Well you feel a lot more confident in yourself when you're not in pain ". (P2, F) 
"(It affected) my confidence because I had what ... well I couldn't smile with 
grinding my teeth the smile is only apart of it, you know, and when I look at 
photographs of when I was younger, there's no comparison ". (P 1, F) 
"I would say it would alter my mood when the pain was there ". (P7, F) 
"It was really distressing... It did make you feel quite low because it would 
happen in periods. So it was certainly affecting me in that respect (everyday 
life) and yeah making me feel really just generally unhappy". (P4, F) 
"I used to cry with the pain, it got that bad... it was awful - Well the pain plus 
the worry of wondering what was wrong with me. That really got me down ... I 
suffered with depression with it ". (P5, F) 
"Despite having fantastic little boy I just wished I was dead because I can't 
cope with this intensity of pain any more ". (P9, F) 
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5.5.2.3. Improvement to quality of life with treatment 
With the symptom improvement, participants reported an improvement to their quality of life. 
However, while there was a clear improvement to the psychosocial impact, the physical impact 
seems to be less improved, and the interviewees reported a long term functional disability. 
For example, while the participants reported having better sleeps with treatment and 
waking up in the morning feeling more active with less or no pain, headaches or stiffness, 
most of them explained that they would still prefer to avoid hard foods and limit yawning 
even after achieving significant improvements to their symptoms and the psychosocial impact. 
"It just became noticeable that I wasn't waking up with like really nasty pains 
or headaches ". (P4, F) 
"And I feel as though I can talk quite easily, you know, quite freely because I 
was a bit scared to speak". (P8, F) 
"I still don't eat apples, that's something ... I'm frightened ... if I do eat 
apples I'll cut them, I won't bite into them ". (P7, F) 
"Well I still don't eat solid like hard chewy or toffee or boiled ". (P5, F) 
"I've got my life back in control. I'm back to work ...! go out with my 
friends... I take my little boy to the park... This sounds really dramatic but Dr 
Wassell has given me my life back". (P9, F) 
As regards the psychosocial impact, participants reported improvement in mood and 
wellbeing, an increase in self confidence, and enjoyment of life especially after knowing what 
was wrong with them: 
"1 had x-rays and so forth and he (the consultant) said what the problem ... 
there was obviously no real sort of like cancer or anything like that which I 
was thinking... I was relieved that it wasn't tumour growing... when you feel a 
lump in the side... " (P8, F) 
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"A bit more confident that I'm not going to just feel like the headache's 
coming on at any minute ". (P4, F) 
"It improved with my well-being as well. I'd get a sort of glow" 
"I can have a day feeling as if I'm on top of the world sort of thing". (P5, F) 
"I can sit back on the couch now put me feet up and watch Eastenders. And I 
know that in the end the pain's there but I sit on the couch and think I couldn't 
do this before ". (P9, F) 
5.5.3. Time scale of improvement 
Since one of the inclusion criteria in this study was having reduction of pain of at least 50% of 
original pain with treatment, all interviewees reported improvement, but with differences in 
definitions, timing and rate of improvement. 
Reduction of different symptoms followed different rates but jaw pain and headaches 
were consistently the most important symptoms and the first to improve. 
Start of improvement 
In general there was always a delay, and improvement was not noticed straightaway at the 
start of treatment. It was difficult for participants to pinpoint when improvement started to 
occur. Some found it took a month to start noticing some recovery of pain or headaches. 
"It took a month probably" (to notice any improvement) (P3, F) 
The same interviewee reported that later in the treatment period she would only wear the 
splint when she felt she needed it, and that would give her an immediate (next day) relief: 
"When I have had any ache in at all I've used the splint, and it has been, you 
know, much better the next day". (P3, F) 
Another interviewee could not remember when she had started to notice improvement, but 
reported a complete relief of her pain within less than one month: 
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"It took about 2-3 weeks to actually clear up... to get rid of the ache 
completely". (P7, F) 
Participants also reported sudden improvement after a change in their conditions or in the 
treatment plan. For example, one lady found improvement after wearing a hard splint for six 
months only when this was adjusted: 
"The splint took 6 months to notice an improvement, just when it was 
adjusted". (P5, F) 
Progress of improvement 
In general improvement was gradual and constant, but in some cases was interrupted. For 
example, certain treatments provided some relief of symptoms for a period of time, followed 
by the improvement ceasing or even relapsing; this led the participants to require further care 
or a change in treatment plan. One participant captured the general pattern quite clearly: 
"It's gradually improving; it just seems to be going on one level now apart 
from the odd thing... the treatment never got worse ". (P3, F) 
"I found that it ... either my jaw had changed shape or the clamping and 
grinding had altered the shape of the splint. It hasn't fitting properly... and I 
was again getting headaches more frequently and then the strange clamping 
thing started". (P4, F) 
"It (the pain) seems to go through days where I might have a good couple of 
weeks or a good odd day. And then all of a sudden whoosh. The pain will ... 
I'll have like, what I call a relapse ". (P9, F) 
End of improvement 
A complete dissolution of symptoms was hardly ever experienced by participants. As seen 
from the examples presented above, some symptoms, such as pain would ease while others 
would remain, such as difficulty in eating. Generally, it was difficult to pinpoint how long it 
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took each symptom to resolve and also to determine an end of improvement. This perhaps just 
reflects the chronicity and periodicity of the TMD condition. So for some participants a 
complete recovery would be achieved within weeks, while for others pain would remain and 
treatment would only help them to cope better with the condition: 
"It took about 2-3 weeks to actually clear up... to get rid of the ache 
completely". (P7, F) 
"I wouldn't say my problems have been completely solved; I live with them 
better some days than I do others ". (P5, F) 
5.5.4. Perception of care 
Participants' perception of the care they received was not originally planned for in the topic 
guide. However, this theme emerged during the interviews as a key issue that was worthy of 
further careful exploration. The topic guide was therefore updated to ensure this subject was 
covered. 
In the following sections this theme is presented under two headings: primary care and 
secondary care. The term primary care is used here to describe any care received before 
reaching the TMD specialist clinic at Newcastle Dental Hospital, and included both general 
medical and dental practices, but in some case could have included other specialists. 
5.5.4.1. Perception of primary care 
Almost none of the participants had a clear idea about their condition before they were seen at 
the Dental Hospital. For example, they did not know that the headaches they were 
experiencing may be part of their TMD problems. Also, one participant was treated by her 
doctor for ear problems, to discover later that her symptoms were caused by TMD. 
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Surprisingly, the majority of participants reported that their dentists referred them to the 
hospital without offering them any kind of primary treatment or even any explanation or 
reassurance about their conditions. For example one participant said: 
"They just kept looking at me teeth, they didn't say anything,... injections and 
drilling into me teeth all the time" - "I think it was here at the Dental Hospital 
that ... (they told me) it might be something to do with your jaw. It was never 
me dentist or nothing". (Participant 2, Female) 
Another participant explained how her dentist avoided taking responsibility for her care: 
"I used to complain to the dentist quite frequently and I was really, really bad 
and 1 told her.. and she said well it wasn't a problem from her". (P5, F) 
One of the participants, who suffered extreme pain to a degree that she wished she was dead, 
went through an unsuccessful multi-referral experience. This led her to suffer longer and to 
feel angry about the health professional: 
" I've got a lot of anger still inside me ... about the people in the profession 
like who didn't believe that they'd done anything wrong, like him who 
threatened to wire me jaw together when he obviously didn't understand about 
the bite of the teeth and that me bite was all wrong. (P9, F) 
Participants generally highlighted their lack of knowledge which resulted in deep concerns 
and worry about the seriousness of the condition. 
The worry and silent suffering before secondary care 
Three of the participants believed they had cancers before they were seen in the Dental 
Hospital. One of them opted to hide her thoughts and worries from her husband for several 
months until she was reassured about the cause of her symptoms. 
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"I was really upset about it, frightened more than anything because I felt as 
though I wasn't able to speak properly ... I couldn't close my mouth properly at 
all and I was quite frightened I didn't say this to my husband". (P8, F) 
The worry by itself was enough motivation for some participants to seek treatment even 
without severe symptoms. One participant said: 
"I was starting to worry about it, I was imaging everything" "I think... that was 
the reason (for seeking treatment), that was the finish I thought ". (P3, F) 
With lack of clear information and genuine worries participants needed social support and 
others' understanding of their suffering, but did not always find it. One interviewee reported: 
"I mean you talk to people and they don't understand what you've got. It is a 
very painful thing... So people just sit and look at you ". (P5, F) 
5.5.4.2. Perception of secondary care 
Participants' experience in Newcastle Dental Hospital was generally positive. This has to be 
interpreted, however, by the fact that all of the participants had achieved at least 50% 
reduction in pain at the time of improvement. 
The interviewees consistently reported their satisfaction with the consultation and 
explanation they received at their initial appointment. Having someone to listen to their 
suffering and informing them about their condition and the degree of its seriousness and 
commonality had contributed a lot of improvement they had achieved: 
"I saw Mr Barclay and... he examined my mouth, obviously, and I had x-rays 
and so forth and he said what the problem ... there was obviously no real sort 
of like cancer or anything like that which I was thinking. I'd been to the 
hospital and I'd been to me own dentist and then here at the dentist and then 
... but it's been fine since I've been to the Jaw Clinic... I feel very confident 
now since I've been here, a lot more confident now ". "Once I had that x-ray 
and Mr Barclay said "nothing" I felt a lot better in myself... I was relieved 
that it wasn't tumour growing" (P8, F) 
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"They explained about the joints, how the joint worked and that, and some 
people have just this problem... It's the relief, " because you get it in your mind 
that it's something ... It's not a worry because I know what it is now 
". (P7, F) 
"It's nice to be somewhere where you feel the people can appreciate what 
you're going through because... like obviously people who, in the dental 
hospital obviously it's their area of work and it's just a relief to get to 
somebody... to understand what you're going through ". "I think I had faith in 
Dr Wassell because I feel he was the only person who listened to what I was 
saying... ". (P9, F) 
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5.6. Discussion 
This study was designed to triangulate with Study One in this project to establish optimal 
review and reference periods to assess TMD treatment outcomes. The Review Period should 
allow for the symptoms to improve to a degree that is both detectable for sufferers and 
meaningful for clinicians monitoring the recovery. The Reference Period used in the outcome 
assessment should also enable sufficient time for the patient to make a valid assessment of the 
condition, but should not be too long so that it refers to the start of treatment where little or no 
improvement had been achieved. 
In contrast to Study One which analysed pain data in a quantitative approach, Study Two 
aimed, using a qualitative approach, to investigate patients' perceived concept of improvement 
after TMD treatment and to explore the temporal characteristics of this improvement. 
TMD is a complex and multidimensional condition that involves pain, physical and 
psychosocial impacts on quality of life (Murray et al., 1996; Turk, 1997; Suvinen et al., 
2005). Therefore, assessing TMD and its recovery merely from a pain point of view might 
undermine the validity of the assessment. In this respect, triangulating data from both studies 
would help by identifying the wider picture of TMD and exploring the characteristics of 
improvement for both painful and non-painful symptoms. 
Triangulating qualitative and quantitative methods has been strongly recommended by 
some authors who recognise that a judicious combination of these methods has an important 
role to play in health services research (Barbour, 1999). Qualitative research is an indispensable 
exploratory tool that supports quantitative studies in three ways: in exploring the process of 
illness, in understanding perceptions and beliefs and to generate a theory that explains a 
phenomenon (Gantley et al., 1999). In contrast, quantitative methods do not explore 
phenomena but work to quantify and measure them, and to prove an established theory. 
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Qualitative research including interviews does not aim and does not permit for statistical 
representativeness (Fitzpatrick and Boulton, 1994; Mays and Pope, 1995). Therefore, the 
sample size is determined in a way that allows data saturation to occur. This is to say, the size 
should be sufficient to explore all expected and emerging themes during the interviews or to 
build a theory. Consequently, the number of the study participants is usually limited in 
comparison with quantitative studies, and the participants are usually determined on a 
purposive method that warrants a reasonable representation of opinions or experiences to be 
represented (Gantley et al., 1999). In this context, the sample in this study was reasonable for 
the purpose of exploring the temporal characteristics of improvement. However, a full 
exploration of emerging themes requires a larger sample and a different approach. 
As one would hope, this study resulted in different themes emerging. Some were 
expected as a function of the topic guide, but another emerged during the interviews. These 
are discussed below. 
5.6.1. Symptoms of TMD and their improvement 
As anticipated, the participants reported that TMD had a multidimensional impact on their 
quality of lives, which, in addition to suffering from symptoms, included physical and 
psychosocial disability. Although pain was the main source of suffering, the main reason for 
seeking treatment, and was often the first and most important noted improvement, other 
symptoms and dimensions of quality of life were also important. 
On the one hand, the major significance of pain in patients' lives supports the approach 
in Study One which assessed recovery time based on pain. This would seem to be a reasonable 
approach. On the other hand, the assessment of improvement and its timing should take other 
symptoms into consideration. 
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The major contribution of pain has been recorded previously (Segü et al., 2005) and is 
not at all surprising. Using a quality of life measure, the Oral Health Impact Profile (OHIP) 
these authors noted that OHIP scores of patients with non-painful joint-related symptoms 
were not significantly different from the normal population. Murray et al. (1996) found that 
patients were able to tolerate the functional manifestations of TMD but not its pain. 
Muscle-related symptoms were considered by participants to have a considerable effect 
on their lives, on their feelings and even on their appearance. The improvement of these 
symptoms was also important and was consistently linked with well being. In contrast, non- 
painful joint-related symptoms such as clicking seem to have only a moderate impact on 
quality of life. This finding is in line with previous reports by Murray et al. (1996) who found 
that quality of life scores, measured using OHIP, were not affected in patients with non- 
painful clicking joints. 
In addition to the above, the present study revealed that other factors should be taken into 
consideration when assessing the condition and treatment outcomes. These include pain 
characteristics and the use of treatment. Firstly, it is clear from patients' narratives that pain 
has different characteristics that need to be considered when assessing treatment outcome. A 
simple measure of severity for example may be insufficient to evaluate the condition. The 
fluctuating nature of TMD pain, for example, was emphasised by most participants, which has 
a major impact on the way pain recovery should be assessed and this supports clearly the 
findings from Study One. In addition, the nature of the pain, for example, being "dull", 
"shooting", "pulling sensation" or "festering" is also an important aspect of assessment as the 
nature of pain might affect the patient as much as the intensity itself. 
Secondly, a reduction in the use of treatment was linked to symptom improvement and 
was considered an improvement on its own, where patients would take less medication and 
need to visit the hospital less often. This aspect of recovery should therefore be also 
considered when assessing treatment outcome. 
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5.6.2. The impact of TMD on quality of life and its improvement 
It was also clear from the data that TMD resulted in a considerable physical disability, 
principally in terms of oral function, but not uncommonly in more general functioning and 
activity. This impact showed marked variation between the interviewees, both in terms of 
nature and severity. Also, improvement in these disabilities differed. For example, 
improvement to sleep made a significant contribution to quality of life, but avoiding certain 
foods seemed less important to patients and in fact did not respond to improvement. In other 
words, there was a long-lasting physical disability for some people. 
The psychosocial disability such as lack of self confidence and mood alteration caused by 
TMD varied enormously between the interviewees. For some it was something that "can be 
put at the back of their mind", but for a minority of others it represented a complete stopping 
of normal life. Assessing this disability appears to be crucial to identify and manage the 
minority of sufferers with extreme QOL impact. Unlike the physical disability, the 
psychosocial impact has been effectively managed by treatment and in particular by providing 
satisfactory assurance and care. 
In conclusion, TMD symptoms and their impact on quality of life appear to have unequal 
importance to sufferers. Pain in particular was the dominant symptom and the one to which 
improvement was principally linked. However, it is essential that treatment outcome 
assessment considers the different impacts of TMD on quality of life and allows sufficient 
times for them to resolve. 
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5.6.3. Time scale of improvement 
As was expected, retrospective recall of time-related information was difficult for patients, 
and therefore data could only be considered as a general guidance. For example, the 
interviewees gave wide margins of time of changes in the condition, and participants tended 
to refer to months instead of weeks. 
It was clear that different symptoms required different times to improve. In general, there 
was a delay in starting to notice an improvement, but it cannot be concluded whether this delay 
was caused by the time needed for symptoms to improve or by the failure of initial treatment. 
The fastest improvement in the condition was noticed immediately after the first visit to 
the Dental Hospital, when patients were assured about their conditions. This "immediate" 
recovery might explain the sharp reduction of pain seen in the plotted graphs in Study One in 
the first few weeks after starting treatment, even before receiving a physical treatment such as 
an occlusal splint. 
Apart from this initial swift change, improvement and its timing were mainly linked to 
reduction in pain, as discussed above. The participants reported gradual yet fluctuating 
improvement. The pain was also reported to have improved in terms of intensity, durability 
and frequency. Both pain and mood were reported to have changed from day to day and within 
the same day. This change in the condition is strongly linked to the results of Study One. 
The implication of this is that the use of a short reference period in the assessment, for 
example, asking the patients about their pain at the day of assessment would subject the 
assessment to major bias by measuring a high or low level of pain only by chance. 
Similarly, assessing treatment before reaching a reasonable plateau and stability of the 
condition risks obtaining a misleading picture about the condition where these symptoms 
could be high or low merely based on the day of assessment. The facts that improvement is 
noticed after a period of time, that it occurs gradually, and that it is fluctuating emphasise the 
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need to allow enough time before assessing treatment outcomes. Within the time frame 
reported in this study, the assessment should allow a few months for patients to notice a 
degree of recovery. This would also allow slow improving symptoms other than pain to be 
captured by an outcome measure. However, it should be noted, that not all symptoms should 
be expected to disappear, and some level of suffering may remain, such as long term 
functional impacts. 
The findings about temporal characteristics of improvement in this study are consistent 
with the review and reference identified in Study One. 
5.6.4. Perception of care 
It was not surprising that different individuals with different symptoms, ages, general health 
and attitudes towards health would suffer differently. However, the psychological suffering 
and its extent before reaching a TMD care facility in the Dental Hospital were striking. 
Participants consistently described their lack of knowledge about their conditions before they 
arrived at the Dental Hospital. This by itself becomes a reason for suffering as some patients 
would start to worry silently about their conditions and imagine a range of scenarios. With 
these worries and a lack of satisfactory assurance and management by health personnel, 
patients would enter a vicious circle of agitation, worry, anger towards the health 
professionals, and more suffering. 
The lack of diagnosis and the experience of multiple referrals had a major impact on 
quality of life. For some participants, these worries were even the main or the only motivation 
to seek medical advice although they were experiencing a wide range of symptoms. The 
implication of this finding would later present as an immediate relief when a clear and 
convincing communication was received from the specialist. This does not only highlight the 
importance of communication in the management of TMD, but also has an impact on the time 
scale of recovery as discussed in section 5.6.3. 
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5.6.5. Strengths and limitations 
This was the first study to explore in-depth the lived experience of TMD. Also, this is the first 
work that endeavours to propose a suitable review time to assess outcome of TMD treatment. 
This study is limited, however, by a number of factors. 
To start with, the small sample size does not allow generalisation of the results outside 
the context for which it was designed. This is the case for any qualitative study which is, by 
its nature, exploratory and cannot claim statistical representativeness. 
Secondly, the emerging data about patient's suffering and how this related to early care 
were initially beyond the scope of this project, which in the fist instance was mainly 
concerned with the appropriate timing of assessment. Indeed, these data initiated an intensive 
piece of work taking place currently in the same research team, with the aim of developing a 
theoretical model to understand the patients' journey through illness and treatment, and to 
propose changes to the management strategy for TMD. 
Thirdly, patients in this study were interviewed at one of their follow-up visits where 
complete recovery and improvement had not been achieved. This was necessary to explore 
the lived experience of improvement close to real time and avoid a long recall period which 
might introduce a memory bias. Although this is a potential limitation of the study, by not 
reporting long-term improvement, the aim was to establish the time at which initial 
improvement occurred allowing a meaningful treatment outcome assessment to be made. This 
is appropriate for clinical trials for example. So, in this respect, long-term monitoring of the 
participants was not relevant. 
Finally, since the study sample was limited to patients showing improvement to 
treatment, data related to suffering cannot be generalised to all TMD patients, as those not 
benefiting from treatment might present different profile of suffering. 
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5.7. Conclusions 
1. (Objective 1) - The impact of TMD on quality of life is multidimensional and includes 
suffering from pain and other symptoms, physical and psychosocial disability. Pain, 
however, was the main source of suffering, and its recovery was often the first and most 
important noted improvement. This finding supports the approach in Study One which 
assessed recovery time based on pain. This would seem to be a reasonable approach. 
2. (Objective 1) - TMD different symptoms and impacts on quality of life follow different 
rates and characteristics of improvement. Timing of outcome measurement, should therefore 
take this into consideration. 
3. (Objective 2) - Improvement of TMD is gradual and fluctuating. Therefore, outcome 
assessment should allow sufficient time for improvement to be noticed and maintained. This 
study concluded that the review period should be around a few months after start of 
treatment, which is in accordance with the conclusion of the first study. 
4. (Objective 2) - Because of the daily fluctuation and gradual nature of TMD improvement, 
the reference period used in outcome assessment should be sufficiently long to allow a valid 
assessment of the condition to be made, but not too long so that it refers to the start of 
treatment where little or no improvement had occurred. In the light of the patient's accounts, 
a reference period of one month would seem reasonable. 
5. (Objective 3) - The results of this study reinforced the importance of clear communication 
and reassurance as key tools in the management of TMD participants. 
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5.8. Summary 
Study Two was conducted to triangulate with Study One. The aim of Study Two was to explore 
TMD patients' perception of improvement with treatment, to investigate rates of recovery 
from the various symptoms, and to verify the review and reference periods identified 
previously in Study One. 
I used a qualitative approach, which involved in-depth interviews with patients 
undergoing conservative treatment for TMD and showing improvement. The interviewees 
consistently informed that amongst all TMD symptoms, pain had the most impact on their 
lives and was the symptom to which improvement was linked the most. This finding confirms 
that the approach adopted in Study One, i. e. determining the review and reference periods 
based on pain recovery was a reasonable approach. 
The temporal characteristics of recovery reported by the interviewees, e. g. the gradual 
fluctuating improvement, are consistent with the findings from Study One. However, using a 
qualitative approach did not allow for an accurate determination of optimal review and 
reference periods. Estimation of these periods could be only conducted within large margins 
of time. Nevertheless, within these limitations time frames for the review and reference 
periods suggested in both studies are consistent. 
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Chapter 6. Study three - Introduction 
6.1. Introduction 
The impact of TMD on quality of life is well documented in the literature, though few 
attempts have been made to quantify its impact. RDC, the well-established and widely-used 
Research Diagnostic Criteria (Aaron et al., 2004) does have a section (Axis II) to measure 
pain-related disability and the psychological status of the patient, but this does not take into 
consideration the social component of quality of life. 
Health care providers are increasingly demanding proof for the benefit of the resource 
they provide. For them, their "customers' opinions" are as valuable as the professionals'. 
Bodies such as the National Institute for Health and Clinical Excellence (NICE) in the U. K., 
which determines the relative values of different treatments, are increasingly demanding that the 
impact of illness on the patient's quality of life is evaluated, allowing treatment decisions to be 
made taking into account the "units" of quality of life they can provide for patients (National 
Institute for Health and Clinical Excellence, 2006). The literature review discussed in detail the 
need for quality of life measures to be developed and used in health care assessment. 
In order to allow this approach, appropriate outcome measures are required that can 
record, not only the impact of the condition on quality of life, but also the change in that 
impact with treatment. Various instruments are available to measure the psycho-social impact 
of dental problems. Most of these are concerned with oral health in general, and include the 
Dental Impact Profile (Strauss and Hunt, 1993), the Oral Health Impact Profile (OHIP) (Slade 
and Spencer, 1994) and the Oral Health Quality of Life - UK (McGrath and Bedi, 2001)'. 
Only one instrument was developed specifically targeted at orofacial pain, the Manchester 
Orofacial Pain Disability Scale (Aggarwal et al., 2005). While promising, this has not been 
extensively tested. For example, its sensitivity to changes with treatment has not been 
determined. The instrument was established from a pool of patients with orofacial pain 
'A more comprehensive review of oral-health related quality of life measures is presented in the literature 
review section 2.6. 
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including those consulting dental casualty and oral medicine clinics, but patients with non painful 
TMD conditions were not represented. So, it is specific to orofacial pain but not to TMD. 
Amongst other oral health-related quality of life (OHrQOL) instruments, the Oral Health 
impact Profile (OHIP) (Aggarwal et al., 2005) is perhaps the most widely tested and used. 
OHIP is a patient-based questionnaire that is structured in seven domains, inspired by the 
World Health Organisation (WHO)'s conception of impairment, disability and handicap 
(World Health Organization, 1980). A preliminary study by Murray et al. (1996) showed it to 
have the capacity to measure the associated impact on quality of life for TMD and orofacial 
pain patients (Aggarwal et al., 2005). OHIP, however, has 49 items and covers all aspects of 
oral problems. Being such a comprehensive instrument, it is cumbersome and may cause 
respondent burden affecting completion rates. Moreover, in relation to TMD it contains many 
items that are potentially redundant, reducing its discriminatory ability and possibly making it 
appear of limited relevance to those affected. For these reasons, shorter condition-specific 
versions of OHIP have been produced, for example OHIP-EDENT for edentulous patients 
(Allen and Locker, 2002). 
OHIP has been translated into many languages, and, as part of validating the translation, 
workers (John et al., 2002; Larsson et al., 2004; Segü et al., 2005) have applied the instrument on 
TMD patients. The original English version, however, has not been examined in this context, 
nor has it been tested for its ability as an outcome measure for TMD treatments. 
The aim of this study was to start the process of developing an outcome measure for 
TMD, using as a starting point an existing measure of oral health (OHIP), which has been 
shown to be sensitive to the impact of TMD. While mainly intended as an outcome measure, 
this instrument should also be able to discriminate between TMD patients and TMD-free 
subjects. The derivation process of the new tool starts by identifying OHIP items impacting 
most on TMD patients. This is followed by examining aspects of validity and reliability of 
OHIP-49 in an English-speaking TMD population, and exploring how these properties may 
change if redundant items were eliminated. 
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6.2. Aim 
To begin the process of developing an outcome measure for TMD, using as a starting point 
the Oral Health Impact Profile (OHIP). 
6.3. Objectives 
1. To adapt OHIP-49 to make it meaningful to TMD patients 
2. To collect full OHIP-49 data from patients of known TMD diagnosis (RDC/TMD- axis I) 
and from TMD free controls 
3. To evaluate and compare the behaviour of each OHIP item in both TMD and controls by 
four different methods: Mean, Median, Prevalence and Item-Impact 
4. To remove redundant items and select a subset of candidate items for a short form TMD 
index, the so called "OHIPIrMD-P" 
5. To explore some psychometric properties of OHIP-49 and "OHIP/TMD-P" in an English 
speaking TMD population. These include aspects of validity: content, criterion and construct 
(discriminant and convergent) validity; as well as stability and internal consistency reliability. 
An outline of the study is presented in Figure 6.1. 
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Figure 6.1. Outline of Study Three 
Identifying OHIP items with clinically 
meaningful difference patients: controls 
Statistical significance of difference 
Median - Mean - Prevalence - Item-Im 
Clinically meaningful thresholds of differ 
Deriving a set of TMD-related OHIP items 
OHIP/TMD-I 
Psychometric properties of 
OHIP/TMD-I 
Content validity 
Criterion validity 
Discriminant validity 
Convergent validity 
Test-retest reliability 
Internal consistency reliability 
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6.4. Methods 
6.4.1. Data collected 
OHIP was the core instrument in this study. Data from OHIP were collected in parallel with 
other validating instruments including a validated pain inventory and two single-item scales of 
pain and perceived oral health. Other data were gathered to ensure the inclusion criteria were 
met and for follow-up purposes. These data were collected using self-completion 
questionnaires, but the researcher was always available to help solve any problems or 
questions raised by participants. Additional clinical data were collected by the researcher for 
diagnostic and administrative purposes. 
6.4.1.1. The Oral Health Impact Profile (OHIP) 
OHIP is a measurement of oral health impact on quality of life, originally developed for 
epidemiological research (Slade and Spencer, 1994). However, it has been used successfully 
as a measure of treatment outcomes (Awad et al., 2000; Allen and McMillan, 2003). A more 
comprehensive review of OHIP and other measures of oral health can be found in the 
literature review (section 2.6). 
OHIP consists of 49 questions structured in seven domains: functional limitation, 
physical pain, psychological discomfort, physical disability, psychological disability, social 
disability and handicap (Appendix 7). An example of the basic style of OHIP items is: Have 
you found it uncomfortable to eat any foods because of problems with your teeth, mouth or 
dentures? 
OHIP uses a Likert response format with five units related to frequency of impact in the 
following order: Never, Hardly ever, Occasionally, Fairly often, Very often; which are coded 
0-4. To improve the appropriateness of OHIP with TMD patients, I slightly modified the 
questions by adding the word `jaws" after "because of problems with your teeth, mouth, or 
182 
Chapter 6. Study three - Methods 
dentures ". This ensured that participants were able to relate the questions to their TMD. The 
modified version of OHIP used in this project is presented in Appendix 7. 
The reference period in the original OHIP is one year. In other words, patients are asked 
to assess their quality of life over the past 12 months. The first and second studies in this 
project established that the reference period for questions for TMD patients should be framed 
at one month. Therefore, the time reference of the OHIP in this study was one month. 
To identify the TMD relevant questions in OHIP, it was administered to two groups: 
TMD patients and healthy controls. For patients the instrument was administered twice, pre- 
and post- treatment, with the aim of exploring its sensitivity to changes with several methods 
of TMD management. 
6.4.1.2. The Multidimensional Pain Inventory (MPI) 
In order to examine the convergent validity of OHIP in the TMD population, the working 
instrument had to be validated against another measure of TMD and its impact on quality of 
life. To that end, the Multidimensional Pain Inventory (MPI) was considered "the gold 
standard" multiaxial pain self-report instrument (Newton-John, 2002). 
MPI (Kerns et al., 1985) is a generic assessment tool for the impact of chronic pain on 
quality of life. It has been validated and extensively used in pain research. Further details are 
presented in section 2.2.6.1. The questionnaire comprises 52 items with a six-point scale 
(Appendix 8). These are divided into three groups: Part 1 consists of 20 questions about 
pain's impact on the patient's life. Part 2 has 14 items asking about the support the patient 
receives from spouse and close relatives. Part 3 contains 18 items about the impact of pain on 
the patient's daily activities such as doing house-hold chores. Since parts two and three were 
of minor relevance to TMD sufferers, only part one was used. This part has some questions 
relating to the other parts, for example item two (pain interference with daily activities) covers 
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at least ten items in part three, and items five and ten (about the response of spouse and 
significant others), which cover most questions in part two. This questionnaire (MPI- part one) 
was administered only to the patient group, on two occasions pre- and post treatment. The 
second application was necessary to explore OHIP's sensitivity to change with treatment in 
future work. 
6.4.1.3. The Visual Analogue Scale (VAS) 
VAS scales of pain intensity were used to examine the construct validity of OHIP. Similar to 
the MPI, these scales were administered twice, pre- and post-treatment. On both occasions 
two VASs were used. The first (VAS1) was related to current jaw pain (pain at the moment), 
while the second (VAS2) asked about jaw pain over the last month. 
The standard VAS was used, which was a horizontal line of 100mm long, bounded with 
"no pain" and "unbearable pain" as the narrative "anchors". A review of the literature on VAS 
is presented in section 2.4.4.4. 
6.4.1.4. Global statement of health status of jaws and mouth 
In addition to self-report measures of pain, a global statement of oral health pre and post- 
treatment was used for two reasons: 
1. The first application was used to examine the convergent validity of OHIP and the new 
short form (OHIP/TMD-I) 
2. The difference in this global rating between its initial and follow-up applications will be 
used to examine OHIP's sensitivity to change with treatment in future analyses. 
The statement read: Overall, ivould you say that the health of your jaws and mouth is: 
Excellent, Very good, Good, Fairly good, Poor? 
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6.4.1.5. Other data 
Other data were collected to confirm the inclusion criteria (see section 6.4.2.1), including: 
" Do you have any pain or problems with your jaw muscles or joints for which you need 
treatment? 
" How long have you had jaw pain or problems for? ... Years ... Months. 
The following two questions were asked for follow-up purposes: 
41 How effective do you feel the treatment was for your pain or jaw problems: Excellent, 
Very good, Good, Fairly good, Poor? 
" Do you think you still need treatment for pain or problems with your jaw muscles or 
joints: Yes, No? 
All patients were examined clinically in a systematic way as described later. For every patient 
a summary of the diagnosis and treatment plan was recorded by the researcher. In addition, the 
full diagnostic form adopted in this research (Appendix 1) was completed whenever possible. 
Finally, a pre-coded registration form was completed for all patients and controls to 
record names, age and gender. This information was kept separate from all other forms used to 
ensure anonymity. 
6.4.2. Study subjects 
The project used a case-series design. TMD patients completed OHIP and other forms twice, 
before and after treatment, while the control group completed OHIP only once. As mentioned 
before, the post-treatment data is not presented in this thesis, and is to be analysed in future. 
6.4.2.1. TMD patient group 
Out of 126 patients initially invited to take part in the study 110 agreed to participate. These 
were newly referred TMD patients recruited consecutively from five restorative clinics in 
Newcastle Dental Hospital. Patients were from both sexes, but were predominantly females 
(84%). They were aged 18-82 years with a mean age of 39 years. For the purpose of matching 
185 
Chapter 6. Study three - Methods 
with controls, these were grouped into six age bands (Figure 6.2). There was no statistically 
significant difference in age, gender or diagnosis between those who participated in the study 
and those who did not. 
Figure 6.2. Distribution of patients and controls in the different age and gender groups 
Participants by age, gender and group 
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Inclusion criteria 
All patients were systematically diagnosed. They were included if they were 18 years or 
older, had symptoms for more than three months and been allocated one or more RDC/TMD 
diagnoses (Appendix 1). Patients presented a wide variety of chronic TMD conditions and 
sub-diagnoses (Table 6.1). 
Table 6.1. Distribution of patients within different diagnostic groups 
(More than one diagnosis is allowed) 
Group I Group 11 Group III 
Myofascial pain Disc Displacements Arthrides 
Without limited opening 52% 
With limited opening 15% 
With reduction 41% 
Without reduction 7% 
Arthralgia 36% 
Osteoarthritis 5% 
Osteoarthrosis 3% 
Percentage of One Diagnosis Two Diagnoses Three Diagnoses 
patients with 52% 36% 12% 
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As regards treatment, the intention of this study was not to influence the treatment plan; 
this was left entirely up to the treating consultant. Treatments included counselling (in every 
case); self-administered physiotherapy (in most cases); medications in the form of painkillers, 
anti-inflammatory agents or anti-depressants; and occlusal treatment by means of soft splint, 
hard splint or occlusal adjustment. In most cases a combination of two or more treatments was 
prescribed. When necessary, patients were also referred to a physiotherapist, a pain specialist, 
or a psychiatrist, though this was uncommon. 
All 110 patients completed the data forms prior to any intervention or advice from 
clinical staff. In addition, ten of them also received these by post one week before their initial 
appointment. This was necessary for the stability (test-retest) analysis. 
One hundred patients were followed-up. Of these, 66 also completed the review at least 
three months after their initial appointment. The review was performed at patients' follow-up 
appointments or by post. These data are not presented in this thesis but are part of future work. 
6.4.2.2. The control group 
A group of TMD-free individuals was needed to test the discriminant validity of the intended 
short version (OHIPITMD-I). This group was age (10 year band) and sex matched to patients 
(Figure 6.2). It consisted of people with no history of TMD who were either attending the 
Dental Hospital to accompany patients or who were non-clinical staff or non-dental students 
at the University of Newcastle. Inclusion was based on pre-determined screening questions 
(Appendix 10) to exclude a history of TMD or a perceived need for treatment for pain or 
problems in the masticatory muscles or TMJs. The controls completed only the modified 
version of OHIP. 
As recruitment of cases and matched controls was simultaneous, the controls were over- 
sampled by 16 cases from different age and sex groups. Redundant records were excluded 
based on the date of recruitment. 
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6.4.2.3. Estimating the sample size 
The sample size was decided initially to allow a sufficient difference in OHIP mean score to 
be detected between TMD patients and the normal population, and also between patients' 
scores before and after treatment. Since patients after treatment are anticipated to have 
residual symptoms that lead to them scoring more on OHIP than the normal population, the 
difference between them and patients prior treatment is expected to be smaller than that 
between TMD patients and controls. This, consequently, requires a bigger sample to capture 
the smaller difference. Therefore, the bigger sample size was used, i. e. which allows the 
detection of a score difference before and after treatment. 
This analysis was based on Altman's nomogram (Altman, 1991; Petrie et al., 2002) and 
performed using the statistical programme Minitabs. To perform this analysis the expected true 
difference before and after treatment in OHIP mean score, as well as the standard deviation of 
the TMD patients pre-treatment had to be determined. Since there was no study in the 
literature that had established these figures in an English speaking population, data from the 
German population (John et al., 2002) was used as the best estimate. These values were 
overall OHIP score = 16.7 (SD = 30.0). 
In Minitab the formula for comparing paired groups was used. At a significance level of 
0.05, and a study power of 90% to be achieved, the number of subjects needed to show a difference 
similar to that reposted in the German OHIP was 89 subjects. However, I had to "over-sample" 
in order to compensate for the expected sample attrition by patients' dropouts from either the 
treatment or the study. I therefore recruited 110 patients and a similar number of controls. 
This increase also allowed for almost all of the RDC groups to be represented in reasonable 
numbers. 
1 MINITABL Release 13.1. Minitab Inc., Quality Plaza, 1829 Pine Hall Rd, State College PA 16801-3008, USA. 
URL: www. minitab. com 
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To ensure the accuracy of this sample size, I calculated this in a different way based on 
the estimated standard error of the sample. This process specifies 99 cases in each group 
assuming a 50 % prevalence at a level which would allow a precision of percentage estimate for 
each item within 10 percentage points (Riffenburgh, 2006). This figure was close to our previous 
estimation. 
6.4.3. Preparatory stage and pilot work 
Approvals for this study were sought from both Newcastle NHS Trust and the Local Research 
Ethics Committee LREC (Newcastle and North Tyneside LREC-1). The study was registered 
in LREC under reference number 04/Q0905/24. Written informed consent was obtained from 
all patients and controls. The information sheet and the consent form are presented elsewhere 
(Appendix 9). 
The study was piloted by administering the full package of instruments to 10 patients and 
10 controls. Participants were interviewed after completing the questionnaires to evaluate the 
feasibility and practicality of procedures. No changes were deemed to be necessary at this 
stage; therefore, pilot data were used in the final analysis. 
6.4.4. Data entry and cleaning 
Anonymised data were entered onto SPSS 121 on a regular basis. All original files were kept 
in a safe box and separate from registration forms. After the completion of data collection and 
entry, the entire data set was cross-checked for typos by reading back the code sequence. Only 
one patient entry was found to be wrong and this was corrected. 
SPSS 12.0.1 for Windows, Release 11 Nov 2003. Chicago, Illinois. http: //www. spss. com . 
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Missing data 
Missing data for OHIP were unanswered questions. As OHIP does not allow for a separate 
not-applicable option, items that were not applicable were marked by patients as 0 (never 
experienced), and therefore were not considered as missing data. For MPI, missing data 
included unanswered questions or those answered as not applicable. 
The study protocol dictated that patients and controls alike were excluded if they had 
missing data of >_ 10% of OHIP items (five items). These were excluded during the 
recruitment stage, and were not counted as part of the final data set. OHIP was the test 
instrument, and provided that sufficient OHIP data were present substantial analysis was still 
possible. For other parts of the data form, patients were not excluded during the recruitment 
stage for missing scores. This is because many had a non painful condition (e. g. disc 
displacement without reduction); hence a considerable number of items was marked as not- 
applicable. At the analysis stage, however, MPI items with > 10% missing data were excluded. 
For both OHIP and MPI, two methods were considered to replace missing values (below 
the exclusion threshold of 10%): 
1. The score was replaced with the question's mean score across participants, or 
2. With a mean for the participant within the same subcategory. 
The first method was adopted and data were replaced. 
The remaining self-report questions were single-items. Missing data for these included 
any unanswered question, which were only a few cases. None of these questions or cases with 
missing data from these questions was excluded. Also replacement of missing data was not 
possible. 
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6.4.5. Data analysis: comparing TMD patient and control groups 
The significance of the difference for each item score between the two groups was measured. 
In addition, summary sample measures for the 49 individual item scores were calculated in 
four ways: Mean, Median, Prevalence and Item-Impact as described below. Raw differences 
between the two groups were examined. 
6.4.5.1. Significance of difference between patients and controls for item and 
domain scores 
Before testing the significance of differences between the groups, it was first essential to 
decide whether parametric or non-parametric tests were to be used. The distribution of data 
was explored for normality and skewness. Kolmogorov-Smirnov test showed that all items' 
data from both patients and controls were not normally distributed. 
Non-parametric tests were the appropriate tests of significance of difference here. This is 
because data were not normally distributed and because it is recommended to employ non- 
parametric tests for ordinal data such as the present (Bowling, 2002). 
Data for each of the individual items and for the combined scores within each domain 
were then compared using a non-parametric test (Mann-Whitney U test). 
6.4.5.2. Mean item scores 
Although the Mean is not generally a suitable test for data at the ordinal level (Bowling, 
2002), there is an argument for using it as a method of exploring the data and to compare 
between different groups (Slade, 2002). Means were calculated for all items for each group 
using SPSS. Differences between the two groups in Mean were measured for each item, and 
items were ranked in a descending order according to their differences. 
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6.4.5.3. Median item scores 
Median is the most appropriate statistic to describe the central tendency of ordinal data 
(Bowling, 2002). The Median was calculated for each item in each group using SPSS. 
Differences in Median were measured for each item, and items were ranked in a descending 
order according to their differences. 
6.4.5.4. Prevalence of items 
Prevalence of a particular impact (i. e. item) is often used in surveys. To measure this, data 
should be in a dichotomous order, i. e. having or not having the impact. Data in other forms 
such as ordinal or numerical must be transformed to binary form. 
In OHIP, the percentage of participants reporting an impact over a specific threshold has 
been widely used before (Allen and Locker, 2002; John et al., 2003). Item occurrence was 
considered as an impact in different ways. In this study, I calculated percentage of subjects in 
each group reporting "FOVO" (the prevalence of item response fairly or very often) for each 
item. Differences in %FOVO between the two groups were then measured for each item, and 
items were ranked in a descending order by their differences. 
The cut-off point used in the present study, FOVO, was somewhat stringent in 
comparisons to previous studies, which used different approaches, e. g. "OFOVO" 
(occasionally, fairly or very often) or any impact (from hardly ever to very often) (Allen and 
Locker, 2002). FOVO was favoured as it captures an impact at a level more likely to require 
treatment. 
6.4.5.5. Item-Impact scores for individual items 
The Item-Impact analysis identifies items that are the most important to the study subjects 
(Locker and Allen, 2002). In the original method (Juniper et al., 1997), the Item-Impact score 
is calculated for each item by multiplying the proportion of responders experiencing this item 
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by its mean importance rating. A modification of this method was introduced by Allen and 
Locker (2002) whereby the Item-Impact is obtained by replacing importance by severity. 
These authors suggested using "Mean" as a measure of severity and "% FOVO" as a measure 
of frequency. Further details about this test, its use in the literature and potential advantages 
and disadvantages are considered elsewhere (sections 2.4.3.5 and 2.6.6). 
I used the modified method to calculate Item-Impact for each item in the two groups. I 
also measured the difference in Item-Impact value between the groups and ranked items in a 
descending order by their differences. 
6.4.5.6. Combined domain and full OHIP scores 
Domain scores were calculated by summing the item scores that comprised each domain for 
each participant (cases and controls). The Mean score for each domain was then calculated 
and compared between cases and controls. Since the domains have different numbers of items 
I calculated and compared the "Mean per item" obtained by dividing the domain Mean by the 
number of items. The full OHIP score was also measured by summing all 49 item scores. A 
Mean for the total OHIP score was also calculated for all subjects in both groups. 
In addition, the percentage of items reported fairly or very often (FOVO) within each 
domain was calculated. The results were compared first between domains to find out the 
domains with largest impact on quality of life, and second between patients and controls. 
6.4.6. Identifying candidate items (OHIP/TMD-I) 
One of the primary aims of this research was to start the process of generating a shorter and 
condition-specific version of OHIP for use as an outcome measure, for example in clinical 
trials. The recommended method to shorten long instruments to produce a condition-specific 
version is the Item-Impact (Locker and Allen, 2002). 1 used this method to initially identify 
candidate items (i. e. those scoring highest in the Item-Impact analysis). The Item-Impact 
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analysis, however, does not yield measures of clinical meaning, and the cut-off points 
between TMD-related and unrelated items could not be drawn based on this analysis alone. 
For this reason, further item-selection criteria were deemed necessary. These were sequential 
"filters" that each item should pass to be selected, such that selected items should: 
1. Show statistically significant differences between the TMD patients and controls 
2. Show "clinically meaningful differences" in the Mean and Median between these two groups 
3. Contain at least two items from each OHIP domain. 
The concept of a "clinically meaningful difference" in scores was explored by using different 
thresholds for clinical significance in the Mean and Median. Items which reached the 
proposed thresholds were identified. Items were selected based on their distribution within the 
OHIP theoretical framework, and the set of identified items was called OHIP/TMD-I. These 
were considered as candidates for the final TMD-QOL product. 
In addition to the previous criteria, it is essential for the outcome measure that each item 
shows a degree of sensitivity to change that is clinically meaningful. Testing responsiveness 
to changes with treatment is not considered in this thesis, but will be part of future analysis. 
6.4.7. Exploring validity and reliability of OH/P and OH/P/TMD-/ 
As described in the literature review (section 1.1.1), the psychometric properties of a new 
instrument should be established, even if it is derived from a previously validated instrument. 
It is highly recommended, however, that these properties are tested in a sample other than that 
used in the derivation phase. The aim of this part of the project was to explore aspects of 
validity and reliability of the full OHIP and compare these to the psychometric properties of 
the proposed set of OHIP items (OHIP/TMD-I). It was not the intention to report the 
establishment of these properties for the new instrument. Further full validation is a 
substantial piece of work and will be completed at a later stage. 
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6.4.7.1. Content validity 
This type of validity explores whether content of the instrument covers everything it should, 
and does not include irrelevant elements. This is assessed by members of the target population. 
The main thrust of the present work was to shorten the original OHIP, and only maintain 
items with the most impact. Future qualitative work would help to ensure the new instrument 
is not missing important themes for TMD patients. Should this be the case, new items will be 
added and appropriately tested. 
In addition, in order to improve this aspect of validity I have slightly modified the questions 
by adding the word `jaws" as a source of the problem listed in the original OHIP as relating 
to "teeth, mouth, or dentures ". This ensured that participants were able to relate the questions 
to their TMD. I also altered the recall (reference) period to one month, which has proven to be 
most suitable for TMD outcome assessment (Study One and Study Two in this project). 
Furthermore, I have maintained the hierarchal structure of OHIP (i. e. Locker's model) in 
order to maximise the content validity of the derived instrument, in agreement with Slade 
(1997b) and Locker and Allen (2002). 
6.4.7.2. Criterion validity 
Criterion validity examines the inter-correlation between the investigated instrument and a 
gold standard measurement of the same concept applied concurrently on the same group. 
When testing the validity of a new shortened instrument, the original version is considered the 
gold standard against which the short form can be tested (Slade, 2002). 
Correlation between and OHIP/ TMD-I and full OHIP was measured by means of 
Pearson's test. 
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6.4.7.3. Discriminant validity 
The instrument should be able to show statistical and clinically meaningful differences where 
these are expected: 
1. Between TMD patients and controls 
2. Before and after treatment. 
If the instrument is not able to capture a difference between TMD sufferers and TMD-free 
subjects, then it is unlikely to capture a difference of a smaller attitude between patients' 
scores pre- and post-treatment. 
The ability of OHIP items to show statistically and clinically significant difference 
between patients and controls was examined. Statistically significant difference was tested 
(see 6.4.5.1 and 6.5.2.1). As part of the shortening procedure, items showing no statistical 
difference between the two groups were not included in OHIP/TMD-I. 
Ensuring that all selected items have the ability to show clinically meaningful difference 
was also part of the distilling process. However, for further examination of this issue, I 
compared the present results with another study that compared the full OHIP scores between 
patients and the normal population in Germany (John et al., 2007). 
6.4.7.4. Convergent validity 
To explore the convergent validity of OHIP and OHIP/TMD-I in the TMD population, these 
instruments were checked against another measure of chronic pain's impact on quality of life 
- the Multidimensional Pain Inventory (MPI), and two other self-report measures of pain 
(visual analogue scales, VAS 1 and VAS2); and against a global rating of oral health. 
Only section one of the MPI was used in this study, which consists of 20 items. Four of 
these items showed a considerable amount of missing data (see page 199) and had to be 
excluded from further analyses. In the following sections, the term MPI refers to the 16 
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remaining items. As described in greater detail in the results section, it was necessary to reverse 
the positive scale for three items where a high score indicates improved QOL. 
Summary scores for MPI and the other above measures were calculated for the patient 
group including Mean, Standard error of mean and Median. 
The convergent validity was expressed as Pearson's correlation coefficients for OHIP49 
and OHIP/TMD-I cross tabulated against the other measures described above. 
6.4.7.5. Test-retest reliability 
I examined the stability of OHIP and its proposed short form (OHIP/TMD-I), i. e. its ability to 
reproduce a TMD patient's scores on two occasions given the condition was "relatively" 
stable. Participants in this stage of the study completed OHIP twice, one week before their 
first appointments, and on the day of first appointment. 
Twenty patients were initially sent an invitation letter to take part in the study which 
included the information sheet, and all the self-report single-items and questionnaires that 
other patients received in their first appointment, including OHIP, MPI, and pain VASs. 
Ten patients agreed to take part. Their scores of full OHIP and OHIP/TMD-I were each 
compared between the two occasions using the Infra-class Correlation Coefficient, and using 
the Wilcoxon test to explore any significant difference between them. 
6.4.7.6. Internal consistency reliability 
It is essential to measure the internal consistency for existing instruments, e. g. scales, with 
established internal consistency when these are used in a population other than that for which 
they were designed (Litwin, 1995). In this study I measured Cronbach' a coefficient for two 
scales: the full OHIP and the proposed short form. 
Internal consistency reliability or the "Homogeneity" test explores the harmony between 
the instrument's elements and investigates whether the questionnaires' individual items are 
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measuring the same underlying construct. Cronbach' a coefficient is the most commonly used 
indicator of homogeneity, which has to reach a value of 0.7 for the questionnaire to have 
acceptable internal consistency (Nunnally and Berbstein, 1994). To improve the internal 
consistency of a scale, it is recommended to exclude redundant items, i. e. those which are not 
measuring the same construct and are reducing the homogeneity of the scale. These are excluded 
based on their value of Corrected Item-Total Correlation obtained as part of the Cronbach' a 
analysis. Items with a value of less than 0.3 are considered redundant (Pallant, 2005). 
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6.5. Results 
6.5.1. Missing data 
Of those who met the inclusion criteria, only three controls and ten patients had missing data 
in the OHIP forms. This ranged from one to three items for each subject, except one case with 
four missing items. 
Missing items varied, but the ones with the highest frequency were items nine and 
eighteen, with a frequency of missing answers of five and three respectively. Both questions 
are related to denture fitting and comfort. 
For MPI, the following items were reported with more than 10% missing data, and were 
therefore excluded from further analyses: 
MPI-05: How supportive is the spouse? Missing in 13 patients 
MPI-10: How worried is the spouse about you? Missing in12 patients 
MPI-14: Pain changed the amount of satisfaction from work. Missing in 21 patients 
MPI-15: How attentive is your spouse to your pain problem? Missing in12 patients. 
There were a further three items with missing data. These items were missing from one to six 
patients, and were replaced by means of patients' scores. In addition, one patient (No. 31) 
answered only five MPI questions. She was therefore excluded from the comparison between 
OHIP and MPI. 
Data from other self-report measures showed very few missing values. Two patients did 
not complete both VAS 1 and VAS2; one of whom did not also give global rating of oral health. 
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6.5.2. Differences between TMD patient and control groups 
6.5.2.1. Significance of difference 
All item scores were higher for patients than controls. Forty one of the 49 items showed 
significant differences between groups at p<0.01 [Mann-Whitney test (Table 6.2)]. The eight 
items that were not significantly different were not obviously related to TMD (e. g. denture 
problems, aesthetics). 
OHIP domain scores were calculated by summing scores from all items in each domain - 
see section 6.5.2.6). All seven OHIP domain scores showed very highly significant 
differences in scores between patients and controls (p<0.001). 
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Table 6.2. Mann-Whitney test and significance of score differences between patients and controls 
Items are ranked in their original order in OHIP 
Item 
No. OHIP item 
Mann- 
Whitney 
Asymp. Sig. 
(2-tailed) 
01 Difficulty chewing foods 836.5 0.00000 
02 Trouble pronouncing words 3546.5 00000 
03 Tooth doesn't look right 5872.5 1 
04 Appearance affected 4822.5 00(1; 00 
05 Breath has been stale 4901.5 0.00900 
06 Sense of taste has worsened 5041 0.00700 
07 Food catching in teeth 5398.5 
08 Digestion has worsened 4670 0.00000 
09 Dentures have not been fitting 5752 
10 Painful aching in mouth 1488 0.00000 
11 Sore jaw 430.5 0.00000 
12 Headaches 1985 0.00000 
13 Sensitive teeth 4734.5 0.00500 
14 Toothache 4407 0.00000 
15 Painful gums 4220.5 0.00000 
16 Uncomfortable to eat foods 1448 0.00000 
17 Sore spots in mouth 4684 0.00200 
18 Uncomfortable dentures 5763 
19 Worried by jaw/dental problems 1077.5 0.00000 
20 Have been self conscious 3706 0.00000 
21 Dental problems made you miserable 1955 0.00000 
22 Uncomfortable about the appearance 4661.5 0.00100 
23 Felt tense 1639 0.00000 
24 Speech has been unclear 4392.5 0.00000 
25 People misunderstood some words 4827 0.00000 
26 Less flavour in food 5259 
27 Unable to brush your teeth properly 3476.5 0.00000 
28 Avoid eating some foods 1560 0.00000 
29 Diet has been unsatisfactory 3916 ý) 
30 Unable to eat with dentures 5807 0.52700* 
31 Avoided smiling 5116 0.01200* 
32 Have to interrupt meals 2629 0.00000 
33 Sleep has been interrupted 2534.5 0.00000 
34 Has been upset 2166 0.00000 
35 Found it difficult to relax 1996 0.00000 
36 Felt depressed 3113 0.00000 
37 Concentration has been affected 2313.5 0.00000 
38 Has been a bit embarrassed 4156 0.00000 
39 Avoided going out 5080 0.00100 
40 Less tolerant of spouse or family 3612 0.00000 
41 Trouble getting on with other people 4712 0.00000 
42 Irritable with other people 3309.5 0.00000 
43 Difficulty doing your usual jobs 4240.5 0.00000 
44 General health has worsened 3765.5 0.00000 
45 Suffered any financial loss 5772.5 
46 Unable to enjoy others company 4355 0.00000 
47 Life in general was less satisfying 2971.5 0.00000 
48 Totally unable to function 5052 0.00000 
49 Unable to work to full capacity 4200 0.00000 
* Highlighted in red are items showing no statistically significant difference 
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6.5.2.2. Mean 
As shown in Table 6.3 the highest Mean score for patients was 3.05 (SE= 1.00) for item 11 
(sore jaw), while the lowest was 0.19 (0.06) for item 45 (sui Bred financial loss). For controls, 
these figures were much lower, with the highest MM Man score cif just 1.59 (0.10) for item 7 (food 
catching in teeth), and lowest 6 Mean score of 0.05 (0.03) for item 48 (totally unable to function). 
Differences in Alean scores between patients rund controls ranged between 0.03 and 2.7 
units, with an average difference of 0,89 unit per item (Table 6.3 and Figure 6.4 A). 
6.5.2.3. Median 
Out of a possible five units (0-4), .: edza,, scores ranged between 0 and 3 in the patient group. 
Table 6.4 shows the range ofM ed/au scores for all 49 items. For patients, there were three 
items with a Median of 3, and a further 13 items with a 4%fedian of 2. The remaining items 
scored eitler 1 or 0. T fiese figures ` °ere very different from the controls' scores where only 
one item (No. 7: food catching in tcetli) showed a Meehan of 2, and another (No. 13: sensitive 
teeth) a Median of 1. `I he Median for the remaining items was 0 reflecting no impact on 
quality of life of the controls during the last month. 
Differences in Me(flan values between patients and controls varied between O and 3 
(Table 6.4 and Figure 6.4 13). Since. AMcrdiaan values for the controls were 0 for almost all items, 
the difference in E1ferdian values between patients and controls reflected mainly the patients' 
figures. As mentioned above, the two exceptions were items 7 and 13. 
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Table 6.3. Differences in item Mean scores between patients and controls 
Items are ranked in a descending order according to the difference 
Item Patients Controls Difference 
No. OHIP item Mean SE Mean SE in Mean 
11 Sore jaw 3.05 0.1 0.35 0.06', 2.70 
01 Difficult chewing foods 2.61 0.102 0.49 0.07', 2.12 
19 Worried by jaw/dental problems 2.53 0.107 0.45 0.075 2.08 
28 Avoid eating some foods 2.29 0.13 0.36 0.073 1.93 
10 Painful aching in mouth 2.55 0.116 0.65 0.08 1.90 
16 Uncomfortable to eat foods 2.45 0.112 0.58 0.081 1.87 
12 Headaches 2.09 0.139 0.31 0.068 1.78 
23 Felt tense 1.96 0.123 0.24 0.055 1.72 
21 Dental problems made you miserable 2.04 0.129 0.39 0.067 1.65 
35 Found it difficult to relax 1.83 0.128 0.26 0.062 1.57 
33 Sleet) has been interrupted 1.76 0.146 0.24 0.059 1.52 
34 Has been upset 1.72 0.128 0.26 0.064 1.46 
37 Concentration has been affected 1.55 0.123 0.18 0.052 1.37 
32 Have to interrupt meals 1.44 0.127 0.15 0.044 1.29 
36 Felt de ressed 1.27 0.128 0.17 0.051 1.10 
20 Have been self conscious 1.65 0.141 0.65 0.095 1.00 
27 Unable to brush your teeth properly 1.33 0.127 0.34 0.064 0.99 
42 Irritable with other people 1.15 0.118 0.16 0.051 0.99 
47 Life in general was less satisfying 1.04 0.11 0.1 0.045 0.94 
40 Less tolerant of spouse or family 1.07 0.122 0.17 0.055 0.90 
44 General health has worsened 0.87 0.111 0.13 0.05 0.74 
29 Diet has been unsatisfactory 0.83 0.11 0.1 0.034 0.73 
02 Trouble pronouncing words 0.85 0.102 0.14 0.051 0.71 
15 Painful gums 1.33 0.122 0.64 0.082 0.69 
49 Unable to work to full capacity 0.78 0.11 0.1 0.036 0.68 
38 Has been a bit embarrassed 1 0.115 0.34 0.07 0.66 
43 Difficult doing our usual jobs 0.75 0.109 0.14 0.051 0.61 
46 Unable to enjoy others company 0.74 0.105 0.14 0.044 0.60 
17 Sore spots in mouth 1.26 0.128 0.68 0.084 0.58 
14 Toothache 1.36 0.115 0.8 0.09 0.56 
22 Uncomfortable about the appearance 1.05 0.126 0.49 0.083 0.56 
24 Speech has been unclear 0.66 0.102 0.12 0.048 0.54 
04 Appearance affected 1.19 0.133 0.69 0.106 0.50 
13 Sensitive teeth 1.71 0.122 1.24 0.114 0.47 
31 Avoided smiling 0.8 0.12 0.36 0.072 0.44 
05 Breath has been stale 1.08 0.109 0.66 0.079 0.42 
08 Digestion has worsened 0.56 0.086 0.16 0.044 0.40 
39 Avoided going out 0.49 0.093 0.1 0.032 0.39 
41 Trouble getting on with other people 0.46 0.084 0.07 0.04 0.39 
25 People misunderstood some words 0.51 0.087 0.13 0.037 0.38 
06 Sense of taste has worsened 0.65 0.097 0.28 0.056 0.37 
48 Totally unable to function 0.39 0.09 0.05 0.027 0.34 
26 Less flavour in food 0.45 0.08 0.18 0.045 0.27 
07 Food catching in teeth 1.78 0.123 1.59 0.098 0.19 
30 Unable to eat with dentures 0.2 0.073 0.08 0.032 0.12 
18 Uncomfortable dentures 0.2 0.072 0.11 0.043 0.09 
45 Suffered any financial loss 0.19 0.058 0.1 0.039 0.09 
09 Dentures have not been fitting 0.22 0.076 0.14 0.051 0.08 
03 Tooth doesn't look right 0.82 0.108 0.79 0.113 0.03 
* Highlighted in green and orange are items with difference in Mean of >2 units, ?1 unit respectively 
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Table 6.4. Differences in item Median scores between patients and controls 
Items are ranked in a descending order according to the difference in Median 
Item 
No. 
OHIP item Patients Controls 
l 
Difference 
in 11ci ian* 
10 Painful aching in mouth 3 03 
11 Sore jaw 3 03 
19 Worried by jaw/dental problems 3 03 
01 Difficulty chewing foods 2 0 2 
12 Headaches 2 0 2 
16 Uncomfortable to eat foods 2 0 2 
20 Have been self conscious 2 0 2 
21 Dental problems made you miserable 2 0 2 
23 Felt tense 2 0 2 
28 Avoid eating some foods 2 0 2 
33 Sleep has been interrupted 2 0 2 
34 Has been upset 2 0 2 
35 Found it difficult to relax 2 0 2 
37 Concentration has been affected 2 0 2 
14 Toothache 1 0 1 
15 Painful gums 1 0 1 
27 Unable to brush your teeth properly 1 0 1 
32 Have to interrupt meals 1 0 1 
36 Felt depressed 1 0 1 
42 Irritable with other people 1 0 1 
47 Life in general was less satisfying 1 0 1 
17 Sore spots in mouth 1 0 1 
04 Appearance affected 1 0 1 
13 Sensitive teeth 2 1 1 
05 Breath has been stale 1 0 1 
38 Has been a bit embarrassed 0.5 0 0.5 
02 Trouble pronouncing words 0 0 0 
08 Digestion has worsened 0 0 0 
24 Speech has been unclear 0 0 0 
25 People misunderstood some words 0 0 0 
29 Diet has been unsatisfactory 0 0 0 
40 Less tolerant of spouse or family 0 0 0 
41 Trouble getting on with other people 0 0 0 
43 Difficulty doing your usual jobs 0 0 0 
44 General health has worsened 0 0 0 
46 Unable to enjoy others company 0 0 0 
48 Totally unable to function 0 0 0 
49 Unable to work to full capacity 0 0 0 
22 Uncomfortable about the appearance 0 0 0 
39 Avoided going out 0 0 0 
06 Sense of taste has worsened 0 0 0 
31 Avoided smiling 0 0 0 
26 Less flavour in food 0 0 0 
07 Food catching in teeth 2 2 0 
45 Suffered any financial loss 0 0 0 
30 Unable to eat with dentures 0 0 0 
18 Uncomfortable dentures 0 0 0 
03 Tooth doesn't look right 0 0 0 
09 Dentures have not been fitting 0 0 0 
* Highlighted in green, orange and yellow are items with difference in Median of 3, 
2 and 1 units respectively 
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6.5.2.4. Prevalence 
The prevalence of individual items varied xvidely (Fable 6.5). Prevalence reported here is 
based on the percentage of subjects reporting impacts occurring fairly often or very often (% 
FOVO), in other words, on a high level of frequency. The most prevalent item amongst TMD 
patients was item 11 (sore jai ) with a% FOVO of 67%. At the other end of the scale, item 45 
(suffered financial loss) showed the lowest frequency with a prevalence of 1 %. 
For controls, the most prevalent item was item 7 (food catching in teeth) with a 
% 1'OVO OF just 13%, tishile t iiteen items had a% FOVO OF zero. Examples of these arc: 
sore jaw, problems Nýitli digestion or with dentures, etc. 
Differences in %FOVO between patients and controls ranged Nvidely across items 
between 1% and 67% as presented in Table 6.5 and Figure 6.4 C. 
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Table 6.5. Differences in item Prevalence (%FOVO) between patients and controls 
Items are ranked in a descending order according to the difference patient: control 
Item 
No. 
OHIP item Patients Controls 
Difference 
in % FOVO 
II Sore jaw 67 0 67 
10 Painful aching in mouth 53 1 52 
19 Worried by jaw/dental problems 53 2 51 
01 Difficulty chewing foods 46 1 45 
16 Uncomfortable to eat foods 47 4 44 
12 Headaches 42 1 41 
28 Avoid eating some foods 41 2 39 
21 Dental problems made you miserable 37 1 36 
23 Felt tense 34 1 33 
33 Sleep has been interrupted 34 1 33 
35 Found it difficult to relax 30 1 29 
34 Has been upset 26 3 24 
32 Have to interrupt meals 25 1 24 
20 Have been self conscious 28 5 23 
37 Concentration has been affected 22 1 21 
27 Unable to brush your teeth properly 19 0 19 
15 Painful gums 21 3 18 
07 Food catching in teeth 30 13 17 
17 Sore spots in mouth 18 2 16 
36 Felt depressed 16 1 15 
13 Sensitive teeth 25 12 13 
05 Breath has been stale 13 0 13 
31 Avoided smiling 14 2 12 
40 Less tolerant of spouse or family 13 1 12 
42 Irritable with other people 13 1 12 
43 Difficult doing our usual jobs 12 1 11 
47 Life in general was less satisfying 12 1 11 
22 Uncomfortable about the appearance 14 3 11 
38 Has been a bit embarrassed 13 2 11 
14 Toothache 14 4 10 
49 Unable to work to full capacity 10 0 10 
44 General health has worsened 10 0 10 
04 Appearance affected 17 8 9 
29 Diet has been unsatisfactory 9 0 9 
46 Unable to enjoy others company 8 1 7 
06 Sense of taste has worsened 7 0 7 
02 Trouble pronouncing words 9 3 7 
48 Totally unable to function 6 0 6 
24 Speech has been unclear 7 2 5 
39 Avoided going out 5 0 5 
08 Digestion has worsened 5 0 5 
25 People misunderstood some words 5 0 5 
30 Unable to eat with dentures 4 0 4 
41 Trouble getting on with other people 5 1 4 
09 Dentures have not been fitting 4 1 3 
26 Less flavour in food 3 0 3 
18 Uncomfortable dentures 3 1 2 
03 Tooth doesn't look right 10 9 1 
45 Suffered any financial loss 1 0 1 
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6.5.2.5. Item-Impact 
Similar to the previous analyses, the Item-Impact (Table 6.6) showed that in comparison to 
the control group, TMD patients reported a high impact of their condition on their quality of 
life and a higher degree of differences across items. 
Unsurprisingly, the same "extreme" items were identified. For example, item 11 (sore 
jaw) had the largest Item-Impact (205.18) in patients, while item 45 (suffered financial loss) 
showed the lowest impact (0. l 7). The controls' figures were again very much lower than the 
corresponding patients'; the question with highest item impact was again No. 7: food catching 
in teeth (20.24), and thirteen items had a value of 0 (reflecting zero Prevalence). 
Differences in Item-Impact values between patients and controls ranged widely between 
0.2 and 205.2 as shown in Table 6.6. 
Figure 6.3. Item-Impact scores for individual items for patients and controls 
Items are sorted in a descending order of patients' scores 
250 
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Table 6.6. Differences in Item-Impact values between patients and controls 
Items are ranked in a descending order according to the difference 
Item 
No. OHIP item Patients 
Controls Difference in Item-Impact 
11 Sore jaw 205.2 0 205.2 
10 Painful aching in mouth 134.5 0.6 133.9 
19 Worried by jaw/dental problems 133.4 0.8 132.6 
01 Difficulty chewing foods 120.8 0.5 120.4 
16 Uncomfortable to eat foods 115.8 2.1 113.7 
28 Avoid eating some foods 93.7 0.7 93.0 
12 Headaches 87.4 0.3 87.1 
21 Dental problems made you miserable 76.0 0.4 75.7 
23 Felt tense 65.9 0.2 65.7 
33 Sleep has been interrupted 59.2 0.2 59.0 
35 Found it difficult to relax 54.9 0.2 54.7 
34 Has been upset 45.4 0.7 44.6 
20 Have been self conscious 46.5 3.6 43.0 
32 Have to interrupt meals 35.4 0.1 35.2 
37 Concentration has been affected 33.8 0.2 33.7 
07 Food catching in teeth 52.7 20.2 32.5 
13 Sensitive teeth 42.4 14.7 27.7 
15 Painful gums 27.8 1.8 26.1 
27 Unable to brush your teeth properly 25.4 0 25.4 
17 Sore spots in mouth 22.9 1.2 21.7 
36 Felt depressed 19.6 0.2 19.5 
14 Toothache 18.7 2.9 15.8 
04 Appearance affected 20.6 5.7 14.9 
42 Irritable with other people 14.6 0.2 14.5 
05 Breath has been stale 13.8 0 13.8 
40 Less tolerant of spouse or family 13.6 0.2 13.5 
22 Uncomfortable about the appearance 14.3 1.3 13.0 
47 Life in general was less satisfying 12.4 0.1 12.3 
38 Has been a bit embarrassed 12.7 0.6 12.1 
31 Avoided smiling 10.9 0.7 10.3 
43 Difficult doing our usual jobs 8.9 0.1 8.8 
44 General health has worsened 8.7 0.1 8.6 
49 Unable to work to full capacity 7.9 0 7.9 
29 Diet has been unsatisfactory 7.6 0 7.6 
02 Trouble pronouncing words 7.9 0.4 7.5 
46 Unable to enjoy others company 6.1 0.1 5.9 
06 Sense of taste has worsened 4.7 0 4.7 
24 Speech has been unclear 4.8 0.2 4.6 
39 Avoided going out 2.7 0 2.7 
08 Digestion has worsened 2.6 0 2.6 
48 Totally unable to function 2.5 0 2.5 
25 People misunderstood some words 2.3 0 2.3 
41 Trouble getting on with other people 2.1 0.1 2.0 
26 Less flavour in food 1.2 0 1.2 
03 Tooth doesn't look right 8.2 7.2 1.0 
30 Unable to eat with dentures 0.7 0 0.7 
09 Dentures have not been fitting 0.8 0.1 0.7 
18 Uncomfortable dentures 0.6 0.1 0.5 
45 Suffered any financial loss 0.2 0 0.2 
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6.5.2.6. Combined domain and full OHIP scores 
On a possible range of 0-245 points on the OHIP total score, patients scored 60.54 on average, 
while the controls' average was only 17.05. The average item score in general measured 1.24 
for patients and 0.35 for controls. 
As shown in Table 6.7, OHIP domains exhibited different scores both within the same 
case group (patients or controls) and between the two groups. Reported here is the Mean per 
item, measured by dividing the mean score for each domain by number of items in the 
domain. 
Table 6.7. Average scores for OHIP domains and total OHIP in patients and controls 
Domains are sorted according to difference between the two groups. 
No of Mean per item 
Difference in 
items 
Patients Controls 
Mean per item 
(substitution) 
Psychological discomfort 5 1.8 0.4 1.4 
Psychological disability 6 1.5 0.2 1.3 
Physical pain 9 1.8 0.6 1.2 
Physical disability 9 0.9 0.2 0.7 
Social disability 5 0.8 0.1 0.7 
Handicap 6 0.7 0.1 0.6 
Function 9 1 0.5 0.5 
Overall OHIP score 49 1.3 0.4 0.9 
For TMD cases, the Mean per item ranged between 0.7 for handicap and 1.8 for 
psychological discomfort and for physical pain. For controls, the scores were much lower, 
with Mean per item ranging from 0.1 for social disability and handicap to 0.6 for physical 
pain. When comparing between TMD sufferers and controls, the largest "Mean per item " 
differences were found for psychological discomfort, psychological disability and physical 
pain (around 1.3 unit), followed by the other domains with a difference of around 0.6 unit. 
(Table 6.7). 
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Patients reporting items with fairly or very often (FOVO) impact on their lives outnumbered 
controls 10 times overall (Table 6.8). Again OHIP domains showed differences within and 
between groups. For example, the difference between patients and controls was largest for 
physical disability (20 times), and lowest for functional limitation (four times higher). 
Table 6.8. Percentage reporting FOVO impact to one or more items across domains and groups 
Domains are sorted according to difference between the two groups. 
% FOVO Difference between the 
Patients Controls two groups (division) 
Physical disability 14.0% 0.7% 20 
Psychological disability 23.3% 1.4% 17 
Handicap 7.9% 0.5% 16 
Psychological discomfort 33.1% 2.4% 14 
Social disability 9.5% 0.7% 14 
Ph sical pain 32.3% 2.9% 11 
Functional limitation 15.6% 3.9% 4 
Overall OHIP score 20.0% 2.0% 10 
6.5.3. Candidate items (OHIP/TMD-I) 
The Item-impact analysis was not sufficient on its own to determine candidate items. Items 
scoring the largest difference between patients and controls in the Item-impact analysis were 
selected if they passed three other sequential "filters" set out in the following three sections. 
6.5.3.1. Statistical significance of difference 
The first inclusion criterion was that items should show a statistically significant difference 
between TMD patients and controls. Eight items (Table 6.9), previously identified as showing 
no statistical differences (Table 6.2), were eliminated. 
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Table 6.9. Items with no statistically significant difference between patients and controls 
Items are sorted in their original order in OHIP 
Item No. OHIP item Mann-Whitney U Asymp. Sig. (2-tailed) 
03 Tooth doesn't look right 5873 0.67 
07 Food catching in teeth 5399 0.22 
09 Dentures have not been fitting 5752 0.91 
18 Uncomfortable dentures 5763 0.56 
26 Less flavour in food 5259 0.02 
30 Unable to eat with dentures 5807 0.53 
31 Avoided smiling 5116 0.01 
45 Suffered any financial loss 5773 0.23 
6.5.3.2. Clinical thresholds of differences 
The second filter to distinguish between TMD related and unrelated items dictated a 
"clinically meaningful" difference between patients and controls essential for each item. 
Although different summary scores were measured, clinically meaningful units were only 
available from the Mean and Median analyses. 
Using the Mean (Figure 6.4 A, and Table 6.10), the top 3 ranked items scored a 
difference between patients and controls of 2 or more units. A further 13 items scored a 
difference of 1 or more unit. A difference of I unit between patients and controls was set as a 
threshold to select candidate items. This difference is arbitrary, but would probably be 
clinically meaningful for clinicians, representing for instance the difference between an 
impact reported as occurring occasionally and fairly often. Clearly, fractions of a unit, i. e. 
values below I unit or between I and 2 units would be difficult to interpret. Also, a cut-off 
point of 2 or more units' difference in the Mean results in the identification of only 3 items, 
which is unlikely to lead to a valid instrument. 
For Median (Figure 6.4 B and Table 6.10), a difference of 3 units was found for 3 
questions with II more items showing a difference of 2 units. All these 14 items were 
amongst the 16 which exceeded the threshold for Mean. 
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Figure 6.4. Item differences between patients and controls in Mean, Median and Prevalence 
Items are sorted in it descending order. 
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Table 6.10. Items showing the largest difference between patients and controls 
in Mean, Median, % FOVO and Item-Impact- items are sorted in their OHIP original order 
OHIP Questions 
Top 16 items 
Difference in 
Mean 
Top 14 items 
Difference in 
Median 
Top 15 items Top 15 items 
Difference in Difference in 
% FOVO Item-Impact 
Q 01 Difficulty chewing foods 
Q 10 Painful aching in mouth 
XX 
X 
X 
XX 
X 
XX 
X 
XX 
Q1l Sore jaw XX XX XX XX 
Q 12 Headaches X X X X 
Q 16 Found it uncomfortable to eat X X X X 
Q 19 Worried by jaw or dental problems XX XX XX XX 
Q 20 Have been self conscious X X X X 
Q 21 Dental problems made you miserable X X X X 
Q 23 Felt tense X X X X 
Q 28 Avoid eating some foods X X X X 
Q 32 Had to interrupt meals X X X 
Q 33 Sleep has been interrupted X X X X 
Q 34 Has been upset X X X X 
Q 35 Found it difficult to relax X X X X 
Q 36 Felt depressed X 
Q 37 Concentration has been affected X X X X 
XX marks top three items in each method. 
Of the 16 items which exceeded the threshold for the Mean, 14 were top items in the 
Median test which exceeded a difference of two units. Also, 15 were top items in the 
Prevalence analysis. These all exceeded a difference in FOVO >20%, and were the top 15 
items in the Item-Impact analysis. 
The 16`h item identified by the Mean was "question 36: felt depressed" which did not 
exceed the threshold of the Median or the arbitrary threshold of 20% difference in FOVO. 
The item which was identified by three analyses but did not exceed the threshold for the 
Median analysis was "question 32: had to interrupt meals " (Table 6.10). 
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6.5.3.3. Representation of OHIP domains 
This was the third criterion for candidate items. The study protocol dictated that the short 
form of OHIP should contain at least two items from each OHIP domain. The 16 items 
identified so far represent only five of OHIP's seven domains, as shown in Table 6.11. The 
two non-represented domains were Social disability and Handicap. 
Table 6.11. Domains of the items with largest difference between patients and controls 
Domain Item No. Question 
Functional limitation Q 01 Difficulty chewing foods 
Q 10 Painful aching in mouth 
Physical pain 
Q11 Sore jaw 
Q 12 Headaches 
Q 16 Found it uncomfortable to eat 
Q19 Worried by jaw or dental problems 
Psychological discomfort Q 20 Have been self conscious 
Q 21 Dental problems made you miserable 
Q 23 Felt tense 
Physical disability 
Q 28 Avoid eating some foods 
Q 32 Had to interrupt meals 
Q 33 Sleep has been interrupted 
Q 34 Has been upset 
Psychological disability Q 35 Found it difficult to relax 
Q 36 Felt depressed 
Q 37 Concentration has been affected 
In this stage two items which had the highest difference in Item-Impact score between 
patients and controls from each of the two unrepresented domains were added (see Table 
6.12). These four items were also top in their corresponding domains using the Mean and 
Prevalence analyses analysis. As for Median, only one item in each of these two domains 
showed a difference of one unit. The remaining items were all equal with a Median of zero. 
Table 6.12. Additional items and their ranking in the four analyses* 
Domain 
Item 
Item Item-Impact Mean %FOVO Median No. rank rank rank rank 
Q 40 Less tolerant of spouse or family I I I N/A** l di bilit S i sa y oc a Q 42 Irritable with other people 2 2 2 1 
Q 47 Life in general was less satisfying 1 1 1 1 di a H an c p Q 44 General health has worsened 2 2 2 N/A** 
* Difference patients: controls 
** This item has the same Median value as the other items in the corresponding domains 
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At this stage, all domains were represented by at least two items, except the functional 
limitation domain with only one item (Table 6.13). The second top item in that domain was 
No. 7 (food catching in teeth). It did not show, however, a statistically significant difference 
between patients and controls. The remaining items in this domain showed either no statistically 
significant different between the case groups or were clearly non-related to TMD and had a 
very low item-impact. Therefore, no additional items were included from this domain. The 
final set of 20 items, so called OHIP/TMD-I, is shown in Table 6.14. 
Table 6.13. Summary scores and domains for OHIP/TMD-I* 
Item Prevalence Item- 
No Question Mean Median /FO VO) Impact 
Domain 
Q 01 Difficulty chewing foods 2.12 2 45% 120.4 
Functional 
limitation 
Q 10 Painful aching in mouth 1.90 3 52% 133.9 
Q 11 Sore jaw 2.70 3 67% 205.2 l h 
Q 12 Headaches 1.78 2 41% 87.1 pain 
P ysica 
Q 16 Found it uncomfortable to eat 1.87 2 44% 113.7 
Q 19 Worried by jaw or dental problems 2.08 3 51% 132.6 
Q 20 Have been self conscious 1.00 2 23% 43 Psychological 
Q 21 Dental problems made you miserable 1.65 2 36% 75.7 discomfort 
Q 23 Felt tense 1.72 2 33% 65.7 
Q28 Avoid eating some foods 1.93 2 39% 93 Physical 
Q 32 Had to interrupt meals 1.29 1 24% 35.2 disability 
Q 33 Sleep has been interrupted 1.52 2 33% 59 
Q34 Has been upset 1.46 2 24% 44.6 
Q35 Found it difficult to relax 1.57 2 29% 54.7 bilitcal disabilit da 
Q 36 Felt depressed 1.10 1 15% 19.5 
y 
Q 37 Concentration has been affected 1.37 2 21% 33.7 
Q 40 Less tolerant of spouse or family 0.90 0 12% 13.5 Social 
Q42 Irritable \N ith other people 0.99 1 12% 14.5 disability 
Q 44 General health has worsened 0.74 0 9% 8.6 
Q 47 Life in general was less satisfying 0.94 1 11% 12.3 
Handicap 
* Difference patients: controls 
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Table 6.14. OHIP/TMD-I 
Question Question Domain 
Number 
Q01 Have you had difficulty chewing any foods because of problems with your 
Functional 
jaws, teeth, mouth or dentures? limitation 
Q 10 Have you had painful aching in your mouth? 
QII Have you had a sore jaw? 
Ph i l in ys ca pa 
Q 12 Have you had headaches because of problems with your jaws, teeth, mouth or dentures? 
Q 16 Have you 
found it uncomfortable to eat any foods because of problems with 
your jaws, teeth, mouth or dentures? 
Q 19 Have you been worried by jaw or dental problems? 
Q 20 Have you been self conscious because of your jaws, teeth, mouth or dentures? Psychological 
discomfort 
Q 21 Have jaw or dental problems made you miserable? 
Q 23 Have you 
felt tense because of problems with your jaws, teeth, mouth or 
dentures? 
Q 28 Have you 
had to avoid eating some foods because of problems with your jaws, 
teeth, mouth or dentures? Physical 
Q 32 Have you 
had to interrupt meals because of problems with your jaws, teeth, disability 
mouth or dentures? 
Q33 
Has your sleep been interrupted because of problems with your jaws, teeth, 
mouth or dentures? 
34 Q Have you 
been upset because of problems with your jaws, teeth, mouth or 
dentures? 
Q35 
Have you found it difficult to relax because of problems with your jaws, teeth, Psychological 
mouth or dentures? disability 
36 Q Have you 
felt depressed because of problems with your jaws, teeth, mouth or 
dentures? 
37 Q 
Has your concentration been affected because of problems with your jaws, 
teeth, mouth or dentures? 
Q 40 
Have you been less tolerant of your spouse or family because of problems with 
your jaws, teeth, mouth or dentures? Social 
Q 42 
Have you been a bit irritable with other people because of problems with your disability 
jaws, teeth, mouth or dentures? 
Q 44 
Have you felt that your general health has worsened because of problems with 
your jaws, teeth, mouth or dentures? 
di Han cap 
Q47 Have you 
felt that life in general was less satisfying because of problems with 
your jaws, teeth, mouth or dentures? 
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6.5.4. Validity and reliability of OHIP and OHIPITMD"l 
This section reports findings about psychometric properties of OHIP and the proposed short 
form in an English speaking TM1D population. It is essential that distilling the original OHIP 
does not compromise its psychometric properties. 
6.5.4.1. Criterion validity 
Vic correlation between full 0f IIP and 01lIPI TMD-I was highly significant with a very 
strong correlation of 0.91 (Table 6.17). 
6.5.4.2. Discriminant validity 
A recent study that used OHIP in a TMD population found a mean difference of 0.53 per item 
between TD sufferers and controls (John et A1., 2.007). In the present study the mean 
difference per item between these two groups was 0.89 for the full 011W and 1.53 for the 
OFIIPMID-1. Clearly, the short specific version of OHIP reported here shows a much greater 
discriminant capability than that of the full ®111'. 
Item selection criteria used in this study ensured that all identified items revealed a 
difference between patients and controls potentially sufficient to detect changes during treatment. 
6.5.4.3. Convergent validity 
Sixteen items of the NIPN were included in this analysis, with their summary measures 
displayed in Table 6.15. On a scale of seven points (0 -- C) individual items' means ranged 
between 0.71 and 4.42 tisith in average of 2.28 per item (SE = 0.16). It should be noted, 
however, that higher scores do not necessarily imply worse QOL, as three items of MPI have 
their positive anchors on the right side, i. e. the higher the score, the better the QOL. 
Pain scores, as measured by VAST (pain at the moment) and VAS2 (pain over the last 
month) w ere available fron. 108 patients. In both scales, values ranged between the two 
possible extremes, i. e. from 0 to 100. VAS i's mean (SE. ) were 36.37 (2.41), while VAS` 's 
mean and SE were bigger: 51.30 (2.80) indicating that the pain on presentation was less than 
the pain experienced over the previous month. 
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Table 6.15. MPI summary measures for patients 
'No. MP[ item* Mean 
Ertror Median 
11 Control over life during the past month ** 4.42 0.16 5 
16 Ability to deal with problems during last month** 4.23 0.165 5 
6 Overall mood during the past month** 3.36 0.138 3 
7 Severit of pain during the last month 3.14 0.17 3 
12 Suffering experienced because of pain 2.91 0.172 3 
20 During the past month how tense or anxious have you been? 2.89 0.174 3 
18 During the past month how irritable have you been? 2.72 0.176 3 
1 Pain at the present moment 2.48 0.151 2 
2 Pain problem interfere with day to day activities 1.97 0.163 2 
4 Pain changed the amount of satisfaction 1.73 0.168 1 
8 Pain changed ability to participate in recreational & social activities 1.43 0.165 1 
3 Pain changed ability to work 1.34 0.16 0 
9 Pain changed the amount of satisfaction from family-related activities 1.26 0.159 0 
13 Pain chan ed marriage and family relationships 0.94 0.143 0 
17 Pain changed ability to do household chores 0.94 0.152 0 
19 Pain changed your friendships with people other than your family? 0.71 0.124 0 
* Items are sorted in a descending order according to their Mean score. Items 5,10,14,15 are excluded. 
** highlighted in orange are items with a positive scale, i. e. the higher the score, the better the QOL. 
The global rating of oral health (Figure 6.5) showed that, on a scale of five points (1- 5: 
Excellent, Very good, Good, Fairly good, Poor), patients rated their oral health as fairly good 
on average (median = 4). True values ranged between 2 and 5, and none reported their oral 
health as excellent. 
Figure 6.5. Global rating of oral health 
E Very good 
" Good 
Q Fairly good 
" Poor 
09Q Missing 
16 
31 Z 
35 B 
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Correlation tests 
A large correlation was found between sum of MPI and both the sum of full OHIP and sum of 
OHIP/TMD-I (r= 0.73) which was significant at the 0.01 level (Table 6.16). 
Table 6.16. Correlation between MPI, full OHIP and OHIP/TMD-I 
Sum of Sum of Sum of 
MPI * full OHIP OHIP/TMD-I 
Pearson Sum of MPl 1 . 73(**) . 
73(**) 
Correlation Sum of full OHIP . 73(**) 1 . 
94(**) 
Sum of OHIP/TMD-1 . 73(**) . 94(**) 
1 
* Sum of MPI items after excluding missing data (items 5,10,14,15 and case 31) and after 
reversing the positive scale in items 6,11,16. 
** Correlation is significant at the 0.01 level (2-tailed). 
A medium correlation was found between sum of full OHIP and both VAS 1 (pain at the 
moment) and VAS2 (pain last month) which was significant at the 0.01 level (Table 6.17). 
The correlation seemed to be slightly stronger with VAS2 (r =0.48) than with VAS I (r= 0.42). 
The correlation was improved for the OHIP/TMD-I score (0.57,0.51 respectively). 
OHIP/TMD-I showed a slightly stronger correlation with VAS scales than did the full OHIP. 
The correlation between global rating of oral health and both OHIP/TMD-I and full 
OHIP was weaker than that with the above pain measures, but still significant at the 0.01 level 
(Table 6.17). It is also noteworthy that the correlation with the full version of OHIP was 
stronger than that with the shortened one (r-0.41,0.34 respectively). 
Table 6.17. Correlation between full OHIP, OHIP/1'MD-1, pain VASs and global rating of oral health 
Sum of full Sum of 
VASI VAS2 Global 
OHIP OHIP/TMD-1 
Pain at the Pain last rating of 
moment month oral health 
Sum of full OHIP I 91(**) . 
42(**) 
. 
48(**) . 
41(**) 
Sum ofOHIP/TMD-I . 91(**) 1 . 
51(**) 
. 57(**) . 
34(**) 
Pearson VAS of pain at the moment . 42(**) . 
51(**) 1 
. 
60(**) . 
09 Correlation 
VAS of pain last month . 48(**) . 57(**) . 60(**) 1 . 
15 
Global rating of oral health . 41(**) . 34(**) . 09 . 15 
1 
** Correlation is significant at the 0.01 level (2-tailed). 
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6.5.4.4. Stability (test-retest reliability) 
The intra-class correlation coefficient ICC analysis showed that patients' scores on OHIP on 
both occasions were highly correlated. ICC measured 0.96 and 0.97 for full OHIP and 
OHIP/TMD-I respectively. 
Wilcoxon test revealed a non-significant difference between the two measurements, both 
for the full OHIP and the short form OHIP/TMD-I (P = 0.1 and 0.07) respectively. 
6.5.4.5. Internal consistency reliability 
Cronbach's a coefficient was calculated to measure homogeneity within items of the full 
OHIP. This showed high internal consistency with a Cronbach' a of 0.95. Some items within 
each scale had, however, less correlation with other items in the scale. Four items in the full 
OHIP showed a Corrected Item-Total Correlation of less than 0.3 (Table 6.18). In other words, 
these items were measuring something different to the scale as a whole in this particular 
patient group, i. e. TMD. The total Cronbach's a coefficient of the full OHIP showed 
improvement if these four items were deleted (Table 6.18). Another two items, Food catching 
in teeth and Sensitive teeth showed improvement to the total Cronbach's a coefficient if 
deleted, but their Corrected Item-Total Correlation exceeded 0.325. 
Cronbach's a measuring homogeneity within items of OHIP/TMD-I showed also high 
internal consistency (a = 0.94). All items within this short form had their Corrected Item- 
Total Correlation value greater than 0.44. 
Table 6.18. Internal consistency for OHIP with low correlation 
Corrected Item- Cronbach's Alpha if 
Total Correlation Item Deleted 
Dentures have not been fitting properly 0.106 0.952 
Cronbach's a 
Unable to eat with dentures 0.113 0.952 
Uncomfortable dentures 0.148 0.952 
Tooth doesn't look right 0.296 0.951 
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6.6. Discussion 
The aim of this study was to develop a quality of life measure of TMD treatment outcomes. 
The Oral Health Impact Profile (OHHIP) was used as a starting point and candidate items were 
identified as a basis for the intended °1 D outcome measure. 
6.6.1. Methodological issues 
OIHIP was chosen because it is a well-established oral health related quality of life (OHrQOL) 
measure, with a strong theoretical framework. It has been NNidelyr used in oral health research 
and proven to be effective as a discriminative tool (Slade, 1997b) and also as an outcome 
measure for different dental and oral interventions {Rogers et cii., 1998; Awad et ui,, 2000; 
Allen and McMillan, 2003). However, it can be argued that OHIP's utility as an outcome 
measure for TMI) patients might be questionable. This is because it ryas originally derived 
from interviews with a cohort of 64 patients aged 60 years old and over, hence the cohort 
might not be sufficiently representative for the general population, and specifically for the 
TMD population whose peak. age group is mid. " 0s - mid 40s (LeResche, 1997b). The counter 
argument is that 0i1W has been shown to be a useful OHHrQOL in different age groups, for 
example in the U. K. National Dental Iieahh surveys (Kelly, ? 00t). Furthermore, 011W has 
been used successfully in TMD research (Jahn et aL, 2002; Larsson cat aL, 2004; Seg i et cal., 
2005; Wolfart et cal,, 2005). 
While this project aimed to identify OHHIP-'IMD relevant items from the existing index, 
ongoing `work is taking place by another colleague to explore, through in-depth interviews 
with TMD patients, whether any other items may be needed to complement the short form 
0111P. Given the ability of the index to measure OHrQOL in TMD patients and the structure 
of the index, many more items may not be required. 
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Although OIIIP has been tested before on the TMD population in different studies, none 
of these studies was conducted usitlg the English versions of 01111) with one exception 
(Murray et cal., 1996). However, the authors used only part of OIIIP and excluded 21 items 
based seemingly on their subjective judgement. The present study was the first to systematically 
distil 011I11' and eliminate redundant items to improve its performance as a potential TMD 
treatment outcome. 
Shortening OIIIP to a more condition CM ID)-specific subset of items would be very 
helpful, firstly to improve its precision and consequently its psychometric properties (Allen 
and Locker, 20021; Allen, 2003). Secondly this would reduce the respondent burden and make 
the questionnaire easier to complete, which would consequently improve the response rate 
(Locker and Allen, 2002). Thirdly, the short form would be easier to use in clinical settings 
and less costly in large national surveys. 
The first step in this research involved adapting O1=11P to be more suitable for'IMD 
conditions, and consequently to improve the psychometric properties of the intended short 
version. This included re-wording 01HHP items so it included a reference to the Jaw. The need 
for adding this word was previously recognised by the authors of the Swedish version of 
CHIP (Larsson et a1., 2004). 
i'xe reference period (recall periodj in this study was changed to one month. since the 
one-year period used in the original OIIIP was not appropriate for TMD, where the condition 
is often unstable and a shorter reference period is needed. The choice of one month was based 
on the results of the first two studies, and has also been supported by other authors (John et 
al., 2002). 
A case series design was used in this study. 'Fhe sample size was initially determined at 
99 which would allow a precision of percentage estimate for each item kNi. thin iii percentage 
points, and would also be more than sufficient to show the expected score change with 
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treatment. This sample size exceeded the size needed for a study power of 90% to just 
compare between patients and controls, but was necessary for future analyses on items' 
sensitivity to changes with treatment. This is because a large sample is needed to detect small 
differences in the condition and where drop out from the study is anticipated and needs to be 
anticipated. This sample size was later extended to 110 patients in order to examine the 
stability (test-retest reliability) of OHIP. 
The patient sample covered a large range of age groups and consequently was similar to 
epidemiologic research on TMD (Dworkin et al., 1990; LeResche, 1997b). However, subjects 
below the age of 18 years were not recruited to comply with the legal-ethical considerations 
related to consent. The wide sample made it possible to include a wide spectrum of TMD 
diagnoses, which ensured representation of different conditions with the potential for various 
complaints and impacts on quality of life. Patients participating in this study underwent a 
variety of treatments prescribed on the basis of what was considered most appropriate by the 
responsible consultant. 
A control group was necessary to eliminate items that appear to have high impact on 
patients' QOL but are in fact representing "background noise", in other words, items that 
score frequently irrespective of TMD status. Ideally, the control group should have been the 
normal population. Unfortunately, however, no normative values for an English speaking 
population have been established. The best available work was the National Dental Health 
Survey in the United Kingdom 1998 (Kelly, 2000), which used OHIP-14. A survey that used 
the full OHIP in a random sample of community dwelling Canadians is also available (Locker 
and Slade, 1993). However, participants were all 50 years old and older who cannot be age 
matched to the TMD population whose peak age group is mid 30s - mid 40s (LeResche, 1997b). 
For this reason, OHIP was administered to an age and sex matched TMD-free control group. 
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6.6.2. Differences between TMD patient and control groups 
In order to examine the difference between the two case groups, data were first explored for 
normality of distribution. Individual item scores for both patients and controls were all 
skewed. This finding is in accordance with Slade (2002) who noted many respondents 
reporting no impact at the defined threshold, resulting in summary scores being non normally 
distributed and restricting the use of parametric statistics (Slade, 2002). For this reason and 
because the data were at the ordinal level (Bowling, 2002), non parametric tests were used to 
compare between the two groups. 
As shown in section 6.5.2.1, overall, OHIP was clearly able to discriminate between the 
two groups and to reflect the impact of TMD on patients' quality of life. Some items showed 
no statistical difference between the two groups. These are not anticipated to capture the 
expected smaller difference between patients before and after treatment. These, however, 
were only eight items, which were considered redundant and were later eliminated. The 
relatively large number of items (41) showing statistically significant difference between 
patients and controls reflects that TMD conditions result in an impact on aspects of life other 
than one might anticipate. This issue has been investigated further (Steele et al., 2006) but it is 
beyond the scope of this thesis. 
As the statistically significant difference was not enough to identify the items most 
relevant to TMD, I measured the difference in each item between patients and controls using 
four analyses: Mean, Median, Prevalence (%FOVO) and Item-Impact. These four analyses 
allowed the data to be viewed from different aspects. 
Using Means is quite a useful approach to analyse the data despite the statistical 
shortcoming that the data were not normally distributed. In addition they were also at the 
ordinal level which cannot be averaged or mathematically manipulated (Bowling, 2002). In 
other words, a mean cannot be calculated for "occasionally" and "fairly often" and so obtain a 
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new rate. However, the values attributed to these levels of frequency, i. e. their orders in the 
scale can be averaged (Slade, 2002). The resulting value does not have a clear narrative 
meaning, but can be used to compare groups (Slade, 2002). For example, if "occasionally" 
with "fairly often" are given the values 2 and 3 respectively, we cannot interpret the meaning of 
a value of 2.7, but we can say that a group whose score is 2.7 is suffering more frequently than 
another with score 2.5. 
The Item-Impact method used in this project was the modified version of Item-Impact 
that has been suggested by Allen and Locker (2002). However, there were three points of 
dissimilarity. First, unlike Allen and Locker (2002), 1 did not rely merely on patient's item- 
impact values, but on the differences between these values and those of the controls. 
Nonetheless, I found only trivial difference between order of items by "patients' preference", 
and that according to difference between the two groups. Allen and Locker (2002) also used 
the proportion of patients who reported any degree of impact from hardly ever to very often. 
Instead, I opted to report the proportion of patients whose lives are compromised on a 
constant or frequent basis by using a more stringent cut-off point for the responses (fairly or 
very often - FOVO). Finally, I did not consider items' weights in calculating item impacts. 
This is because OHIP item weights did not have any effect on the final results (Allen and 
Locker, 1997). In a different study, John et al. (2002) found a strong correlation (rs = 0.99) 
between the sum of weighted and unweighted data and preferred the use of simpler 
unweighted score. I followed this line in this study. 
Differences in summary scores between patients and controls 
All individual item summary scores varied between the two case groups. For example, a 
difference of 0.89 unit was noted in the mean item score. Also, for all but two items in the 
control group, median scores were 0 reflecting no impact on quality of life. By contrast, 
median scores for 26 items in the patient group were equal or greater than one unit. 
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Furthermore, the percentage of items reported as occurring fairly or very often (%FOVO) was 
ten times higher in the patient group than the control group (20% : 2%). Finally, on average 
the item-impact score for patients was 25 times that of the controls (35 : 1.5). These 
differences clearly show that the English version of OHI P was able to discriminate between 
patients and controls. 
What was also clear from the results is that items varied extensively in their summary 
scores within the same group. In particular, some items were highly prevalent amongst 
sufferers, while others less frequently affected quality of life. 
These findings were similar to those reported by John et al. (2002) and Larsson et al. 
(2004) who used the full OHIP in TMD patient samples in Germany and Sweden respectively. 
For example, mean overall OHIP score in the patient sample was 60.5 (SD=31.6). The 
German values were 45 (30.9) and the Swedish values were 61 (39). 
It was difficult to make detailed comparisons between the present findings and previous 
studies that have used OHIP in TMD due to differences in the items and analyses used 
(Murray et al., 1996; Segü et al., 2005). Furthermore, Murray et al. omitted in the OHIP 
questions references to problems with mouth, teeth or dentures and limited the cause of the 
impact on quality of life to pain. However, within these limitations I could conduct some 
comparisons which are reported in their relevant sections. 
Variation of TMD impact on OHIP domains 
The present data suggest that the psychosocial impact of TMD is considerable. For example, 
the psychological discomfort and psychological disability were the domains with largest 
differences between patients and controls in mean scores (Mean per item). The physical pain 
domain came third in order. This might be due to the fact that this domain comprises many 
less relevant items to TMD such as gum pain and toothache, which might have compromised 
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the domain score. On the other side of the scale, I found that social disability and handicap 
domains showed the lowest scores in the patient group. This might be interpreted by the fact 
that advanced impact on quality of life is uncommon and there is a floor effect in these two 
domains. This also explains why social disability and handicap domains were not represented 
in the first round of identifying TMD relevant items. 
The percentage differences in reporting items at the FOVO threshold between patients 
and controls were striking. TMD sufferers reported frequent or constant impact on different 
domains of quality of life that was 4-20 times higher than those of the controls (Table 6.8). 
These findings are in close agreement with Larsson et al. (2004), Murray et al. (1996) 
and Segü et al. (2005). It was not possible, however, to compare the present findings about 
the pain and function domains against the latter two studies who initially excluded the entire 
pain domain and many items from the function domain from their version of OHIP. Also, the 
percentage of patients reporting a frequent or constant impact in Murray et al. 's study (1996) 
was higher than all other studies including the present findings. Although the domain order 
was almost identical, some domain scores in Murray et al. 's were more than twice as high as 
our data. For example, the psychological discomfort impact was reported by 33% of the 
present patient sample compared with 667.8% in Murray et al. 's study. This unusual high 
level of suffering was explained by the authors as a result of recruiting patients suffering 
neurological pain disorders who scored higher on psychological related domains than did 
TMD patients, hence increasing the total domain score. Furthermore, these authors recognised 
the fact that their patient sample was drawn from a tertiary care clinic, whose patients 
presented with the more severe conditions. 
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6.6.3. Candidate items (OHIP/TMD-I) 
As the statistical difference between patients and controls was not sufficient on its own to 
exclude all irrelevant items, another method was needed to distil the original OHIP. Different 
methods to shorten long instruments have been used in the past such as regression factor and 
item-impact analyses. Recommended uses of these methods were discussed in the literature 
review section in greater detail (section 2.4.3.5). Based on that review I opted to select items 
based on their item-impact score. While this is the method of choice to shorten long 
evaluative questionnaires (Guyatt et al., 1986; Juniper et al., 1996; Locker and Allen, 2002), 
the method ranks items, but does not yield cut-off points between relevant and less relevant 
items, nor does it produce meaningful units that can be used to draw such points. Therefore, 
other criteria were needed to "filter" OHIP items and identify TMD relevant items in a 
systematic way. 
The criteria used dictated that items with the largest difference between patients and 
controls in Item-impact will be included if they showed statistically significant differences 
and demonstrated clinically meaningful differences in the Mean and Median scores between 
TMD sufferers and controls. Moreover, in order to maintain the structure of the index, 
additional items were chosen to represent all OHIP domains. Ideally, the next step would be 
checking that all items are sensitive to change with treatment. Follow-up data were collected 
to carry out this analysis, but this constitutes further work and is not reported in this thesis. 
As expected, the Item-Impact analysis produced a continuum of values and did not show 
any cut-off points that could be used to discriminate between high- and low-impact items. It 
was found that all four summary scores (Mean, Mean, Prevalence, and Item-impact) 
consistently identified the same top items. 
The concept of a clinically meaningful difference (patient/control) was adopted. Items 
that reached the determined threshold were chosen initially as candidate items. The minimum 
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difference of OHIP score between the groups was taken as one unit in the mean item score. 
Although this was arbitrary it allows an overall narrative difference that is meaningful in 
clinical research. If OHIP fails to demonstrate a minimum difference of one unit per item, it is 
unlikely that it will be able to capture the smaller difference between patients' scores before 
and after treatment. In other words, it will not be able to demonstrate improvement with 
treatment in a clear clinical term - the very reason for which it was shortened. 
At this stage, 16 items were identified in the Mean analysis, of which 14 items were top 
items in the Median analysis. Also, amongst these 16 items were the 15 most prevalent items 
(%FOVO), and the top 15 in the Item-Impact analysis. 
The 16th item identified by the Mean test was "question 36: felt depressed because of 
problems with jaws etc... " which was not amongst top items in the Median analysis nor did it 
exceed the arbitrary threshold of 20% difference in FOVO. The decision to include or exclude 
this item was based on the argument that shortening long questionnaires always involves a 
combination of statistical considerations and subjective judgement (Coste et al., 1997; Juniper 
et al., 1997). Pure statistical methods may, for instance, exclude items with low prevalence, 
although these may be rated high by a minority of patients. Therefore, a clinical decision is 
needed to ensure that this minority is represented. This was the case for question 36. It was 
felt that excluding this item from the intended questionnaire would omit an improvement 
outcome for 16% of patients who reported being depressed often or very often (versus 1% 
only in the control group). For that reason, item 36 was included for the time-being. This 
identified 16 items in the intended instrument. 
Maintaining OHIP structure 
Having established OHIP's main TMD related items, their distribution was checked within 
the OHIP domain framework. It was found that the domains reflecting the most severe impact 
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on quality of life, i. e. Social disability and Handicap were not represented. This is explained 
by the fact that only a small proportion of the TMD population reported impacts on their lives 
at this level. 
In order to maintain OHIP's theoretical hierarchal structure and still include items that 
are most important to patients, it was necessary to initially include at least the top two items in 
the Item-Impact analysis from each domain. This was important for two reasons. Firstly, to 
include items affecting a minority of TMD patients who suffer the more extreme impact on 
quality of life, e. g. related Social disability and Handicap. This argument is in line with 
findings by Segü et al. (2005) who reported a significant difference in the above domains 
between patients and controls in a subgroup of the patient group diagnosed as having an 
advanced condition. Similarly, Murray et al. (1996) found that around 40% of the orofacial 
patient population (including patients with TMD) reported the above domains at the fairly or 
very often (FOVO) level. Secondly, Moran et al. (2001) argued that when reducing an 
instrument at least two items per domain should be retained in order to maintain 
responsiveness and reliability at an acceptable level. This argument has been supported by 
previous work to shorten OHIP (Slade, 1997b) where the author maintained two items per 
domain to produce OHIP-14. 
This analysis identified 20 items for OHIPTFMD-I with each domain being represented 
by two or more items, except Functional limitation with one item only. Further work aiming 
to investigate the need to add items to OHIP to improve its content validity may be able to 
cover the shortage of this domain. Also, further work is needed to exclude items with low 
responsiveness to changes with treatment, which would compromise the performance of the 
proposed TMD quality of life measure. 
Table 6.19 compares candidate items identified by this study as a TMD-specific short 
form of OHIP and those chosen by Murray et al. (1996). Of the 30 items chosen by the latter 
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authors, 16 were identified in this study. The remaining 14 items were either not included in 
the original OHIP (2 items), related to speech (3), to appearance (1), to tooth brushing (1), to 
social impact (4) or to general disability (3). While the last two categories were represented in 
the present study, other items were clearly not related to TMD. On the other hand, four items 
that exist in the present study were excluded by Murray et al. (1996). These were related to 
pain or to general health. 
Table 6.19. Comparison between candidate items and items chosen by Murray et at (1996) 
OHIP item 
Murray 
et al. 
Moufti 
et a! 
01. Difficulty che"in g am foods 1 
16. Uncomfortable to eat any foods 1 
19. Worried by jaw or dental problems 
20. Being self conscious 1 
21. Bein miserable 1 I 
23. Feeling tense 1 
28. Avoid eating some foods 1 
32. Having to interrupt meals 1 
33. Sleep being interrupted 1 1 
34. Being upset 1 1 
35. Difficult to relax I 
36. Feeling depressed 1 
37. Concentration being affected 1 
40. Less tolerance of spouse or family 1 
42. Bit irritable with other people 1 
47. Life in general less satisfying 1 
02. Trouble pronouncing any words 0 
24. Speech being unclear 1 0 
25. People misunderstood some words 1 0 
27. Being unable to brush teeth properly 1 0 
31. Avoid smiling 1 0 
38. Being a bit embarrassed 1 0 
39. Avoid going out 1 0 
41. Trouble getting on with other people 1 0 
43. Difficulty doing your usual jobs 1 0 
46. Unable to enjoy other people's company as much 1 0 
48. Totally unable to function 1 0 
49. Unable to work to full capacity 1 0 
10. Painful aching in mouth 0 1 
11. Having a sore jaw 0 1 
12. Having headaches 0 1 
44. General health has worsened 0 1 
* Avoid eating with other people I N/A 
* Longer to complete a meal I N/A 
* Items added to original OHIP by Murray et a/. (1996) 
0= item is not in this version, 1= item is in this version 
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6.6.4. Validity and reliability of OH/P and OH/P/TMD-/ 
It has been argued that reducing the number of items may adversely affect measurement. This 
is especially the case with the content validity and reliability (Nunnally and Berbstein, 1994; 
Locker and Allen, 2002). It is therefore essential to test the psychometric properties of a 
newly derived short form even if the mother instrument has been validated. It is highly 
recommended that validation of the new short version should be conducted in a sample other 
than the one it was derived from (Coste eta!., 1997; Locker and Allen, 2002). 
What is reported in this study is not the validation process of a short form of OHIP, e. g. 
OHIP/TMD-I, but an examination of OHIP-49's psychometric properties in an English- 
speaking TMD population and an exploration of how these properties may change after 
excluding redundant items. 
Content and criterion validity 
There has been debate in the literature about the content validity of the full OHIP. Although 
the full version was proven to be a valid instrument for cross-sectional and longitudinal 
studies on TMD (John et al., 2002), other studies opted to administer only part of OHIP, using 
items that were believed to be more TMD relevant (Murray et al., 1996; Segu' et al., 2005). 
These authors recognised the burden that non TMD related items might have with 
consequences on the instrument's performance. 
In this study, it was found that the full OHIP was able to capture the impact of TMD on 
quality of life. However, by examining the performance of each item of OHIP, items with 
weak performance were identified and excluded, thus enhancing the content validity of OHIP. 
This was further complemented by amending the reference period to one month, and adding 
the word "jaw" to the source of patients suffering in the body of OHIP items. In addition, the 
short version contained items from all OHIP domains in order to maintain the hierarchal 
structure of OHIP (i. e. Locker's model), thus agreeing with Slade (1997b) and with Allen and 
Locker (2002). 
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Further development of the TMD outcome measure will involve examining whether 
other items need to be added to OHIP. Murray et al. (1996) and John et al. (2002) suggested 
the addition of two items: "Taking longer to complete a meal" and "Avoiding eating with 
others ". A parallel research involving in-depth interviews with TMD patients is being 
undertaken by the same research team to address this issue. But, it is beyond the scope of this 
thesis to report the findings of that research. 
Criterion validity for OHIP in the TMD population has been established (John et al., 
2002) (Murray et al., 1996; Segü et al., 2005). The full version works as the gold standard 
against which the validity of the short versions can be examined (Slade, 2002). In this study, a 
very strong correlation of 0.91 was found between the full OHIP and OHIP/TMD-I reflecting 
the validity of the short form. 
Construct validity 
This aspect of validity has two components: the Discriminant validity (also known as Known- 
group validity or the Group validity) and the Convergent validity. 
The discriminant validity was explored by comparing OHIP scores in the TMD patient and 
control groups. This demonstrated the ability of full OHIP to discriminate between patients 
and controls; not only 41 of its 49 items showed statistically significant difference between 
the two groups, but also a difference of 0.89 unit per item was recorded on average. The 
proposed subset of items, OHIPITMD-I, poses a stronger ability to discriminate between the 
two groups. This was demonstrated by the fact that all its items have statistically significant 
differences between the two groups, and that a difference of 1.53 unit per item was recorded 
on average. 
To test the convergent validity of OHIP, different parallel patient-derived measures were 
used, including perceived pain severity and its impact on quality of life and global rating of 
mouth health. Use of these parallel measures was necessary not only to explore the convergent 
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validity of OHIP in the TMD population, but also to examine OHIP's sensitivity to changes 
with treatment in a future work. 
The need for different parallel instruments to check OHIP against came from the fact that 
OHIP is a multidimensional instrument. Therefore different measures were needed to explore 
the convergent validity of the different OHIP domains. This same argument was used before 
to validate the Swedish version of OHIP (Larsson et al., 2004). Moreover, TMD itself is a 
multidimensional condition. Previous studies (Segü et al., 2005) validated OHIP against 
measures of pain only arguing that the greater the pain, the greater is the functional limitation 
and psychological discomfort. While pain is a major source of suffering, it cannot be 
considered the only source. For example, in the second part of this project, it was reported, 
that the worries from the condition was sometimes the reason for seeking the medical attention, 
and many patients reported improvement in their conditions after a consultation session. 
The first of these self-report measures was the Multidimensional Pain Inventory MPI 
(Kerns et al., 1985). MPI is considered "the gold standard multi-axial pain self-report 
instrument" (Newton-John, 2002). Furthermore, it is recommended as one of the best two 
indices in pain trials (Turk et al., 2006). In this study only part one of the MPI was used. This 
is because part two of (about relatives' support) and part three (about the impact on daily 
activities) are more related to severe or generalized pain conditions where others' support and 
performing daily activities are key issues for the patients. Furthermore, part one has items that 
cover these two parts. 
The second self-report measures were two visual analogues scales of perceived pain 
severity. Perceived pain scales have been extensively used to validate long self-report 
measures (Locker and Miller, 1994; Locker, 1998), and different types of these scales have 
been used. Numerical Rating Scales (NRS), for example, have been used to explore the 
validity of OHIP (Murray et al., 1996; Segü et al., 2005). Although this is technically less 
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demanding than visual analogue scales consisting of continuous lines on which patients mark 
the extent of their pain, the VAS is preferred as it avoids leading respondents to clustered 
answers (see section 2.4.4.4). 
The third patient-derived measure used to check OHIP's convergent validity was a 
global rating of oral health. This has been used to validate both the original and the German 
version of OHIP (Locker and Slade, 1993; John et al., 2002). Other workers have used different 
scales of perceived health, For example, to validate the Swedish version of OHIP the authors 
asked patients to rate their general health but not the health of their mouth (Larsson et al., 2004). 
OHIP showed good convergent construct validity in the TMD population. All tests of 
correlation between either the full OHIP or the subset of items, i. e. OHIP/TMD-I and other 
pain self-report measures showed large correlation which was significant at the 0.01 level. 
The correlation with perceived oral health was weaker than that with pain measures and weaker 
in OHIPITMD-I but still significant at the 0.01 level. These findings are comparable to findings 
in the Swedish OHIP (medium correlation with self-report pain measures) (Segü et al., 2005), 
and the German OHIP (medium correlation with global rating of oral health) (John et al., 2002). 
Reliability 
The test-retest reliability for established instruments must be re-examined when they are used 
in a different population than that on which they were originally tested (Litwin, 1995). But 
testing stability is challenging in clinical settings because the condition itself is often unsettled. 
The interval between the two occasions has to be long enough to avoid memory effects, i. e. 
patients recalling their initial answers, and not too long so that the condition changes. 
In this study, both the full OHIP and the short form OHIP/TMD-I showed high stability, 
ICC measured 0.96 and 0.97 respectively. These figures are comparable with those for the 
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Swedish OHIP where stability was measured over one to two weeks in a sample of TMD 
patients (ICC for OHIP's different domains measured between 0.87 and 0.98). 
The internal consistency reliability was very high for both the full OHIP (0.95) and the 
proposed short form (0.94). Cronbach's a coefficient showed that the exclusion of four items 
from OHIP would improve the internal reliability. These four items (related to denture and 
food catching) had been previously shown not to have any statistical significance differences 
between patients and controls, and none of these was in the OHIP/TMD-I short form. 
These findings are consistent with previous studies, e. g. Larsson et al. (2004) who found 
am internal reliability of 0.91. 
6.6.5. Strengths and limitations 
This study was the first to systematically distil OHIP to produce a TMD specific version that 
might be suitable, once fully tested, as a TMD treatment outcome. Also, although the English 
version of OHIP has been previously administered to TMD patients (Murray et al., 1996), the 
authors used only part of the original instrument. The present study was the first to use the full 
English version in a TMD population and to explore in detail the impact of TMD on patients' 
lives. The use of the full version showed that items not expected to show higher impact than 
that seen in TMD free controls have indeed scored higher. These findings will undergo a 
future exploration. 
Two aspects of the protocol were adopted to give more strength to this study: First, the 
sample size allowed for a study power of greater than 90% and for a power of 80% for the 
future sensitivity anlysis. A wide range of TMD diagnoses were represented. All patients 
completed baseline OHIP questionnaires before any consultation from the clinical staff in 
order to avoid bias. 
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If the aim of this project was to validate OHIP or its newly derived short form I should 
have used additional parallel measures to ensure the convergent validity of all OHIP's 
subscales. This includes, in addition to the global rating of health and measures of pain, 
measures of the jaw/mouth function such as the Mandibular Function Impairment 
Questionnaire (MFIQ) (Stegenga et al., 1993), and a measure of the psychological health such 
as RDC / Axis-Il (Dworkin and LeResche, 1992). Similarly, the small patient sample used for 
the test-retest analysis does not permit for generalising conclusions about OHIP's stability 
other than for the purpose of initial exploration of psychometric properties. 
The type and length of treatments provided in this study were not standardised, but rather 
based on what was considered most appropriate by the responsible consultant. This was 
deemed necessary to represent a wide spectrum of treatment modalities, and to avoid 
influencing the consultant's opinion. 
The candidate items were derived using the item-impact method and the ranking of mean 
and median values. Other methods to shorten long instruments are available such as the 
Factor analysis, which may be able to show how items cluster. This is turn may inform the 
theoretical structure of OHIP. In this respect, John et al (2004) have postulated that OHIP 
should be reconfigured into four rather than seven domains. These were: psychosocial impact, 
orofacial pain, oral function and appearance. The heterogeneous nature of TMD dictates a 
large number of subjects for this type of analysis. Hence, it would be premature to apply it to 
the current data set. 
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6.7. Conclusions 
1. (Objective]) - OHIP-49 was adapted to improve its utility as a measure of TMD treatment 
outcome. The word `jmv" was added to the question wording as a source of suffering, and the 
reference period was altered to one month. 
2. (Objective 2) - The adapted version of OHIP was administered on 110 TMD patients and 
matching TMD free controls. 
3. (Objective 3) - There are profound differences between TMD patients and healthy controls in 
OHIP scores. OHIP-49 is capable of discriminating between TMD patients and TMD free subjects. 
This is a prerequisite for the instrument to be able to demonstrate difference between pre- and post- 
treatment. The psychosocial impact of TMD on patients is substantial. The results of this work 
will help clinicians dealing with TMD to address patients' suffering in their treatment plan. 
4. (Objective 3) - All item scores were higher for patients than controls, but the difference was 
not always statistically or clinically significant. Redundant items may reduce the performance 
of OHIP, and need to be eliminated to make a better instrument. 
5. (Objective 4) - Twenty candidate items which may form the basis of a clinical outcome 
measure were identified and called "OHIP/TMD-I". First, items showing no statistical 
significance difference between TMD patients and controls were eliminated. Second, items 
showing largest differences between TMD patients and controls were identified using 
summary measures including Mean, Median, Prevalence and Item-Impact. Third, items were 
selected taking into consideration the theoretical framework of OHIP domains. 
6. (Objective 4) - The domain functional disability was only represented by a single item and may 
require further items outwith OHIP 
7. (Objective 5) - The psychometric properties of the full OHIP and of the short form 
"OHIP/TMD-P" were initially explored including content, discriminant, convergent and 
criterion validity; test-retest and internal consistency reliability. Both versions showed 
satisfactory properties, with the short form performing better in some aspects. This cannot be 
generalised before testing the short form in a new sample. 
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6.8. Summary 
The aim of this study was to start the development of a quality of life outcome measure for TMD. 
The intention was to obtain a TMD specific short form of the Oral Health Impact Profile (OHIP) 
and to explore aspects of psychometric properties for the derived instrument, the so-called 
"OHIPf MD-P". 
An adapted version of OHIP was used. Adaptation included adding the word `jaw" to the 
question wording and changing the reference period in the original OHIP to one month. A 
prerequisite for this version to be a useful outcome instrument is to demonstrate ability to 
discriminate between TMD patients and TMD free controls. 
TMD patients completed the adapted version with the aim of identifying OHIP items with the 
largest impact on patients' quality of life in comparison to matching controls. Criteria were set to 
select candidate items for the short form, and 20 items were identified. The validity and reliability 
of the full OHIP and its short form were examined by a series of tests. 
The adapted English-language version of OHIP was able to discriminate between patients 
and controls. The identified 20 items had comparable or better psychometric properties than those 
of the original OHIP. Further work is needed to examine the sensitivity to change of these items, 
an essential characteristic in outcome measures, and to investigate whether items are missing from 
OHIP and needed to be added. Once fully completed, the psychometric properties of the short 
form need to be examined in a new independent patient sample. 
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7.1. Conclusions 
Study One established optimal review and reference periods for TMD outcome assessment by 
examining pain recovery progress of patients undergoing conservative treatment for TMD. 
Part A of this study identified patients showing definite improvement to treatment using 
two methods. First, by visually analysing pain / time plots of daily pain intensity, and second 
by examining these pain scores numerically. The visual examination revealed patients had 
three patterns of pain / time response characteristics: Improvers, non-improvers and 
borderline improvers. The numerical analyses identified almost the same patients identified 
by the visual assessment as improvers. The best agreement occurred with a combined 50% 
reduction in mean and maximum monthly pain scores (aggregated sensitivity and specificity = 
1.74). This was defined as a suitable cut-off point to discriminate numerically between 
improvers and non-improvers. 
Optimal review period and reference periods were established in part B of this study. 
These were 15 weeks and 4 weeks respectively. 
Study Two was conducted to triangulate with Study One. It used qualitative data from ten 
in-depth interviews with patients undergoing conservative treatment for TMD and showing 
improvement. The study found that perception of suffering from TMD and its recovery were 
mainly linked to the experience of pain. This confirmed that the approach adopted in Study 
One, i. e. establishing the review and reference periods based on pain recovery was a 
reasonable approach. 
The interviewees reported temporal characteristics of recovery such as gradual and 
fluctuating improvement similar to what was found in Study One. However, the limitations of 
qualitative approach did not allow for an accurate estimation of the review and reference 
periods. Nevertheless, within these limitations time frames for these periods suggested in both 
studies were consistent. 
241 
Chapter 7. Conclusion of project and further work 
In Study Three a TMD-specific short form of OHIP was derived and aspects of its 
psychometric properties were explored. This subset of OHIP items comprised the core of a 
TMD quality of life outcome measure under development. 
The Oral Health Impact Profile (OHIP) was adapted to improve its utility and content 
validity for TMD. The adapted version included the word `jaw" as a source of the impact on 
quality of life and had a one-month reference period. 
The adapted version demonstrated remarkable ability to discriminate between TMD 
patients and TMD-free controls, a prerequisite to be a useful as an outcome instrument. The 
discriminative validity was further improved by reducing OHIP to a 20-item short version, 
OHIPITMD-I, maintaining items with significant statistical and clinical differences between 
patients and controls. OHIPI TMD-I performed comparably or better than the full OHIP in 
other psychometric tests. Further work needed to continue the development of the proposed 
TMD outcome instrument is outlined below. 
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7.2. Recommendations for further investigation 
7.2.1. Study One 
1. The pain diaries collected in this study offered valuable information that could be used for 
numerous future analyses, including: 
a. Investigating the role of daily psychological stress on the illness status. This could be 
explored by analyzing the differences in jaw pain level, headache hours and consumed 
number of painkillers with relation to weekdays versus weekends. 
b. Investigating the relationship between jaw pain and headache, and exploring the initial 
reason for consuming painkillers in TMD: jaw pain versus headache. 
c. Testing the validity of summary measures of pain intensity taken at follow-up 
appointments against daily data, and trying to explore what patients refer to by summary 
measure: average, maximum, or recent experience. 
2. Standardised visual assessment of plotted pain changes with treatment is a promising 
method of outcome assessment in clinical trials. While characteristics of pain patterns may 
differ across chronic conditions, the same principle is still applicable. 
3. Whilst systematic, and preferable to the use of an unsubstantiated statistical approach 
alone, the visual assessment is still clinician-led. Further work may be required to establish 
the nature of a clinically meaningful change, from the patients' perspective as well as the 
clinicians (e. g. rescue medicine). 
4. Analysing rescue medicine data has potentially an important value in assessing TMD 
treatment outcome, especially if analgesic type and use is standardised. 
5. Area under the curve is a complicated test, which is not available in all statistics packages. 
Assuming only few data are missing, it is not favoured over the simple Mean test. 
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7.2.2. Study Two 
1. This study revealed interesting information about the suffering of TMD and patients' 
journey through illness and treatment. In-depth qualitative research is needed to give 
further insight on the lived experience of TMD and orofacial pain in general. This seems 
necessary to ensure that management and outcome assessment of these conditions map 
appropriately to patients' own perceptions and expectations. In this context, this further 
insight can also help to add any themes to OHIP that may be deemed necessary. Another 
research project is currently undertaken by the same research team to address this point and 
also to develop a theoretical model for TMD. 
2. Different characteristics of TMD pain and symptoms were expressed by the participants in 
this study. These are worthy of further exploration, which could potentially improve our 
understanding and differential diagnosis of TMD. 
7.2.3. Study Three 
Further work is needed to: 
1. Explore if extra items needed for OHIPTI'MD-I using qualitative interviews with patients. 
This is ongoing work by the research team. 
2. Analyse the follow-up data for the TMD patient group to determine sensitivity of the 
OHIP/TMD-I items to change with treatment 
3. Examine the psychometric properties of the final set of items using an independent sample 
of TMD patients 
4. Explore the difference in TMD impact on patients with different subgroups, including age, 
gender and RDCf MD diagnosis sub-groups 
5. Check the characteristics of the control groups against the British National Survey (Kelly, 
2000) 
6. Perform a factor analysis to verify the appropriateness of the domain structure as it relates 
to TMD 
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Appendix 1 
TMD diagnostic criteria and 
examination forms 
Appendices 
Appendix 1 is divided into four parts. It starts with a summary of the Research Diagnostic 
Criteria (RDC). These are presented in the original paper (Dworkin and LeResche, 1992) in a 
theoretical manner and over numerous pages. Therefore, it was necessary to summarise these 
in a one-sheet form to facilitate the operational procedures of making a diagnosis in busy 
dental and hospital clinics. 
Presented next is the modified form of the Temporomandibular Index (TMI) (Pehling et 
al., 2002). The advantages of this index are outlined in section 2.2.4.3. However, as discussed 
in that section, some work was needed to overcome the shortcomings of this index. The 
original form is complicated and contains procedures of dubious utility and reliability, for 
example, the differentiation between coarse and fine crepitus. In addition, it endeavours to 
produce a score for each patient, given equal weights to different signs. 
The third part of this appendix is the Graded Chronic Pain Scale section of the History 
Questionnaire of the RDC. 
Lastly, presented in part four are examples of the Arabic version of the RDC. The 
literature review of this thesis reported that one very important feature of the RDC is its 
worldwide appeal. RDC was available in 17 languages at the time of submitting this thesis. 
However, they were not all obtained using a scientific approach such as the Forward - 
Back ward Translation method used for example to produce the German version (John et al., 
2006a). The Arabic version, with which the author of this thesis is familiar was clearly made 
by a non-native speaker and was poorly devised. Therefore, there is a need to produce a new 
version using recognised methods such as the above mentioned. 
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Research Diagnostic Criteria for the Temporomandibular Disorders RDC/TMD 
Groi n.. Criteria 
Muscle Disorders 
Myofascial pain I. Reported pain in masticatory muscles 2. Pain on palpation in at least 3 sites -, one of them at least in the sane Key: Painful muscles side of the reported pain 
Myofascial pain with limited I. Myofascial pain 
opening 2. Pain-free unassisted ' opening< 40 mm 
Key: Painful muscles +limited 3. Passive ° stretch >5 mm (from pain-free unassisted opening to 
movement 
"painful" assisted opening) 
Disc Displacements 
* No pain in the joint neither reported nor on palpation 
T 
2 . Reproducible 
, click on any excursion " with either opening or 
closing click 
Disc displacement with reduction 3. With click on opening and closing (unless excursive click 
Key: Reproducible clicking confirmed): 
"Click on opening occurs at >_ 5 mm interincisal distance than on 
closing 
. Clicks eliminated by protrusive opening 
1. History of locking or catching that interfered with eating 
Disc displacement without 2. Absence of TMJ clicking meeting DDR criteria 
reduction with limited opening 
3. Unassisted "painful" opening < 35mm 
Key: Limited opening with no 
4. Passive stretch <5 mm (from "painful" unassisted opening to 
" " painful assisted opening) 
clicking 5. Contralateral excursion < 7mm Or Uncorrected ipsilateral deviation 
_ 
on opening 
1. History of locking or catching that interfered with eating 
Disc displacement without 2. The presence of TMJ sounds excluding DDR clicking 
reduction without limited opening 3. Unassisted "painful" opening > 35mm 
Key: History of previously limited 4. Passive stretch ?5 mm (from "painful" unassisted opening to 
opening-imaging needed to confirm "painful" assisted opening) 
DD 5. Contralateral excursion' 7mm 
6_ (ý)tioiwl imagim-, (_lrthrography or MRI) to confirm DD 
Oth er Common Joint Diseases 
Arthralgia I Pain on I %1.1 pallor ion either laterally or intra auricular 
Key: Painful TMJ / no crepitus 
2. Self reported joint pain with or without jaw movement 
3. Absence of crepitus, and Possibility of clicking 
Osteoarthritis I. Pain as for Arthralgia (reported and on palpation) 
Key Painful TMJ + crepitus 2. Crepitus on any movement or Tomogram evidence of joint changes 
Osteoarthrosis 1. Crepitus on any movement or Tomogram evidence of joint changes 
Ke : Non painful TMJ + crepitus 2. No reported joint pain , neither on palpation nor on any movement 
I In the jaw, temples, face, preauricular area, or inside the ear, at rest or function 
2 There are 20 sites (ten on each side): posterior, middle and anterior Temporalis; origin, body and insertion of 
Masseter; posterior mandibular region; Submandibular region; lateral Pterygoid; tendon of Temporalis. 
3 Interincisal opening plus overbite or interincisal opening minus anterior open bite. 
4 Passive stretch: The examiner's index and thumb are used to moderately force the mouth to open wider than 
unassisted opening. Patients are instructed to raise a hand to signal when the stretch becomes too uncomfortable. 
5 All clicks must be reproduced 2 out of 3 consecutive trials 
6 Contra- or ipsilateral or protrusive 
7 Erosion of cortical delineation, sclerosis of parts or all the condyle and articular eminence, flattening of joint surfaces, 
osteophyte formation 
8 Erosion of cortical delineation, sclerosis of parts or all the condyle and articular eminence, flattening of joint surfaces, 
osteophyte formation 
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Patient's code Date // 20 
TMD EXAMINATION 
Examiner: Please follow the following instructions fill in all the form items 
1. For all items pleas circle [0] if the exam item is negative and [1] if the exam item is 
positive 
2. For Vertical incisal overlap use ( +) for overbite, (-) for anterior open bite 
3. Make sure there is no unstable denture 
Facial Asymmetry [0] [I] Specify if yes 
Muscle Hypertrophy [0] [I] Spec if}' if yes 
Do you have a pain on the right side of your face, the left side or both? Right Left None Both 
Please circle one 
Could you point to the areas where you feel pain? Right Left 
Please circle one on each side None None 
Jaw joint Jaw joint 
Muscles Muscles 
Both Both 
Final Diagnosis 
Group/side Right Left 
RUC I 
RUC 11 
RDC III 
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Joint examination 
Palpate the following (]Kg pressure) 
Right Left 
Joint Pain Tender lateral [0] [1] [0] [1] 
Tender ear canal [0] [1] [0] [1] 
Tender on any movement [0] [1] [0] [1] 
Joint sounds Opening click Occurs at....... min [0] [1] [0] [1] 
Closing click Occurs at ....... mm 
[0] [1] [0] [1] 
Reciprocal click eliminated by protrusive opening [0] [I] [0] [1] 
Excursion click (Contra - or ipsilateral) [0] [1] [0] [1] 
Protrusion click [0] [1] [0] [1] 
Crepitus [0] [1] [0] [1] 
Muscle examin 
Palpate the following (1 Kg extra-oral4y, 0.5Kg infra-orally') 
Right Left 
Neck & Sternomastoid [0] [1 ] [0] [1] 
Shoulder Posterior intrinsic neck [0] [1 ] [0] [1] 
Trapezius [0] [1 ] [0] [I] 
Shoulder [0] [1 ] [0] [1] 
Extraoral Anterior Temporalis [0] [1 ] [0] [I] 
muscles MiddleTemporalis [0] [1 ] [0] [l] 
Posterior Temporalis [0] [1 ] [0] [1] 
Origin of the Masseter [0] [I ] [0] [I] 
Body of the Masseter [0] [1 ] [0] II] 
Insertion of the Masseter [0] [1 ] 101 111 
Posterior mandibular region [0] [1 ] [01 [º1 
Submandibular region [0] [1 ] [0] [I] 
tendon of the Temporalis [0] [1 ] [0] [I] Intraoral 
Lateral Pterygoid area [0[[1 ] [0] [1I 
muscles 
Total intra- and extra-oral muscles only F-1 
Function examination 
Examiner: please ask the subject to open 3 tunes 
Deviation on opening [0] [1] To Right or Left? [R] I L] Uncorrected? [0] 111 
Please describe opening pattern :......................................... ............... ........ ........................ 
Maxillary and Mandibular incisors used -}- Vertical incisal overlap (Please def ine + or -) .... mm Opening movement including incisal overlap 
Movement Amount Painful 
If painful, where is the 
movement pain located? 
Maximum pain-free unassisted opening ......... mm Maximum "painful" unassisted opening ......... mm [01 [I] ........................... Maximum "painful" assisted opening ......... mm [0] [1] ........................... 
Excursion movement (normal amount is >7 min) 
If painful, 
Movement Amount Restricted Painful where is the pain 
excursion movement located? 
To right ........... mm [0] [1] [0] [1] ........................... To left ......... mm [0] [11 [0] [11 ........................... Protrusion 
......... mm [0] [1] [0] [1] ........................... 
Examiner: Please check steps I&2 for accuracy 
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Graded Chronic Pain Scale 
Please read each question and respond accordingly. For each of the questions below circle only one 
response. 
1. How would you rate your facial pain on a0 to 10 scale at the present time, that is right now, where 
0 is "no pain" and 10 is "pain as bad as could be"? 
No pain Pain as bad as could be 
0123456789 10 
2. In the past six months, how intense was your worst pain rated on a0 to 10 scale where 0 is "no 
pain" and 10 is "pain as bad as could be"? 
No pain Pain as bad as could be 
0123456789 10 
3. In the past six months, on the average, how intense was your pain rated on a0 to 10 scale where 0 is 
"no pain" and 10 is "pain as bad as could be"? [That is, your usual pain at times you were experiencing 
pain]. 
No pain Pain as bad as could be 
0123456789 10 
4. In the past six months, how much has facial pain interfered with your daily activities rated on a0 to 
10 scale where 0 is "no interference" and 10 is "unable to carry on any activities"? 
No interference Unable to carry on any activities 
0123456789 10 
5. In the past six months, how much has facial pain changed your ability to take part in recreational, 
social and family activities where 0 is "no change" and 10 is "extreme change"? 
No change Unable to carry on any activities 
0123456789 10 
6. In the past six months, how much has facial pain changed your ability to work including 
housework) where 0 is "no change" and 10 is "extreme change"? 
No change Unable to carry on any activities 
0123456789 10 
7. About how many days in the last six months have you been kept from your usual activities (work, 
school or housework) because of facial pain? ----------- Days 
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Examples from the Arabic version of the RDC 
Presented here are examples of questions from the Arabic version of the RDC obtained from 
the RDC website (http: //rdc-tmdinternational. org). This is followed by an English 
interpretation made by the author of this thesis. 
£ . ll vJLA,: 
II t. I)2i X -j yr jI IJ C jtS I Wi XI Lr1c S jU ll4! e c sa; 
, eyýliý11 'e. c : týl ý jl e 
1zi i ýI;. oall ýiý11 X11 "e )L $c :uJ1l. o1S 14wß -Aua ýIwI LlI 
You have to mark on the line X in a place parallel in relation to the degree of the phenomenon's 
intensity. Putting the -X in the left side of the line indicates the absence of the phenomenon, while the 
closer the mark is to the right side of the line then the phenomenon is increasing. 
W= c. iS : ýIº r; 15i I x_11 b. We lg e }, ýY I %k: ºjl YI Lli .8 
1--------------------------------------------I 
8. During the last 6 months, what is the intensity of the painfully ache that you have been suffering 
from? No pain --- Unbearable pain. 
(This question corresponds to question No 2 in the Graded Chronic Pain Scale) 
rü SysýW / lei c: siS i11 ýl. ý. oIl ýs}II ee lg "e,; iYl %1: º. ýýI }q. LYl L tk&. 9 
I--------------------------------------------I 
j C>4 LA 
9. During the last 6 months, what is the intensity of the modified ache that you have been suffering 
from? No pain --- Unbearable pain. 
(This question corresponds to question No 3 in the Graded Chronic Pain Scale) 
I. A q'19 eyII ä: º. ýº11 ý. ý, YI c1» . 11 
I-------------------------------------------- I 
11. During the last 6 months, to what extent has been disturbing the pain of your face the performance 
to your usual activities? Have been unable to do any activity -- without annoyance 
(This question corresponds to question No 4 in the Graded Chronic Pain Scale) 
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Appendix 2 
Formula for calculating the area 
under the curve in Study One 
Appendices 
Simon Kometa 
Problem Description: I have a series of variables, named Y1 to Y4, in an SPSS data file. These variables 
represent outcomes at 4 ordered time points. For each case, I want to calculate the area under the curve of 
Y1 to Y4 as a function of time. The values of time are assumed to be 1,2,3, and 4, i. e. time is the 
sequence number of the Y variable. The result should be stored in a new variable in the active file. This 
area function will be equivalent to the AREA function that is available in in the BMDP command language. In 
BMDP, the /TRANSFORM paragraph command: yarea = area(y1, y2, y3, y4). calculates YAREA as (Y1 + 2"Y2 + 
2`Y3 + Y4)/2. How can I implement such a function in SPSS? 
Resolution Subject: SPSS transformation commands do not include a built-in area function such as the 
BMDP AREA function. 
Resolution Description: 
SPSS transformation commands do not include a built=in area function 
such as the BMDP AREA function. However, the desired area calculation 
can be easily performed with a combination of the functions available 
in SPSS. Assuming that the variables Yl to Y4 are adjacent to each 
other in the open data file and that they are correctly ordered, the 
following command would store the area in the new variable YAREA. 
IF (NMISS(yl TO y4) - 0) yarea = (2'SUM(yl to y4) - yl - y4)/2 . 
The command above can be implemented through the menus in SPSS 
versions with a graphic user interface. 
1. From the Data Editor window, choose Transform->Compute from the 
menus. 
2. Enter YAREA as the Target Variable. 
3. Enter "(2"SUM(y1 to y4)-yi -y4)/2" into the Numeric Expression box 
(without the quoiation marks). 
4. Click the If button. In the dialog box that appears, click the radio button 
"include if case satisfies condition". 
5. Enter "NMISS(yl TO Y4) a 0" into the box underneath this choice 
(again, no quotation marks) and click Continue. 
6. Click OK. 
If the variables Y1 to Y4 are not adjacent and ordered in the data 
file, then you will need to list the all the variables as arguments 
for the NMISS and SUM functions, as in NMISS(yl, y2, y3, y4). 
The IF condition checks that there are no missing values in the 
sequence for the current case. If there are missing values among the 
Yvariables, then YAREA will be system missing for the current case. 
(This is also true for the AREA function in BMDP). It would be 
possible to write commands that would allow YAREA to be calculated in 
the presence of some missing values. This would involve a more 
extensive set of commands which would depend on the particular 
arrangements of missing values that the user considered allowable 
and the particular adjustment desired. 
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Individual plots of pain/time 
response to treatment in Study One 
Appendices 
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Borderline improvers' charts 
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Non-improvers' charts 
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Professionals' visual assessment of individual pain/time plots 
Second Visual Third Visual 
assessment assessment 
Patient No. RW JS JM RW JS JM 
1 112 111 
2 323 222 
3 333 333 
4 111 111 
5 333 333 
6 111 111 
7 333 333 
8 112 122 
9 222 322 
10 212 211 
11 111 111 
12 323 322 
13 111 111 
14 111 111 
15 111 111 
16 121 111 
17 111 111 
18 111 111 
19 223 221 
20 223 321 
21 212 111 
22 323 333 
23 111 211 
24 111 111 
25 111 111 
26 111 111 
27 333 333 
28 333 323 
29 323 222 
30 212 111 
31 323 333 
32 111 111 
33 112 111 
34 111 111 
35 233 322 
36 333 333 
37 333 333 
38 222 221 
39 333 333 
1: Improvers 
2: Borderline-improvers 
3: Non-improvers 
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UNIVERSITY OF 
NEWCASTLE UPON TYNE 
Participant Information Sheet 
DETERMINATION OF A SUITABLE REFERENCE PERIOD 
FOR ASSESSING TREATMENT OUTCOME OF TEMPOROMANDIBULAR 
DISORDERS (TMD) 
"How your TMD symptoms changed over time and with treatment? " 
You are being invited to take part in a research study, aimed to find out how your symptoms 
changed over time and with treatment. Before you decide it is important for you to understand 
why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish to take part. 
Thank you for reading this. 
What is the purpose of the study? 
Temporomandibular disorders (TMD) are a set of uncomfortable and painful symptoms either 
in the jaw muscles, jaw joints or both. This study is designed to explore the changes in 
discomfort and pain levels in treated TMD patients. 
What are the possible benefits of taking part? 
It is hoped that the information that is gained from this study may give us a greater 
understanding of the issues of pain and discomfort and their measurement following TMD 
treatment. We are unable to pay a fee for your participation in this study as your attendance 
would be part of your routine treatment. We cannot guarantee that your participation in this 
study will be of direct benefit to you. 
Why have I been chosen for the study? 
Over the last few months, you have been treated in the Dental Hospital for the TMD problems 
you have been experiencing. You are invited now to take part in this study which aims to 
investigate your own experience of such symptoms and problems, and how they changed over 
time and with treatment. Altogether 20 patients will be invited to participate. 
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Do I have to take part? 
It is up to you to decide whether or not to take part in this study. If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form. If you 
decide to take part you are still free to withdraw at any time and without giving a reason. 
A 
decision to withdraw at any time, or a decision not to take part, will not affect the standard of 
care you receive in any way. 
What will happen to me if I take part and what do I have to do? 
As a part of your routine review appointment, we would like to invite you, on this occasion, to 
an informal discussion with the researcher. The discussion will take no more than 30 minutes, 
and will take place in a quiet room next to the clinic. The researcher will tape record the 
discussion on a small portable tape machine. This is to make sure that we don't miss anything 
important. 
Will my taking part in this study be kept confidential? 
Your name will not be recorded on the tape, but we will make a record of your age and sex. 
Personal details and opinions you may express during the course of the discussion will be 
kept strictly confidential'. The tape recording will be kept in a secure manner in accordance 
with the provisions of the Data Protection Act (1998). The tape recordings will be stored in a 
locked cupboard with access only available to the researcher who has asked you to participate. 
The tape will be then transcribed and the recording will be destroyed within one year of the 
discussion. Afterwards, the transcriptions will be analysed, but will be coded so that we have 
no direct way of knowing which transcription belongs to which person. 
The results of this study may be published in a scientific journal or presented at a research 
conference. In either case, your name will not be mentioned as part of the publication. 
Who is organising and funding the research? 
Who has reviewed the study? 
This study has been organised by the School of Dental Sciences - Newcastle University, and 
is being carried out as part of a clinical PhD programme. It has been reviewed by 
Northumberland and Tyne & Wear Local Ethical Research Committee. 
Contact for Further Information 
If you have any questions please don't hesitate to ask either the interviewer or the consultant 
in charge of the clinic**. The clinic consultants will also deal with any clinical issues arising 
in the interview. 
We would like finally, to thank you for the time you spent reading this sheet, and for 
participating in our study. It is much appreciated 
Version Number: 4 
Date May 2005 
Confidentiality will be assured as with all research of this type, except in extreme circumstances where 
information is received relating to certain criminal activities, and all participants should be aware of this before 
they reveal possibly incriminating information. 
** Drs RW Wassell and JG Steele, Senior Lecturers & Honorary Consultants. Department of Restorative 
Dentistry, The School of Dental Sciences, University of Newcastle upon Tyne, NE2 4BW 
Tel 0191 222 7825 - Fax 0191 222 6137 
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Patient identification number for this study:........... 
Ethics reference: 2003/38 
DETERMINATION OF A SUITABLE REFERENCE PERIOD 
FOR ASSESSING TREATMENT OUTCOME OF TEMPOROMANDIBULAR DISORDERS (TMD) 
Researchers: Mr. Adel Moufti, Mrs Jill Smith 
Please initial box 
1. I confirm that I have read and understand the information sheet Version 4, dated May Q 
2005 for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any Q 
time without giving any reason, without my medical care or legal rights being 
affected. 
3. I understand that sections of any of my medical notes may be looked at by Q 
responsible individuals from the Dental School in Newcastle University or from 
regulatory authorities where it is relevant to my taking part in research. I give 
permission for these individuals to have access to my records. 
CONSENT FORM 
4. I agree to take part in the above study Q 
Name of Patient Date Signature 
Researcher Date 
1 for patient; 1 for researcher; 1 to be kept with hospital notes 
Signature 
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Topic guide used for the interviews 
in Study Two 
Appendices 
Topic Guide for Qualitative Interviews 
Introduction 
Check the following 
1. Adequate opportunity for participant to read information sheet 
2. Consent form understood and signed 
3. Consultant in charge is clearly established 
"Thank you for agreeing to be interviewed, it really is very helpful. The purpose of the 
interview is to help us find out a little more about how the treatment for TMD works by 
asking people who have been through treatment, and listening to their answers. Because the 
information is often quite detailed and we need to pay very careful attention to what you say 
as you say it, for this reason we prefer to record the discussion so we can check on specific 
points when we need to. The tape will be destroyed when we have finished with it. We will 
not record your name or other personal details on the tape. " 
Overall history and change 
Establish when symptoms started and when treatment was sought and started. Careful open 
questioning to gain an overall perspective on improvements or otherwise in condition? 
Clarify timescale in as much detail as possible and probe further. Ensure the following are 
covered: 
1. Why treatment has been sought (range of symptoms, effect on life? ) Probe 
2. Range of treatments provided and by whom, Probe and clarify as necessary 
3. Which ones were considered to be effective? Why? (Briefly) 
4. When each treatment started? Probe 
5. When last treatment started? 
6. What improvement occurred and when it was noted 
What would you consider improvement to be? 
How long it took to see any improvement - in reference to what time? 
7. Was improvement gradual or sudden? 
Whether improvement is continuing (or not) 
When any improvement stopped 
Probe how improvement fluctuated 
Whether there were times when it got worse, when treatment went backwards 
Quality of Life 
1. Has improvement made any change to daily life? 
2. Which problems motivated you to seek this treatment? 
3. To what extent have your problems been solved? 
Conclude 
1. Would you like to add any thing? 
2. Thank you very much indeed for your help 
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Matrices used to map and 
summarise themes emerging from 
interviews in Study Two 
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The Oral Health Impact Profile 
- adapted version 
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Over the last month... 
1. Have you had difficulty chewing any foods because of problems with your jaws, 
teeth, mouth or dentures? 
1234s 
Never Hardly ever Occasionally Fairly often Very often 
2. Have you had trouble pronouncing any words because of problems with your jaws, 
teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
3. Have you noticed a tooth which doesn't look right? 
s 1234 
Never Hardly ever Occasionally Fairly often Very often 
4. Have you felt that your appearance has been affected because of problems with your 
jaws, teeth, mouth or dentures? 
s 1234 
Never Hardly ever Occasionally Fairly often Very often 
5. Have you felt that your breath has been stale because of problems with your jaws, 
teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
6. Have you felt that your sense of taste has worsened because of problems with your 
jaws, teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
7. Have you had food catching in your teeth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
8. Have you felt that your digestion has worsened because of problems with your jaws, 
teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
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Over the last month... 
9. Have you felt that your dentures have not been fitting properly? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
10. Have you had painful aching in your mouth? 
1234s 
Never Hardly ever Occasionally Fairly often Very often 
11. Have you had a sore jaw? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
12. Have you had headaches because of problems with your jaws, teeth, mouth or 
dentures? 
2345 
Never Hardly ever Occasionally Fairly often Very often 
13. Have you had sensitive teeth, for example, due to hot or cold foods or drinks? 
t2345 
Never Hardly ever Occasionally Fairly often Very often 
14. Have you had toothache? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
15. Have you had painful gums? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
16. Have you found it uncomfortable to eat any foods because of problems with your jaws, teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
17. Have you had sore spots in your mouth? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
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Over the last month... 
18. Have you had uncomfortable dentures? 
1234s 
Never Hardly ever Occasionally Fairly often Very often 
19. Have you been worried by jaw or dental problems? 
1234$ 
Never Hardly ever Occasionally Fairly often Very often 
20. Have you been self conscious because of your jaws, teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
21. Have jaw or dental problems made you miserable? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
22. Have you felt uncomfortable about the appearance of your jaws, teeth, mouth or 
dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
23. Have you felt tense because of problems with your jaws, teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
24. Has your speech been unclear because of problems with your jaws, teeth, mouth or 
dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
25. Have people misunderstood some of your words because of problems with your jaws, 
teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
26. Have you felt that there has been less flavour in your food because of problems with 
your jaws, teeth, mouth or dentures? 
12343 
Never Hardly ever Occasionally Fairly often Very often 
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Over the last month... 
27. Have you been unable to brush your teeth properly because of problems with your 
jaws, teeth, mouth or dentures? 
1234s 
Never Hardly ever Occasionally Fairly often Very often 
28. Have you had to avoid eating some foods because of problems with your jaws, teeth, 
mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
29. Has your diet been unsatisfactory because of problems with your jaws, teeth, mouth 
or dentures? 
1234 
Never Hardly ever Occasionally Fairly often Very often 
30. Have you been unable to eat with your dentures because of problems with them? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
31. Have you avoided smiling because of problems with your jaws, teeth, mouth or 
dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
32. Have you had to interrupt meals because of problems with your jaws, teeth, mouth or 
dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
33. Has your sleep been interrupted because of problems with your jaws, teeth, mouth or 
dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
34. Have you been upset because of problems with your jaws, teeth, mouth or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
35. Have you found it difficult to relax because of problems with your jaws, teeth, mouth 
or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
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Over the last month... 
36. Have you felt depressed because of problems with your jaws, teeth, mouth or 
dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
37. Has your concentration been affected because of problems with your jaws, teeth, 
mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
38. Have you been a bit embarrassed because of problems with your jaws, teeth, mouth 
or dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
39. Have you avoided going out because of problems with your jaws, teeth, mouth or 
dentures? 
12345 
Never Hardly ever Occasionally Fairly often Very often 
40. Have you been less tolerant of your spouse or family because of problems with your 
jaws, teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
41. Have you had trouble getting on with other people because of problems with your 
jaws, teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
42. Have you been a bit irritable with other people because of problems with your jaws, 
teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
43. Have you had difficulty doing your usual jobs because of problems with your teeth, 
mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
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Over the last month... 
44. Have you felt that your general health has worsened because of problems with your 
jaws, teeth, mouth or dentures? 
1234 
Never Hardly ever Occasionally Fairly often Very often 
45. Have you suffered any financial loss because of problems with your jaws, teeth, 
mouth or dentures? 
1234 s 
Never Hardly ever Occasionally Fairly often Very often 
46. Have you been unable to enjoy other people's company as much because of problems 
with your jaws, teeth, mouth or dentures? 
t234s 
Never Hardly ever Occasionally Fairly often Very often 
47. Have you felt that life in general was less satisfying because of problems with your 
jaws, teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
48. Have you been totally unable to function because of problems with your jaws, teeth, 
mouth or dentures? 
1234s 
Never Hardly ever Occasionally Fairly often Very often 
49. Have you been unable to work to your full capacity because of problems with your 
jaws, teeth, mouth or dentures? 
1234S 
Never Hardly ever Occasionally Fairly often Very often 
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The Multidimensional Pain 
Inventory 
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In the following 20 questions, you will be asked to describe your jaw pain and problems and 
how it affects your life. Under each question is a scale to record your answer. Read each 
question carefully and then circle a number on the scale under that question to indicate how 
that specific question applies to you. An example may help you to better understand how you 
should proceed to answer these questions. 
Example: How frequently do you read the newspaper? (Never) 0 12 3456 (Daily) 
If you never read the newspaper, you would want to circle the number 0. If you read the 
newspaper nearly every day, you would then circle the number 6. Thus, lower numbers should 
be used for less frequent newspaper reading, and higher numbers for more frequent reading. 
SECTION 1 
1. Rate the level of your pain at the present moment. 
(No pain) 01 23456 (Very intense pain) 
2. In general, how much does your pain or problem interfere with your day to day activities? 
(No interference) 01 23456 (Extreme interference) 
3. Since the time you developed a pain problem, how much has have your pain or problems 
changed your ability to work? 
(No change) 0 12 3456 (Extreme change) 
Check here, if you have retired for reasons other than your pain problem. Q 
4. How much have your pain or problems changed the amount of satisfaction or enjoyment 
you get from participating in social and recreational activities? 
(No change) 0 12 3456 (Extreme change) 
5. How supportive or helpful is your spouse (significant other) to you in relation to your pain 
or problems? 
(Not at all supportive) 01 23456 (Extremely supportive) 
6. Rate your overall mood during the past week. 
(Extremely low mood) 01 23456 (Extremely high mood) 
7. On the average, how severe have your pain or problems been during the last week? 
(No at all severe) 0 12 3456 (Extremely severe) 
8. How much have your pain or problems changed your ability to participate in recreational 
and other social activities? 
(No change) 0 12 3456 (Extreme change) 
9. How much has have your pain or problems changed the amount of satisfaction you get from family-related activities? 
(No change) 0 12 3456 (Extreme change) 
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10. How worried is your spouse (significant other) about you in relation to your pain 
problem? 
(Not at all worried) 0 12 3456 (Extremely worried) 
11. During the past week how much control do you feel that you have had over your life? 
(Not at all in control) 0 12 3456 (Extremely in control) 
12. How much suffering do you experience because of your pain? 
(No suffering) 01 23456 (Extreme suffering) 
13. How much have your pain changed or problems your marriage and other family 
relationships? 
(No change) 0 12 3456 
14. How much have your pain or problems changed the amount of satisfaction or enjoyment 
you get from work? 
(No change) 0 12 3456 (Extreme change) 
Check here, if you are not presently working Q. 
15. How attentive is your spouse (significant other) to your pain problem? 
(Not at all attentive) 01 23456 (Extremely attentive) 
16. During the past week how much do you feel that you've been able to deal with your 
problems? 
(Not at all) 01 23456 (Extremely well) 
17. How much have your pain or problems changed your ability to do household chores? 
(No change) 01 23456 (Extreme change) 
18. During the past week how irritable have you been? 
(Not at all irritable) 0 12 3456 (Extremely irritable) 
19. How much have your pain or problems changed your friendships with people other than 
your family? 
(No change) 01 23456 (Extreme change) 
20. During the past week how tense or anxious have you been? 
(Not at all tense or anxious) 0 12 3456 (extremely tense and anxious) 
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SECTION 2 
In this section, we are interested in knowing how your spouse (or significant other) responds 
to you when he or she knows that you are in pain. 
On the scale listed below each question, circle a number to indicate how often your spouse for 
significant other) responds to you in that particular way when you are in pain. Please answer 
all of the 14 questions. 
1. Ignores me. 
(Never) 0123456 (Very often) 
2. Asks me what he/she can do to help. 
(Never) 0 12 3456 (Very often) 
3. Reads to me. 
(Never) 0 12 3456 (Very often) 
4. Expresses irritation at me. 
(Never) 0 12 3456 (Very often) 
5. Takes over my jobs or duties. 
(Never) 01 23456 (Very often) 
6. Talks to me about something else to take my mind off the pain. 
(Never) 01 23456 (Very often) 
7. Expresses frustration at me. 
(Never) 0 12 3456 (Very often) 
8. Tries to get me to rest. 
(Never) 0123456 (Very often) 
9. Tries to involve me in some activity. 
(Never) 0 12 3456 (Very often) 
10. Expresses anger at me. 
(Never) 0 12 3456 (Very often) 
11. Gets me some pain medications. 
(Never) 0 12 3456 (Very often) 
12. Encourages me to work on a hobby. 
(Never) 0 12 3456 (Very often) 
13. Gets me something to eat or drink. 
(Never) 01 23456 (Very often) 
14. Turns on the T. V. to take my mind off my pain. 
(Never) 0 12 3456 (Very often) 
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SECTION 3 
Listed below are 18 common daily activities. Please indicate how often you do each of these 
activities by circling a number on the scale listed below each activity. Please complete all 18 
questions. 
1. Wash dishes. 
2. Mow the lawn. 
3. Go out to eat. 
4. Play cards or other games. 
S. Go grocery shopping. 
6. Work in the garden. 
7. Go to a movie. 
8. Visit friends. 
(Never) 0 12 3456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0 12 3456 (Very often) 
9. Help with the house cleaning. 
(Never) 0 12 3456 (Very often) 
10. Work on the car. 
11. Take a ride in a car. 
12. Visit relatives. 
13. Prepare a meal. 
14. Wash the car. 
15. Take a trip. 
16. Go to a park or beach. 
17. Do a load of laundry. 
(Never) 0 12 3456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0123456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0 12 3456 (Very often) 
(Never) 0123456 (Very often) 
18. Work on a needed house repair. 
(Never) 0 12 3456 (Very often) 
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Participant information sheet and 
consent form used in Study Three 
Appendices 
Pahcnts' copy 
Participants Information Sheet 
UNIVERSITY OF 
NEWCASTLE UPON TYNE 
Development of a Quality of Life Instrument (QOL) 
To Assess Treatment Outcome of Temporomandibular Disorders (TMD) 
How do your jaw problems impact on everyday life? 
How do things change over time and with treatment? 
You are being invited to take part in a research study, aimed to find out how your symptoms 
influence your life and how changes occur over time and with treatment. Before you decide to 
participate it is important that you understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with others 
if you wish. Ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
What is the purpose of the study? 
Temporomandibular disorders (TMD) are a set of uncomfortable and painful symptoms either 
in the jaw muscles, jaw joints or both. The aim of this study is to develop a questionnaire to 
measure the impact of these jaw problems on patients' quality of life before and after 
treatment. 
Why have I been chosen for the study? 
You have been diagnosed as having TMD jaw problems. You are, thus, invited to take part in 
this study. We are interested in investigating how your life is affected by TMD, and monitor 
changes occurring with treatment. Altogether 100 patients and 100 TMD free individuals will 
be invited to participate. 
What ivill happen to me if I take part and ivhat do I have to do? 
You are asked to complete a package of three questionnaires that evaluate your pain, 
discomfort and how your jaw problem impacts on your everyday life. The questionnaires will 
be given twice, now and 4 months later. On the second occasion, we may send you the 
questionnaires by post or ask you to fill them in the next time you attend this clinic. The 
questionnaires can usually be answered within 30 minutes. 
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Your records in the dental hospital will be examined by the researcher to confirm the 
diagnosis and to monitor your treatment progress. It is important to highlight that the study 
has no influence on the treatment you are receiving in any way. 
What are the possible benefits of taking part? 
The information gained from this study will be used to develop a method of measuring how 
TMD patients respond to different treatments. This will be an important contribution in 
determining which are the best treatments. We cannot guarantee that your participation in this 
study will be of direct benefit to you, and we are unable to pay a fee for your participation in 
this study. 
Do I have to take part? 
It is up to you to decide whether or not to take part in this study. If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect the standard of 
care you receive in any way. 
Will my taking part in this study be kept confidential? 
Your name will not be written on any of the questionnaires, but a code number; so that we 
have no direct way of knowing which package belongs to which person. 
Personal details and opinions you may express will be kept strictly confidential in accordance 
with the provisions of the Data Protection Act (1998). Your answers will be stored in a locked 
cupboard with access only available to the researcher who has asked you to participate. 
Afterwards, the questionnaires will be analysed, and the results of this study may be published 
in a scientific journal or presented at a research conference. In either case, your name will not 
be mentioned as part of the publication. 
Who is organising and funding the research? 
Who has reviewed the study? 
This study has been organised by the School of Dental Sciences - Newcastle University, and is being carried out as part of a clinical PhD programme. It has been reviewed by Newcastle 
& North Tyneside Local Research Ethics Committee I. 
Contact for Further Information 
If you have any questions please don't hesitate to ask either the researchers or the consultant 
in charge of the clinic**. 
We would like finally, to thank you for the time you spent reading this sheet, and, should you 
agree for participating in our study. It is much appreciated. 
Version 2 
Date: April 2004 
' Dr Adel MOUFTI. Dept. of Restorative Dentistry, The School of Dental Sciences, University of Newcastle 
upon Tyne, NE2 4BW 
Dr RW Wassell and Prof. JG Steele, Senior Lecturers & Honorary Consultants. Dept. of Restorative Dentistry, 
The School of Dental Sciences, University of Newcastle upon Tyne, NE2 4BW 
Tel 0191 222 7825 - Fax 0191222 6137 
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i; iiiii UNIVERSITY OF NEWCASTLE UPON TYNE 
Participants Information Sheet 
Development of a Quality of Life Instrument (QOL) 
To Assess Treatment Outcome of Temporomandibular Disorders (TMD) 
How do jaw problems impact on everyday life? 
You are being invited to take part in a research study, aimed to find out how jaw problems 
influence patients' everyday life. At the outset we should explain that we are looking for 
control subjects who do not have these problems so that we can establish a baseline for 
comparison. 
Before you decide it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and discuss 
it with others if you wish. Ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
What is the purpose of the study? 
Temporomandibular disorders (TMD) are a set of uncomfortable and painful symptoms either 
in the jaw muscles, jaw joints or both. The aim of this study is to develop a questionnaire to 
measure the impact of these jaw problems on patient's quality of life before and after 
treatment. 
Why have I been chosen for the study? 
The researcher has asked you a couple of questions and found that you do not have a jaw 
problem. You are, thus, invited to take part in this study as a control subject. Your 
participation will help us exploring the differences between TMD patients and people like you 
who do not suffer with jaw problems. Altogether 100 patients and 100 control subjects will be 
invited to participate. 
What ivill happen to me if I take part and what do I have to do? 
You are asked to answer two questionnaires that evaluate dental & oral pain and discomfort, 
and the impact of those on everyday life. The questionnaires contain items that apply to 
every one including TMD patients and control subjects who may have other problems 
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with their teeth and mouth. You will need to answer the questions as accurately as possible 
to enable us find out how you feel. In total, the questions can be answered within 30 minutes. 
What are the possible benefits of taking part? 
The information gained from this study will be used to develop a method of measuring how 
TMD patients respond to different treatments. This will be an important contribution in 
determining which are the best treatments. We cannot guarantee that your participation in this 
study will be of direct benefit to you, and we are unable to pay a fee for your participation in 
this study. 
Do I have to take part? 
It is up to you to decide whether or not to take part in this study. If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect access to 
treatment or standard of care in any way. 
Will my taking part in this study be kept confidential? 
Your name will not be written on any of the questionnaires, but a code number; so that we 
have no direct way of knowing which answer sheet belongs to which person. 
Personal details and opinions you may express will be kept strictly confidential in accordance 
with the provisions of the Data Protection Act (1998). Your answers will be stored in a locked 
cupboard with access only available to the researcher who has asked you to participate. 
Afterwards, the questionnaires will be analysed, and the results of this study may be published 
in a scientific journal or presented at a research conference. In either case, your name will not 
be mentioned as part of the publication. 
Who is organising and funding the research? 
Who has reviewed the study? 
This study has been organised by the School of Dental Sciences - Newcastle University, and 
is being carried out as part of a clinical PhD programme. It has been reviewed by Newcastle 
& North Tyneside Local Research Ethics Committee 1. 
Contact for Further Information 
If you have any questions please don't hesitate to ask either the researcher* or the consultant 
in charge of the clinic*. 
We would like finally, to thank you for the time you spent reading this sheet, and, should you 
agree, for participating in our study. It is much appreciated. 
Version 2 
Date: April 2004 
' Dr Adel MOUFTI. Dept. of Restorative Dentistry, The School of Dental Sciences, University of Newcastle 
upon Tyne, NE2 4BW 
Dr RW Wassell and Prof. JG Steele, Senior Lecturers & Honorary Consultants. Dept. of Restorative Dentistry, The School of Dental Sciences, University of Newcastle upon Tyne, NE2 4BW 
Tel 0191 222 7825 - Fax 0191222 6137 
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Appendices 
Participant identification number for this study:........... 
Ethics reference: 04100905/24 
Development of a Quality of Life Instrument (QOL) 
To Assess Treatment Outcomes of Temporomandibular Disorders (TMD) 
Name of Researcher: Air. Adel rtoufti 
Please initial box 
1. I confirm that I have read and understand the information sheet Version 2 dated April a 
2004 for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any a 
time without giving any reason, without my medical care or legal rights being 
affected. 
(For TMD patients only): Q 
3. I understand that sections of any of my medical notes may be looked at by 
responsible individuals from the Dental School in Newcastle University or from 
regulatory authorities where it is relevant to my taking part in research. I give 
permission for these individuals to have access to my records. 
CONSENT FORM 
4.1 agree to take part in the above study II 
Name of Participant Signature 
Researcher 
Date 
Date Signature 
1 for patient; 1 for researcher; 1 to be kept with hospital notes (for patients only). 
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Appendix 10 
Form used to check inclusion 
criteria for controls in Study Three 
Appendices 
University of Newcastle - School of Dental Sciences 2004 
Confidential 
Participant's code number aao [] 
Age QQ Sex Q 
Date El Ell] M[ []D 
[To be completed by the researcher] 
1- Do you have any pain or problems with your jaw muscles or joints for which you need 
treatment? 
Circle one choice: 
No I do not need treatment 
Yes I need treatment 
4 Proceed to next question 
- Not suitable as a control 
2- Are you under treatment for pain or problems with your jaw muscles or joints? 
Not under treatment - Proceed to next page 
Under treatment: Currently 4 Not suitable as a control 
Recently 4 Not suitable as a control 
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